.
s-block molecular entity - Ontology Report - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:s-block molecular entity
go back to main search page
Accession:CHEBI:33674 term browser browse the term
Definition:An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element.
Synonyms:related_synonym: s-block compounds;   s-block molecular entities


 Loading Annotations... 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
X

show annotations for term's descendants           Sort by:
(+)-artemisinin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I3 nuclear receptor subfamily 1 group I member 3 increases activity
multiple interactions
EXP artemisinin results in increased activity of NR1I3 protein; artemisinin results in increased activity of NR1I3 protein alternative form; artemisinin results in increased activity of NR1I3 protein mutant form
androstan-3-ol inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form]; artemisinin inhibits the reaction [androstan-3-ol results in decreased activity of NR1I3 protein alternative form]; artemisinin inhibits the reaction [Imidazoles results in decreased activity of NR1I3 protein alternative form]; Imidazoles inhibits the reaction [artemisinin results in increased activity of NR1I3 protein mutant form]
CTD PMID:21778469 PMID:27732639 NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
JBrowse link
(R)-adrenaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NPPA natriuretic peptide A affects abundance EXP NPPA protein affects the abundance of Epinephrine CTD PMID:2951327 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
JBrowse link
(R)-noradrenaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRB1 adrenoceptor beta 1 increases activity EXP Norepinephrine results in increased activity of ADRB1 protein CTD PMID:10344530 NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
JBrowse link
G ADRB2 adrenoceptor beta 2 multiple interactions EXP [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine CTD PMID:2884805 NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
JBrowse link
G NPPA natriuretic peptide A increases expression EXP Norepinephrine results in increased expression of NPPA protein CTD PMID:8952593 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions
increases activity
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased activity of PIK3CG protein]; [Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
G POMC proopiomelanocortin increases response to substance EXP POMC protein results in increased susceptibility to Norepinephrine CTD PMID:6279499 NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
JBrowse link
G PRKCZ protein kinase C zeta multiple interactions
increases phosphorylation
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Norepinephrine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
G REN renin increases activity EXP Norepinephrine results in increased activity of REN protein CTD PMID:8952593 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
1,2-dihexadecanoyl-sn-glycero-3-phosphocholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLCG1 phospholipase C gamma 1 decreases activity
multiple interactions
EXP 1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein
dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein]
CTD PMID:2001791 NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
JBrowse link
1,4-dithiothreitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP Dithiothreitol metabolite results in increased expression of HSPA5 protein CTD PMID:17416481 NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
JBrowse link
1,4-phenylenediamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP8 caspase 8 increases activity
multiple interactions
EXP 4-phenylenediamine results in increased activity of CASP8 protein
benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP8 protein]
CTD PMID:20156547 NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
JBrowse link
G CASP9 caspase 9 multiple interactions
increases activity
EXP benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP9 protein] CTD PMID:20156547 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
JBrowse link
1-stearoyl-2-arachidonoylphosphatidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLCG1 phospholipase C gamma 1 increases activity EXP 1-stearoyl-2-arachidonoylphosphatidic acid results in increased activity of PLCG1 protein CTD PMID:2001791 NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
JBrowse link
15-deoxy-Delta(12,14)-prostaglandin J2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HIF1A hypoxia inducible factor 1 subunit alpha increases expression EXP 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein CTD PMID:17658243 NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
JBrowse link
16-Ketoestrone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 increases reduction EXP DHRS4 protein results in increased reduction of 16-ketoestrone CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
17beta-estradiol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 affects transport EXP ABCC2 protein affects the transport of Estradiol CTD PMID:15507541 NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
JBrowse link
G ESR1 estrogen receptor 1 affects expression EXP Estradiol affects the expression of ESR1 protein CTD PMID:16483645 NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
JBrowse link
17beta-estradiol 17-glucosiduronic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of estradiol-17 beta-glucuronide CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
17beta-hydroxy-5alpha-androstan-3-one term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SOD2 superoxide dismutase 2 multiple interactions EXP Dihydrotestosterone promotes the reaction [Hydrogen Peroxide results in decreased activity of SOD2 protein] CTD PMID:16682413 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
JBrowse link
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP [Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin CTD PMID:20510202 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
2-hydroxypropanoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SCT secretin decreases abundance EXP SCT protein results in decreased abundance of Lactic Acid CTD PMID:2418308
2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SOD1 superoxide dismutase 1 affects response to substance EXP SOD1 protein affects the susceptibility to Nafenopin CTD PMID:6333936 NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
JBrowse link
3',5'-cyclic AMP term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G P2RY2 purinergic receptor P2Y2 multiple interactions EXP [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] CTD PMID:10604969 NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
JBrowse link
3'-CMP term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions EXP [delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate CTD PMID:2579070 NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
JBrowse link
3-isobutyl-1-methyl-7H-xanthine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator multiple interactions EXP [1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of CFTR protein CTD PMID:15161604 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
JBrowse link
3-oxo-5beta-cholanic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP 3-oxocholan-24-oic acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KCNH2 potassium voltage-gated channel subfamily H member 2 multiple interactions EXP Cisapride binds to and results in decreased activity of KCNH2 protein CTD PMID:12388285 NCBI chr16:15,009,031...15,041,786
Ensembl chr16:15,009,031...15,041,504
JBrowse link
4-nitrophenyl phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALPI alkaline phosphatase, intestinal increases chemical synthesis EXP ALPI protein results in increased chemical synthesis of nitrophenylphosphate CTD PMID:1495895 NCBI chr25:44,107,418...44,110,947 JBrowse link
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G P2RY2 purinergic receptor P2Y2 multiple interactions EXP pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] CTD PMID:10604969 NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
JBrowse link
5-Nitro-2-(3-phenylpropylamino)benzoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator decreases activity EXP 5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CFTR protein CTD PMID:15496164 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
JBrowse link
8-(4-chlorophenylthio)-cAMP term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator multiple interactions EXP [1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of CFTR protein CTD PMID:15161604 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
JBrowse link
9-cis-retinal term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 increases reduction EXP DHRS4 protein results in increased reduction of 9-cis-retinal CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
Acetyl tributyl citrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP 2-acetyltributylcitrate results in increased activity of NR1I2 protein CTD PMID:21742782 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
JBrowse link
acetylcholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KCNJ3 potassium inwardly rectifying channel subfamily J member 3 multiple interactions EXP Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium] CTD PMID:10666054 NCBI chr36:1,354,686...1,496,397
Ensembl chr36:1,354,678...1,493,766
JBrowse link
G KCNJ6 potassium inwardly rectifying channel subfamily J member 6 multiple interactions EXP Acetylcholine promotes the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium] CTD PMID:10666054 NCBI chr31:32,752,585...33,010,999
Ensembl chr31:32,755,899...32,934,478
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 multiple interactions EXP Acetylcholine results in increased phosphorylation of and results in increased activity of MAPK14 protein CTD PMID:9688607 NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
JBrowse link
acetylsalicylic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Aspirin results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
acyclovir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AVP arginine vasopressin decreases activity EXP Acyclovir results in decreased activity of AVP protein CTD PMID:2724137 NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
JBrowse link
aldosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGT angiotensinogen increases abundance EXP AGT results in increased abundance of Aldosterone CTD PMID:2831029 NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
JBrowse link
G POMC proopiomelanocortin increases abundance EXP POMC protein results in increased abundance of Aldosterone CTD PMID:2831029 NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
JBrowse link
all-trans-retinoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 increases activity EXP Tretinoin results in increased activity of CASP3 protein CTD PMID:16953078 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G CLDN1 claudin 1 multiple interactions
increases expression
EXP CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA]
Tretinoin results in increased expression of CLDN1 mRNA; Tretinoin results in increased expression of CLDN1 protein
CTD PMID:17035595 NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033
JBrowse link
G CLDN4 claudin 4 increases expression
multiple interactions
EXP Tretinoin results in increased expression of CLDN4 mRNA; Tretinoin results in increased expression of CLDN4 protein
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]
CTD PMID:17035595 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
G CYP26A1 cytochrome P450 family 26 subfamily A member 1 increases degradation
multiple interactions
EXP CYP26A1 protein results in increased degradation of Tretinoin
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN4 mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA]; CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD PMID:17035595 NCBI chr28:7,423,955...7,432,359
Ensembl chr28:7,428,772...7,432,370
JBrowse link
G NOS3 nitric oxide synthase 3 increases expression EXP Tretinoin results in increased expression of NOS3 mRNA; Tretinoin results in increased expression of NOS3 protein CTD PMID:17267746 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
JBrowse link
G OCLN occludin multiple interactions
increases expression
EXP CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of OCLN mRNA]
Tretinoin results in increased expression of OCLN mRNA; Tretinoin results in increased expression of OCLN protein
CTD PMID:17035595 NCBI chr 2:54,500,299...54,545,430
Ensembl chr 2:54,500,299...54,545,430
JBrowse link
G TJP1 tight junction protein 1 increases expression
multiple interactions
EXP Tretinoin results in increased expression of TJP1 mRNA; Tretinoin results in increased expression of TJP1 protein
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of TJP1 mRNA]
CTD PMID:17035595 NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
JBrowse link
allopurinol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLN phospholamban affects expression EXP Allopurinol affects the expression of PLN mRNA; Allopurinol affects the expression of PLN protein; Allopurinol affects the expression of PLN protein modified form CTD PMID:17071724 NCBI chr 1:58,579,095...58,590,541
Ensembl chr 1:58,579,145...58,590,535
JBrowse link
G SLC8A1 solute carrier family 8 member A1 affects expression EXP Allopurinol affects the expression of SLC8A1 mRNA; Allopurinol affects the expression of SLC8A1 protein CTD PMID:17071724 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
amiodarone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC8A1 solute carrier family 8 member A1 decreases activity EXP Amiodarone results in decreased activity of SLC8A1 protein CTD PMID:15288574 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
amlodipine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin increases expression EXP Amlodipine results in increased expression of REN protein CTD PMID:10218729 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
amosulalol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRB1 adrenoceptor beta 1 multiple interactions EXP amosulalol binds to and results in decreased activity of ADRB1 protein CTD PMID:6129981 NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
JBrowse link
G ADRB2 adrenoceptor beta 2 multiple interactions EXP amosulalol binds to and results in decreased activity of ADRB2 protein CTD PMID:6129981 NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
JBrowse link
amphotericin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL6 interleukin 6 multiple interactions
increases expression
EXP N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein] CTD PMID:24105867 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta increases expression
multiple interactions
EXP Amphotericin B results in increased expression of PRKACG protein
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein]
CTD PMID:24105867 NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146
JBrowse link
G REN renin decreases secretion EXP Amphotericin B results in decreased secretion of REN protein CTD PMID:7391978 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
G TNF tumor necrosis factor increases expression EXP Amphotericin B results in increased expression of TNF protein CTD PMID:24105867 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
arachidonic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G P2RY2 purinergic receptor P2Y2 multiple interactions EXP [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid] CTD PMID:10604969 NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
JBrowse link
Aroclor 1254 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [Chlorodiphenyl (54% Chlorine) binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [Chlorodiphenyl (54% Chlorine) binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
JBrowse link
arsane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation EXP Arsenic results in increased phosphorylation of MAPK1 protein CTD PMID:29306782 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation EXP Arsenic results in increased phosphorylation of MAPK3 protein CTD PMID:29306782 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
arsenous acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein CTD PMID:23236503 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein CTD PMID:23236503 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G SLC9A1 solute carrier family 9 member A1 increases expression EXP Arsenic Trioxide results in increased expression of SLC9A1 protein CTD PMID:23236503 NCBI chr 2:73,054,742...73,103,364
Ensembl chr 2:73,054,742...73,103,364
JBrowse link
atenolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin multiple interactions EXP Atenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein] CTD PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
atropine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase multiple interactions EXP [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein] CTD PMID:16915560 NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
JBrowse link
G SCT secretin multiple interactions EXP Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates] CTD PMID:3562434
barium(0) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KCNJ3 potassium inwardly rectifying channel subfamily J member 3 multiple interactions EXP Barium inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium] CTD PMID:10666054 NCBI chr36:1,354,686...1,496,397
Ensembl chr36:1,354,678...1,493,766
JBrowse link
G KCNJ6 potassium inwardly rectifying channel subfamily J member 6 multiple interactions EXP Barium inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium] CTD PMID:10666054 NCBI chr31:32,752,585...33,010,999
Ensembl chr31:32,755,899...32,934,478
JBrowse link
benazepril term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DES desmin decreases expression EXP benazepril results in decreased expression of DES mRNA CTD PMID:20137276 NCBI chr37:25,933,525...25,939,910
Ensembl chr37:25,933,455...25,940,985
JBrowse link
benzyl alcohol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C41 cytochrome P450 2C41 affects metabolic processing EXP CYP2C11 protein affects the metabolism of Benzyl Alcohol CTD PMID:8592870
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 affects metabolic processing EXP CYP2E1 protein affects the metabolism of Benzyl Alcohol CTD PMID:8592870 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
bis(2-ethylhexyl) phthalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I3 nuclear receptor subfamily 1 group I member 3 increases activity EXP Diethylhexyl Phthalate results in increased activity of NR1I3 protein CTD PMID:27732639 NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
JBrowse link
bisphenol A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AADAT aminoadipate aminotransferase decreases expression EXP bisphenol A results in decreased expression of AADAT mRNA CTD PMID:38866337 NCBI chr25:20,920,118...20,944,251
Ensembl chr25:20,920,139...20,945,387
JBrowse link
G ABCA8 ATP binding cassette subfamily A member 8 increases expression EXP bisphenol A results in increased expression of ABCA8 mRNA CTD PMID:38866337 NCBI chr 9:15,420,305...15,497,175 JBrowse link
G ABCA9 ATP binding cassette subfamily A member 9 increases expression EXP bisphenol A results in increased expression of ABCA9 mRNA CTD PMID:38866337 NCBI chr 9:15,515,462...15,574,890
Ensembl chr 9:15,420,835...15,783,045
JBrowse link
G ABCB4 ATP binding cassette subfamily B member 4 decreases expression EXP bisphenol A results in decreased expression of ABCB4 mRNA CTD PMID:38866337 NCBI chr14:13,542,610...13,614,334
Ensembl chr14:13,548,462...13,614,571
JBrowse link
G ABCC5 ATP binding cassette subfamily C member 5 increases expression EXP bisphenol A results in increased expression of ABCC5 mRNA CTD PMID:38866337 NCBI chr34:16,856,624...16,947,844
Ensembl chr34:16,856,633...16,946,422
JBrowse link
G ACACA acetyl-CoA carboxylase alpha increases expression EXP bisphenol A results in increased expression of ACACA mRNA CTD PMID:38866337 NCBI chr 9:36,904,204...37,188,096
Ensembl chr 9:36,905,293...37,187,892
JBrowse link
G ACAD9 acyl-CoA dehydrogenase family member 9 increases expression EXP bisphenol A results in increased expression of ACAD9 mRNA CTD PMID:38866337 NCBI chr20:3,155,754...3,205,307
Ensembl chr20:3,021,167...3,205,279
JBrowse link
G ACIN1 apoptotic chromatin condensation inducer 1 increases expression EXP bisphenol A results in increased expression of ACIN1 mRNA CTD PMID:38866337 NCBI chr 8:3,370,469...3,405,710
Ensembl chr 8:3,371,004...3,405,682
JBrowse link
G ACKR2 atypical chemokine receptor 2 increases expression EXP bisphenol A results in increased expression of ACKR2 mRNA CTD PMID:38866337 NCBI chr23:11,904,020...11,962,291
Ensembl chr23:11,960,981...11,962,135
JBrowse link
G ACP3 acid phosphatase 3 decreases expression EXP bisphenol A results in decreased expression of ACP3 mRNA CTD PMID:38866337 NCBI chr23:29,294,641...29,353,970
Ensembl chr23:29,294,843...29,343,499
JBrowse link
G ACSBG1 acyl-CoA synthetase bubblegum family member 1 increases expression EXP bisphenol A results in increased expression of ACSBG1 mRNA CTD PMID:38866337 NCBI chr 3:58,319,222...58,367,087
Ensembl chr 3:58,319,376...58,366,854
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 increases expression EXP bisphenol A results in increased expression of ACSL1 mRNA CTD PMID:38866337 NCBI chr16:45,735,675...45,806,235
Ensembl chr16:45,735,703...45,804,970
JBrowse link
G ACTN3 actinin alpha 3 increases expression EXP bisphenol A results in increased expression of ACTN3 mRNA CTD PMID:38866337 NCBI chr18:50,787,353...50,801,036
Ensembl chr18:50,787,353...50,801,197
JBrowse link
G ACVR2A activin A receptor type 2A increases expression EXP bisphenol A results in increased expression of ACVR2A mRNA CTD PMID:38866337 NCBI chr19:49,642,429...49,726,720
Ensembl chr19:49,641,219...49,723,420
JBrowse link
G ADA adenosine deaminase decreases expression EXP bisphenol A results in decreased expression of ADA mRNA CTD PMID:38866337 NCBI chr24:32,083,786...32,119,810
Ensembl chr24:32,083,931...32,111,160
JBrowse link
G ADGRG4 adhesion G protein-coupled receptor G4 decreases expression EXP bisphenol A results in decreased expression of ADGRG4 mRNA CTD PMID:38866337 NCBI chr  X:106,700,740...106,784,092
Ensembl chr  X:106,680,887...106,785,009
JBrowse link
G ADGRG6 adhesion G protein-coupled receptor G6 decreases expression EXP bisphenol A results in decreased expression of ADGRG6 mRNA CTD PMID:38866337 NCBI chr 1:33,967,783...34,106,950
Ensembl chr 1:33,969,268...34,104,228
JBrowse link
G ADHFE1 alcohol dehydrogenase iron containing 1 increases expression EXP bisphenol A results in increased expression of ADHFE1 mRNA CTD PMID:38866337 NCBI chr29:16,019,183...16,054,060
Ensembl chr29:16,019,246...16,050,535
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing increases expression EXP bisphenol A results in increased expression of ADIPOQ mRNA CTD PMID:38866337 NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
JBrowse link
G AGBL4 AGBL carboxypeptidase 4 increases expression EXP bisphenol A results in increased expression of AGBL4 mRNA CTD PMID:38866337 NCBI chr15:11,056,440...12,435,428
Ensembl chr15:11,056,447...12,435,448
JBrowse link
G AGFG2 ArfGAP with FG repeats 2 increases expression EXP bisphenol A results in increased expression of AGFG2 mRNA CTD PMID:38866337 NCBI chr 6:9,122,324...9,143,858
Ensembl chr 6:9,122,298...9,143,774
JBrowse link
G AHCYL1 adenosylhomocysteinase like 1 increases expression EXP bisphenol A results in increased expression of AHCYL1 mRNA CTD PMID:38866337 NCBI chr 6:41,945,224...41,983,917
Ensembl chr 6:41,946,974...41,985,643
JBrowse link
G AHCYL2 adenosylhomocysteinase like 2 increases expression EXP bisphenol A results in increased expression of AHCYL2 mRNA CTD PMID:38866337 NCBI chr14:7,347,173...7,509,113
Ensembl chr14:7,350,102...7,509,157
JBrowse link
G AIF1L allograft inflammatory factor 1 like decreases expression EXP bisphenol A results in decreased expression of AIF1L mRNA CTD PMID:38866337 NCBI chr 9:52,944,925...52,966,953
Ensembl chr 9:52,947,570...52,966,894
JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 increases expression EXP bisphenol A results in increased expression of AIFM1 mRNA CTD PMID:38866337 NCBI chr  X:101,275,027...101,307,551
Ensembl chr  X:101,275,017...101,307,367
JBrowse link
G AK1 adenylate kinase 1 decreases expression EXP bisphenol A results in decreased expression of AK1 mRNA CTD PMID:38866337 NCBI chr 9:55,539,179...55,548,132
Ensembl chr 9:55,539,260...55,548,132
JBrowse link
G AK5 adenylate kinase 5 decreases expression EXP bisphenol A results in decreased expression of AK5 mRNA CTD PMID:38866337 NCBI chr 6:69,282,997...69,520,903
Ensembl chr 6:69,284,288...69,521,020
JBrowse link
G AKAP8 A-kinase anchoring protein 8 increases expression EXP bisphenol A results in increased expression of AKAP8 mRNA CTD PMID:38866337 NCBI chr20:46,800,917...46,817,397
Ensembl chr20:46,800,872...46,817,397
JBrowse link
G AKIRIN1 akirin 1 decreases expression EXP bisphenol A results in decreased expression of AKIRIN1 mRNA CTD PMID:38866337 NCBI chr15:3,759,559...3,771,651
Ensembl chr15:3,763,374...3,771,551
JBrowse link
G ALAS1 5'-aminolevulinate synthase 1 increases expression EXP bisphenol A results in increased expression of ALAS1 mRNA CTD PMID:38866337 NCBI chr20:37,552,813...37,566,417
Ensembl chr20:37,552,814...37,566,638
JBrowse link
G ALCAM activated leukocyte cell adhesion molecule increases expression EXP bisphenol A results in increased expression of ALCAM mRNA CTD PMID:38866337 NCBI chr33:10,983,363...11,195,170
Ensembl chr33:10,983,363...11,370,085
JBrowse link
G ALDH18A1 aldehyde dehydrogenase 18 family member A1 decreases expression EXP bisphenol A results in decreased expression of ALDH18A1 mRNA CTD PMID:38866337 NCBI chr28:9,101,578...9,148,063
Ensembl chr28:9,102,282...9,147,992
JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 decreases expression EXP bisphenol A results in decreased expression of ALDH1L2 mRNA CTD PMID:38866337 NCBI chr10:33,310,523...33,365,677
Ensembl chr10:33,310,558...33,365,228
JBrowse link
G ALDH7A1 aldehyde dehydrogenase 7 family member A1 increases expression EXP bisphenol A results in increased expression of ALDH7A1 mRNA CTD PMID:38866337 NCBI chr11:15,828,581...15,878,556
Ensembl chr11:15,815,936...15,878,516
JBrowse link
G ALKBH2 alkB homolog 2, alpha-ketoglutarate dependent dioxygenase increases expression EXP bisphenol A results in increased expression of ALKBH2 mRNA CTD PMID:38866337 NCBI chr26:17,911,892...17,918,911
Ensembl chr26:17,911,763...17,917,788
JBrowse link
G ALS2 alsin Rho guanine nucleotide exchange factor ALS2 increases expression EXP bisphenol A results in increased expression of ALS2 mRNA CTD PMID:38866337 NCBI chr37:10,755,595...10,825,073
Ensembl chr37:10,756,515...10,812,292
JBrowse link
G AMMECR1 AMMECR nuclear protein 1 increases expression EXP bisphenol A results in increased expression of AMMECR1 mRNA CTD PMID:38866337 NCBI chr  X:83,401,728...83,517,565
Ensembl chr  X:83,406,049...83,517,498
JBrowse link
G ANGPT4 angiopoietin 4 increases expression EXP bisphenol A results in increased expression of ANGPT4 mRNA CTD PMID:38866337 NCBI chr24:20,021,625...20,068,805
Ensembl chr24:20,022,322...20,064,023
JBrowse link
G ANKRD50 ankyrin repeat domain containing 50 increases expression EXP bisphenol A results in increased expression of ANKRD50 mRNA CTD PMID:38866337 NCBI chr19:15,876,656...15,907,899
Ensembl chr19:15,876,566...15,903,238
JBrowse link
G ANKRD66 ankyrin repeat domain 66 increases expression EXP bisphenol A results in increased expression of ANKRD66 mRNA CTD PMID:38866337 NCBI chr12:14,919,258...14,933,438 JBrowse link
G ANTXR2 ANTXR cell adhesion molecule 2 increases expression EXP bisphenol A results in increased expression of ANTXR2 mRNA CTD PMID:38866337 NCBI chr32:4,143,407...4,302,194
Ensembl chr32:4,148,310...4,302,071
JBrowse link
G AOC2 amine oxidase copper containing 2 increases expression EXP bisphenol A results in increased expression of AOC2 mRNA CTD PMID:38866337 NCBI chr 9:20,180,005...20,185,863
Ensembl chr 9:20,180,205...20,185,103
JBrowse link
G AOPEP aminopeptidase O (putative) decreases expression EXP bisphenol A results in decreased expression of AOPEP mRNA CTD PMID:38866337 NCBI chr 1:71,770,687...72,009,374
Ensembl chr 1:71,677,068...72,009,395
JBrowse link
G AP1G1 adaptor related protein complex 1 subunit gamma 1 increases expression EXP bisphenol A results in increased expression of AP1G1 mRNA CTD PMID:38866337 NCBI chr 5:77,512,865...77,589,136
Ensembl chr 5:77,432,517...77,565,801
JBrowse link
G AP3M2 adaptor related protein complex 3 subunit mu 2 increases expression EXP bisphenol A results in increased expression of AP3M2 mRNA CTD PMID:38866337 NCBI chr16:23,500,988...23,518,193
Ensembl chr16:23,454,325...23,518,193
JBrowse link
G AP3S2 adaptor related protein complex 3 subunit sigma 2 decreases expression EXP bisphenol A results in decreased expression of AP3S2 mRNA CTD PMID:38866337 NCBI chr 3:52,807,462...52,865,290
Ensembl chr 3:52,807,462...52,865,245
JBrowse link
G APBB2 amyloid beta precursor protein binding family B member 2 increases expression EXP bisphenol A results in increased expression of APBB2 mRNA CTD PMID:38866337 NCBI chr 3:71,454,814...71,830,482
Ensembl chr 3:71,454,585...71,826,749
JBrowse link
G APEX2 apurinic/apyrimidinic endodeoxyribonuclease 2 increases expression EXP bisphenol A results in increased expression of APEX2 mRNA CTD PMID:38866337 NCBI chr  X:46,692,667...46,703,309
Ensembl chr  X:46,693,191...46,702,195
JBrowse link
G APLP2 amyloid beta precursor like protein 2 increases expression EXP bisphenol A results in increased expression of APLP2 mRNA CTD PMID:38866337 NCBI chr 5:4,704,155...4,786,011
Ensembl chr 5:4,705,491...4,786,079
JBrowse link
G APMAP adipocyte plasma membrane associated protein increases expression EXP bisphenol A results in increased expression of APMAP mRNA CTD PMID:38866337 NCBI chr23:1,148,662...1,183,997
Ensembl chr23:1,150,778...1,184,003
JBrowse link
G APOB apolipoprotein B decreases expression EXP bisphenol A results in decreased expression of APOB mRNA CTD PMID:38866337 NCBI chr17:15,877,937...15,916,032
Ensembl chr17:15,878,244...15,915,135
JBrowse link
G AQR aquarius intron-binding spliceosomal factor increases expression EXP bisphenol A results in increased expression of AQR mRNA CTD PMID:38866337 NCBI chr30:2,571,359...2,670,715
Ensembl chr30:2,571,554...2,670,597
JBrowse link
G ARFGEF2 ADP ribosylation factor guanine nucleotide exchange factor 2 increases expression EXP bisphenol A results in increased expression of ARFGEF2 mRNA CTD PMID:38866337 NCBI chr24:35,648,650...35,744,815
Ensembl chr24:35,648,431...35,744,584
JBrowse link
G ARHGDIB Rho GDP dissociation inhibitor beta decreases expression EXP bisphenol A results in decreased expression of ARHGDIB mRNA CTD PMID:38866337 NCBI chr27:31,662,817...31,681,951
Ensembl chr27:31,662,925...31,681,642
JBrowse link
G ARHGDIG Rho GDP dissociation inhibitor gamma decreases expression EXP bisphenol A results in decreased expression of ARHGDIG mRNA CTD PMID:38866337 NCBI chr 6:40,222,014...40,225,037
Ensembl chr 6:40,221,103...40,223,115
JBrowse link
G ARMH4 armadillo like helical domain containing 4 increases expression EXP bisphenol A results in increased expression of ARMH4 mRNA CTD PMID:38866337 NCBI chr 8:33,411,953...33,575,083
Ensembl chr 8:33,412,665...33,551,054
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator increases expression EXP bisphenol A results in increased expression of ARNT mRNA CTD PMID:38866337 Ensembl chr17:59,941,353...60,010,867
Ensembl chr17:59,941,353...60,010,867
JBrowse link
G ARRB1 arrestin beta 1 increases expression EXP bisphenol A results in increased expression of ARRB1 mRNA CTD PMID:38866337 NCBI chr21:23,261,020...23,304,448
Ensembl chr21:23,235,711...23,297,786
JBrowse link
G ASB9 ankyrin repeat and SOCS box containing 9 decreases expression EXP bisphenol A results in decreased expression of ASB9 mRNA CTD PMID:38866337 NCBI chr  X:11,505,941...11,533,335
Ensembl chr  X:11,505,941...11,533,135
JBrowse link
G ASH2L ASH2 like, histone lysine methyltransferase complex subunit increases expression EXP bisphenol A results in increased expression of ASH2L mRNA CTD PMID:38866337 NCBI chr16:27,334,419...27,366,994
Ensembl chr16:27,334,420...27,366,950
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) decreases expression EXP bisphenol A results in decreased expression of ASNS mRNA CTD PMID:38866337 NCBI chr14:22,718,020...22,734,109
Ensembl chr14:22,718,042...22,734,054
JBrowse link
G ATOSA atos homolog A increases expression EXP bisphenol A results in increased expression of FAM214A mRNA CTD PMID:38866337 NCBI chr30:18,221,930...18,308,390
Ensembl chr30:18,221,987...18,306,807
JBrowse link
G BATF3 basic leucine zipper ATF-like transcription factor 3 decreases expression EXP bisphenol A results in decreased expression of BATF3 mRNA CTD PMID:38866337 NCBI chr 7:10,843,859...10,854,269
Ensembl chr 7:10,843,850...10,857,847
JBrowse link
G BCAT1 branched chain amino acid transaminase 1 decreases expression EXP bisphenol A results in decreased expression of BCAT1 mRNA CTD PMID:38866337 NCBI chr27:22,536,297...22,643,350
Ensembl chr27:22,535,254...22,636,959
JBrowse link
G BCL2L2 BCL2 like 2 increases expression EXP bisphenol A results in increased expression of BCL2L2 mRNA CTD PMID:38866337 NCBI chr 8:3,569,335...3,573,922
Ensembl chr 8:3,569,399...3,586,070
JBrowse link
G BLID BH3-like motif containing, cell death inducer decreases expression EXP bisphenol A results in decreased expression of BLID mRNA CTD PMID:38866337 NCBI chr 5:11,989,993...12,083,555 JBrowse link
G BMP4 bone morphogenetic protein 4 increases expression EXP bisphenol A results in increased expression of BMP4 mRNA CTD PMID:38866337 NCBI chr 8:29,997,563...30,254,307
Ensembl chr 8:29,997,569...30,004,557
JBrowse link
G BMPR1B bone morphogenetic protein receptor type 1B decreases expression EXP bisphenol A results in decreased expression of BMPR1B mRNA CTD PMID:38866337 NCBI chr32:17,761,555...17,978,056
Ensembl chr32:17,870,904...18,016,444
JBrowse link
G BNIP3 BCL2 interacting protein 3 decreases expression EXP bisphenol A results in decreased expression of BNIP3 mRNA CTD PMID:38866337 NCBI chr28:40,037,681...40,050,499
Ensembl chr28:40,038,643...40,049,797
JBrowse link
G BSDC1 BSD domain containing 1 increases expression EXP bisphenol A results in increased expression of BSDC1 mRNA CTD PMID:38866337 NCBI chr 2:68,848,324...68,874,321
Ensembl chr 2:68,848,550...68,873,520
JBrowse link
G BSPRY B-box and SPRY domain containing increases expression EXP bisphenol A results in increased expression of BSPRY mRNA CTD PMID:38866337 NCBI chr11:67,702,949...67,726,809
Ensembl chr11:67,704,845...67,726,155
JBrowse link
G BTBD7 BTB domain containing 7 increases expression EXP bisphenol A results in increased expression of BTBD7 mRNA CTD PMID:38866337 NCBI chr 8:62,437,825...62,547,419
Ensembl chr 8:62,441,752...62,522,836
JBrowse link
G BTG1 BTG anti-proliferation factor 1 increases expression EXP bisphenol A results in increased expression of BTG1 mRNA CTD PMID:38866337 NCBI chr15:32,646,520...32,648,222
Ensembl chr15:32,647,472...32,647,762
JBrowse link
G BUB1B BUB1 mitotic checkpoint serine/threonine kinase B increases expression EXP bisphenol A results in increased expression of BUB1B mRNA CTD PMID:38866337 NCBI chr30:7,361,982...7,410,162
Ensembl chr30:7,322,912...7,438,052
JBrowse link
G BVES blood vessel epicardial substance decreases expression EXP bisphenol A results in decreased expression of BVES mRNA CTD PMID:38866337 NCBI chr12:62,542,274...62,581,110
Ensembl chr12:62,545,666...62,579,548
JBrowse link
G C10H12orf75 chromosome 10 C12orf75 homolog decreases expression EXP bisphenol A results in decreased expression of C10H12ORF75 mRNA CTD PMID:38866337 NCBI chr10:33,093,491...33,100,926 JBrowse link
G C13H8orf82 chromosome 13 C8orf82 homolog decreases expression EXP bisphenol A results in decreased expression of C13H8ORF82 mRNA CTD PMID:38866337
G C1QTNF2 C1q and TNF related 2 decreases expression EXP bisphenol A results in decreased expression of C1QTNF2 mRNA CTD PMID:38866337 NCBI chr 4:50,352,245...50,372,412
Ensembl chr 4:50,367,910...50,372,597
JBrowse link
G C1QTNF3 C1q and TNF related 3 decreases expression EXP bisphenol A results in decreased expression of C1QTNF3 mRNA CTD PMID:38866337 NCBI chr 4:73,787,706...73,817,410 JBrowse link
G C20H19orf44 chromosome 20 C19orf44 homolog increases expression EXP bisphenol A results in increased expression of C20H19ORF44 mRNA CTD PMID:38866337 NCBI chr20:46,019,750...46,039,201
Ensembl chr20:46,020,441...46,037,713
JBrowse link
G C26H12orf43 chromosome 26 C12orf43 homolog increases expression EXP bisphenol A results in increased expression of C26H12ORF43 mRNA CTD PMID:38866337 NCBI chr26:16,826,481...16,835,832
Ensembl chr26:16,826,489...16,835,796
JBrowse link
G C28H10orf90 chromosome 28 C10orf90 homolog decreases expression EXP bisphenol A results in decreased expression of C28H10ORF90 mRNA CTD PMID:38866337 NCBI chr28:35,514,489...35,721,091
Ensembl chr28:35,515,286...35,720,509
JBrowse link
G C30H15orf48 chromosome 30 C15orf48 homolog decreases expression EXP bisphenol A results in decreased expression of C30H15ORF48 mRNA CTD PMID:38866337 Ensembl chr30:11,795,781...11,800,915
Ensembl chr30:11,795,781...11,800,915
JBrowse link
G C5AR2 complement C5a receptor 2 increases expression EXP bisphenol A results in increased expression of C5AR2 mRNA CTD PMID:38866337 NCBI chr 1:108,644,195...108,652,628
Ensembl chr 1:108,644,945...108,645,958
JBrowse link
G C7 complement C7 increases expression EXP bisphenol A results in increased expression of C7 mRNA CTD PMID:38866337 NCBI chr 4:68,450,660...68,502,753
Ensembl chr 4:68,451,578...68,513,386
JBrowse link
G CA12 carbonic anhydrase 12 decreases expression EXP bisphenol A results in decreased expression of CA12 mRNA CTD PMID:38866337 NCBI chr30:27,903,460...27,957,162
Ensembl chr30:27,905,837...27,957,742
JBrowse link
G CA9 carbonic anhydrase 9 decreases expression EXP bisphenol A results in decreased expression of CA9 mRNA CTD PMID:38866337 NCBI chr11:52,205,619...52,211,281
Ensembl chr11:52,205,668...52,211,267
JBrowse link
G CALU calumenin decreases expression EXP bisphenol A results in decreased expression of CALU mRNA CTD PMID:38866337 NCBI chr14:7,869,946...7,899,302
Ensembl chr14:7,872,076...7,925,078
JBrowse link
G CANX calnexin increases expression EXP bisphenol A results in increased expression of CANX mRNA CTD PMID:38866337 NCBI chr11:1,966,612...1,998,620
Ensembl chr11:1,927,888...1,998,604
JBrowse link
G CARMIL1 capping protein regulator and myosin 1 linker 1 increases expression EXP bisphenol A results in increased expression of CARMIL1 mRNA CTD PMID:38866337 NCBI chr35:23,268,438...23,581,794
Ensembl chr35:23,268,723...23,581,403
JBrowse link
G CATSPER3 cation channel sperm associated 3 increases expression EXP bisphenol A results in increased expression of CATSPER3 mRNA CTD PMID:38866337 NCBI chr11:23,018,770...23,057,945
Ensembl chr11:23,021,663...23,052,820
JBrowse link
G CAV1 caveolin 1 decreases expression EXP bisphenol A results in decreased expression of CAV1 mRNA CTD PMID:38866337 NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
JBrowse link
G CCDC141 coiled-coil domain containing 141 increases expression EXP bisphenol A results in increased expression of CCDC141 mRNA CTD PMID:38866337 NCBI chr36:22,437,363...22,626,200
Ensembl chr36:22,492,052...22,625,957
JBrowse link
G CCDC170 coiled-coil domain containing 170 decreases expression EXP bisphenol A results in decreased expression of CCDC170 mRNA CTD PMID:38866337 NCBI chr 1:41,858,005...41,932,286
Ensembl chr 1:41,858,020...41,932,260
JBrowse link
G CCL2 C-C motif chemokine ligand 2 decreases expression EXP bisphenol A results in decreased expression of CCL2 mRNA CTD PMID:38866337 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G CCL4 chemokine (C-C motif) ligand 4 decreases expression EXP bisphenol A results in decreased expression of CCL4 mRNA CTD PMID:38866337 NCBI chr 9:37,681,342...37,682,691
Ensembl chr 9:37,676,966...37,710,209
JBrowse link
G CCL8 C-C motif chemokine ligand 8 decreases expression EXP bisphenol A results in decreased expression of CCL8 mRNA CTD PMID:38866337 NCBI chr 9:38,949,184...38,950,702
Ensembl chr 9:38,948,184...38,950,803
JBrowse link
G CCR4 C-C motif chemokine receptor 4 decreases expression EXP bisphenol A results in decreased expression of CCR4 mRNA CTD PMID:38866337 NCBI chr23:3,844,072...3,847,770
Ensembl chr23:3,844,173...3,845,255
JBrowse link
G CD109 CD109 molecule increases expression EXP bisphenol A results in increased expression of CD109 mRNA CTD PMID:38866337 NCBI chr12:35,712,589...35,839,153
Ensembl chr12:35,712,271...35,839,044
JBrowse link
G CD36 CD36 molecule (CD36 blood group) increases expression EXP bisphenol A results in increased expression of CD36 mRNA CTD PMID:38866337 NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
JBrowse link
G CD3G CD3 gamma subunit of T-cell receptor complex increases expression EXP bisphenol A results in increased expression of CD3G mRNA CTD PMID:38866337 NCBI chr 5:15,379,788...15,391,271
Ensembl chr 5:15,380,633...15,391,214
JBrowse link
G CD40 CD40 molecule decreases expression EXP bisphenol A results in decreased expression of CD40 mRNA CTD PMID:38866337 NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
JBrowse link
G CD55 CD55 molecule increases expression EXP bisphenol A results in increased expression of CD55 mRNA CTD PMID:38866337 NCBI chr 7:6,361,037...6,396,063
Ensembl chr 7:6,360,964...6,386,226
JBrowse link
G CD72 CD72 molecule decreases expression EXP bisphenol A results in decreased expression of CD72 mRNA CTD PMID:38866337 NCBI chr11:52,170,893...52,179,035
Ensembl chr11:52,170,893...52,178,301
JBrowse link
G CD74 CD74 molecule decreases expression EXP bisphenol A results in decreased expression of CD74 mRNA CTD PMID:38866337 NCBI chr 4:58,689,745...58,698,421
Ensembl chr 4:58,689,752...58,698,151
JBrowse link
G CDC42EP3 CDC42 effector protein 3 decreases expression EXP bisphenol A results in decreased expression of CDC42EP3 mRNA CTD PMID:38866337 NCBI chr17:29,949,452...29,973,008
Ensembl chr17:29,950,210...29,973,008
JBrowse link
G CDK8 cyclin dependent kinase 8 decreases expression EXP bisphenol A results in decreased expression of CDK8 mRNA CTD PMID:38866337 NCBI chr25:13,043,949...13,179,752
Ensembl chr25:13,045,343...13,179,656
JBrowse link
G CDKN1C cyclin dependent kinase inhibitor 1C increases expression EXP bisphenol A results in increased expression of CDKN1C mRNA CTD PMID:38866337 NCBI chr18:46,860,636...46,861,697 JBrowse link
G CDPF1 cysteine rich DPF motif domain containing 1 increases expression EXP bisphenol A results in increased expression of CDPF1 mRNA CTD PMID:38866337 NCBI chr10:19,928,742...19,950,129
Ensembl chr10:19,929,142...19,932,650
JBrowse link
G CDYL chromodomain Y like decreases expression EXP bisphenol A results in decreased expression of CDYL mRNA CTD PMID:38866337 NCBI chr35:4,844,757...5,074,967
Ensembl chr35:4,844,779...5,073,670
JBrowse link
G CELF2 CUGBP Elav-like family member 2 increases expression EXP bisphenol A results in increased expression of CELF2 mRNA CTD PMID:38866337 NCBI chr 2:25,003,810...25,818,264
Ensembl chr 2:25,004,580...25,520,136
JBrowse link
G CENPS centromere protein S decreases expression EXP bisphenol A results in decreased expression of CENPS mRNA CTD PMID:38866337 NCBI chr 2:85,379,378...85,389,175 JBrowse link
G CEP68 centrosomal protein 68 increases expression EXP bisphenol A results in increased expression of CEP68 mRNA CTD PMID:38866337 NCBI chr10:64,545,010...64,561,481
Ensembl chr10:64,538,166...64,561,684
JBrowse link
G CEP89 centrosomal protein 89 decreases expression EXP bisphenol A results in decreased expression of CEP89 mRNA CTD PMID:38866337 NCBI chr 1:119,124,042...119,197,394
Ensembl chr 1:119,123,933...119,197,338
JBrowse link
G CFAP119 cilia and flagella associated protein 119 increases expression EXP bisphenol A results in increased expression of CCDC189 mRNA CTD PMID:38866337 NCBI chr 6:17,414,722...17,419,011
Ensembl chr 6:17,414,809...17,418,848
JBrowse link
G CFAP53 cilia and flagella associated protein 53 increases expression EXP bisphenol A results in increased expression of CFAP53 mRNA CTD PMID:38866337 NCBI chr 7:78,612,226...78,649,518
Ensembl chr 7:78,597,746...78,651,472
JBrowse link
G CGREF1 cell growth regulator with EF-hand domain 1 decreases expression EXP bisphenol A results in decreased expression of CGREF1 mRNA CTD PMID:38866337 NCBI chr17:21,093,664...21,106,797 JBrowse link
G CHKA choline kinase alpha increases expression EXP bisphenol A results in increased expression of CHKA mRNA CTD PMID:38866337 NCBI chr18:49,717,512...49,784,653
Ensembl chr18:49,745,437...49,781,882
JBrowse link
G CHN1 chimerin 1 decreases expression EXP bisphenol A results in decreased expression of CHN1 mRNA CTD PMID:38866337 NCBI chr36:18,785,470...18,990,409
Ensembl chr36:18,786,073...18,980,993
JBrowse link
G CHRDL1 chordin like 1 increases expression EXP bisphenol A results in increased expression of CHRDL1 mRNA CTD PMID:38866337 NCBI chr  X:83,816,131...83,936,497
Ensembl chr  X:83,817,880...83,936,949
JBrowse link
G CIART circadian associated repressor of transcription increases expression EXP bisphenol A results in increased expression of CIART mRNA CTD PMID:38866337 NCBI chr17:59,524,715...59,529,535
Ensembl chr17:59,525,987...59,529,402
JBrowse link
G CIDEA cell death inducing DFFA like effector a increases expression EXP bisphenol A results in increased expression of CIDEA mRNA CTD PMID:38866337 NCBI chr 7:77,685,383...77,703,320
Ensembl chr 7:77,684,863...77,702,934
JBrowse link
G CIDEC cell death inducing DFFA like effector c increases expression EXP bisphenol A results in increased expression of CIDEC mRNA CTD PMID:38866337 NCBI chr20:8,386,334...8,402,076
Ensembl chr20:8,386,415...8,401,774
JBrowse link
G CILK1 ciliogenesis associated kinase 1 increases expression EXP bisphenol A results in increased expression of CILK1 mRNA CTD PMID:38866337 NCBI chr12:20,453,322...20,511,463
Ensembl chr12:20,450,834...20,511,673
JBrowse link
G CIPC CLOCK interacting pacemaker increases expression EXP bisphenol A results in increased expression of CIPC mRNA CTD PMID:38866337 NCBI chr 8:49,926,494...49,947,006
Ensembl chr 8:49,926,978...49,945,326
JBrowse link
G CITED1 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 increases expression EXP bisphenol A results in increased expression of CITED1 mRNA CTD PMID:38866337 NCBI chr  X:56,327,104...56,332,608
Ensembl chr  X:56,327,182...56,332,047
JBrowse link
G CLCC1 chloride channel CLIC like 1 decreases expression EXP bisphenol A results in decreased expression of CLCC1 mRNA CTD PMID:38866337 NCBI chr 6:42,807,432...42,829,317
Ensembl chr 6:42,807,064...42,829,273
JBrowse link
G CLDN1 claudin 1 increases expression EXP bisphenol A results in increased expression of CLDN1 mRNA CTD PMID:38866337 NCBI chr34:22,303,058...22,319,101
Ensembl chr34:22,303,850...22,319,033
JBrowse link
G CLMP CXADR like membrane protein decreases expression EXP bisphenol A results in decreased expression of CLMP mRNA CTD PMID:38866337 NCBI chr 5:11,255,054...11,289,578
Ensembl chr 5:11,267,038...11,286,682
JBrowse link
G CLSPN claspin increases expression EXP bisphenol A results in increased expression of CLSPN mRNA CTD PMID:38866337 NCBI chr15:6,400,084...6,430,295
Ensembl chr15:6,400,062...6,430,279
JBrowse link
G CMA1 chymase 1 decreases expression EXP bisphenol A results in decreased expression of CMA1 mRNA CTD PMID:38866337 NCBI chr 8:4,438,244...4,441,189
Ensembl chr 8:4,438,244...4,441,189
JBrowse link
G CNIH1 cornichon family AMPA receptor auxiliary protein 1 decreases expression EXP bisphenol A results in decreased expression of CNIH1 mRNA CTD PMID:38866337 NCBI chr 8:30,365,010...30,379,356
Ensembl chr 8:30,359,499...30,408,357
JBrowse link
G CNN1 calponin 1 decreases expression EXP bisphenol A results in decreased expression of CNN1 mRNA CTD PMID:38866337 NCBI chr20:49,830,859...49,837,432
Ensembl chr20:49,831,265...49,837,385
JBrowse link
G COLEC12 collectin subfamily member 12 increases expression EXP bisphenol A results in increased expression of COLEC12 mRNA CTD PMID:38866337 NCBI chr 7:67,192,191...67,373,524
Ensembl chr 7:67,193,626...67,372,755
JBrowse link
G COX19 cytochrome c oxidase assembly factor COX19 increases expression EXP bisphenol A results in increased expression of COX19 mRNA CTD PMID:38866337 NCBI chr 6:15,897,702...15,908,020
Ensembl chr 6:15,897,774...15,904,998
JBrowse link
G CPEB4 cytoplasmic polyadenylation element binding protein 4 increases expression EXP bisphenol A results in increased expression of CPEB4 mRNA CTD PMID:38866337 NCBI chr 4:38,604,065...38,665,200
Ensembl chr 4:38,607,948...38,664,821
JBrowse link
G CPM carboxypeptidase M decreases expression EXP bisphenol A results in decreased expression of CPM mRNA CTD PMID:38866337 NCBI chr10:10,968,830...10,999,887 JBrowse link
G CPQ carboxypeptidase Q decreases expression EXP bisphenol A results in decreased expression of CPQ mRNA CTD PMID:38866337 NCBI chr29:41,058,641...41,461,567
Ensembl chr29:41,058,306...41,461,563
JBrowse link
G CPXM1 carboxypeptidase X, M14 family member 1 increases expression EXP bisphenol A results in increased expression of CPXM1 mRNA CTD PMID:38866337 NCBI chr24:18,453,874...18,460,350
Ensembl chr24:18,453,712...18,461,738
JBrowse link
G CRABP2 cellular retinoic acid binding protein 2 decreases expression EXP bisphenol A results in decreased expression of CRABP2 mRNA CTD PMID:38866337 NCBI chr 7:41,277,580...41,282,158
Ensembl chr 7:41,277,644...41,281,833
JBrowse link
G CRB3 crumbs cell polarity complex component 3 decreases expression EXP bisphenol A results in decreased expression of CRB3 mRNA CTD PMID:38866337 NCBI chr20:53,717,844...53,722,127
Ensembl chr20:53,718,103...53,720,381
JBrowse link
G CRYBG3 crystallin beta-gamma domain containing 3 increases expression EXP bisphenol A results in increased expression of CRYBG3 mRNA CTD PMID:38866337 NCBI chr33:4,864,458...4,967,707
Ensembl chr33:4,864,458...4,966,440
JBrowse link
G CSF2 colony stimulating factor 2 decreases expression EXP bisphenol A results in decreased expression of CSF2 mRNA CTD PMID:38866337 NCBI chr11:20,342,880...20,346,959
Ensembl chr11:20,344,648...20,346,959
JBrowse link
G CSNK1G1 casein kinase 1 gamma 1 increases expression EXP bisphenol A results in increased expression of CSNK1G1 mRNA CTD PMID:38866337 NCBI chr30:28,661,726...28,832,193
Ensembl chr30:28,654,200...28,788,801
JBrowse link
G CTCF CCCTC-binding factor increases expression EXP bisphenol A results in increased expression of CTCF mRNA CTD PMID:38866337 NCBI chr 5:81,808,512...81,863,811
Ensembl chr 5:81,809,393...81,858,655
JBrowse link
G CTHRC1 collagen triple helix repeat containing 1 decreases expression EXP bisphenol A results in decreased expression of CTHRC1 mRNA CTD PMID:38866337 NCBI chr13:4,801,049...4,811,565
Ensembl chr13:4,805,577...4,811,282
JBrowse link
G CTNS cystinosin, lysosomal cystine transporter increases expression EXP bisphenol A results in increased expression of CTNS mRNA CTD PMID:38866337 NCBI chr 9:47,474,488...47,490,951
Ensembl chr 9:47,473,901...47,490,252
JBrowse link
G CTR9 CTR9 homolog, Paf1/RNA polymerase II complex component increases expression EXP bisphenol A results in increased expression of CTR9 mRNA CTD PMID:38866337 NCBI chr21:33,915,804...33,949,597
Ensembl chr21:33,915,772...33,949,103
JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 increases expression EXP bisphenol A results in increased expression of CXCL12 mRNA CTD PMID:38866337 NCBI chr28:2,895,916...2,903,543 JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 decreases expression EXP bisphenol A results in decreased expression of CXCL8 mRNA CTD PMID:38866337 NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
JBrowse link
G CYB5D1 cytochrome b5 domain containing 1 increases expression EXP bisphenol A results in increased expression of CYB5D1 mRNA CTD PMID:38866337 NCBI chr 5:32,714,130...32,721,719 JBrowse link
G CYGB cytoglobin increases expression EXP bisphenol A results in increased expression of CYGB mRNA CTD PMID:38866337 NCBI chr 9:4,191,114...4,201,438
Ensembl chr 9:4,184,959...4,200,164
JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 increases expression EXP bisphenol A results in increased expression of CYP27A1 mRNA CTD PMID:38866337 NCBI chr37:25,366,475...25,401,978
Ensembl chr37:25,366,472...25,401,509
JBrowse link
G CYP2J2 cytochrome P450 family 2 subfamily J member 2 decreases expression EXP bisphenol A results in decreased expression of CYP2J2 mRNA CTD PMID:38866337 NCBI chr 5:49,942,241...49,986,603
Ensembl chr 5:49,942,193...49,984,617
JBrowse link
G CYP2U1 cytochrome P450 family 2 subfamily U member 1 increases expression EXP bisphenol A results in increased expression of CYP2U1 mRNA CTD PMID:38866337 NCBI chr32:28,426,250...28,445,399
Ensembl chr32:28,438,173...28,444,383
JBrowse link
G CYSRT1 cysteine rich tail 1 decreases expression EXP bisphenol A results in decreased expression of CYSRT1 mRNA CTD PMID:38866337 NCBI chr 9:48,447,774...48,449,765 JBrowse link
G DAZAP2 DAZ associated protein 2 increases expression EXP bisphenol A results in increased expression of DAZAP2 mRNA CTD PMID:38866337 NCBI chr27:3,617,346...3,621,592
Ensembl chr27:3,615,726...3,621,587
JBrowse link
G DBNDD2 dysbindin domain containing 2 decreases expression EXP bisphenol A results in decreased expression of DBNDD2 mRNA CTD PMID:38866337 NCBI chr24:32,661,966...32,701,789
Ensembl chr24:32,697,708...32,700,203
JBrowse link
G DCLK1 doublecortin like kinase 1 decreases expression EXP bisphenol A results in decreased expression of DCLK1 mRNA CTD PMID:38866337 NCBI chr25:4,441,945...4,783,542
Ensembl chr25:4,345,771...4,778,047
JBrowse link
G DCPS decapping enzyme, scavenger decreases expression EXP bisphenol A results in decreased expression of DCPS mRNA CTD PMID:38866337 NCBI chr 5:8,168,887...8,212,582
Ensembl chr 5:8,172,313...8,212,832
JBrowse link
G DCX doublecortin increases expression EXP bisphenol A results in increased expression of DCX mRNA CTD PMID:38866337 NCBI chr  X:84,408,762...84,541,157
Ensembl chr  X:84,408,895...84,517,827
JBrowse link
G DDAH1 dimethylarginine dimethylaminohydrolase 1 decreases expression EXP bisphenol A results in decreased expression of DDAH1 mRNA CTD PMID:38866337 NCBI chr 6:62,548,852...62,683,687
Ensembl chr 6:62,549,152...62,683,729
JBrowse link
G DDIT4L DNA damage inducible transcript 4 like increases expression EXP bisphenol A results in increased expression of DDIT4L mRNA CTD PMID:38866337 NCBI chr32:22,062,630...22,067,364
Ensembl chr32:22,064,393...22,068,562
JBrowse link
G DDRGK1 DDRGK domain containing 1 increases expression EXP bisphenol A results in increased expression of DDRGK1 mRNA CTD PMID:38866337 NCBI chr24:18,085,865...18,098,868
Ensembl chr24:18,084,725...18,097,157
JBrowse link
G DEF6 DEF6 guanine nucleotide exchange factor increases expression EXP bisphenol A results in increased expression of DEF6 mRNA CTD PMID:38866337 NCBI chr12:4,463,512...4,483,544
Ensembl chr12:4,463,913...4,483,556
JBrowse link
G DENND2A DENN domain containing 2A increases expression EXP bisphenol A results in increased expression of DENND2A mRNA CTD PMID:38866337 NCBI chr16:8,377,389...8,479,791
Ensembl chr16:8,376,316...8,478,890
JBrowse link
G DENND5A DENN domain containing 5A increases expression EXP bisphenol A results in increased expression of DENND5A mRNA CTD PMID:38866337 NCBI chr21:32,465,278...32,573,381
Ensembl chr21:32,370,913...32,574,588
JBrowse link
G DHDH dihydrodiol dehydrogenase increases expression EXP bisphenol A results in increased expression of DHDH mRNA CTD PMID:38866337 NCBI chr 1:107,434,363...107,445,068
Ensembl chr 1:107,434,323...107,445,107
JBrowse link
G DHRS2 dehydrogenase/reductase 2 decreases expression EXP bisphenol A results in decreased expression of DHRS2 mRNA CTD PMID:38866337 NCBI chr 8:3,820,269...3,847,217
Ensembl chr 8:3,836,476...3,845,916
JBrowse link
G DHRS9 dehydrogenase/reductase 9 increases expression EXP bisphenol A results in increased expression of DHRS9 mRNA CTD PMID:38866337 NCBI chr36:13,859,935...13,881,432
Ensembl chr36:13,866,959...13,880,179
JBrowse link
G DIO1 iodothyronine deiodinase 1 decreases expression EXP bisphenol A results in decreased expression of DIO1 mRNA CTD PMID:38866337 NCBI chr 5:55,081,894...55,098,560
Ensembl chr 5:55,082,604...55,098,529
JBrowse link
G DKK1 dickkopf WNT signaling pathway inhibitor 1 decreases expression EXP bisphenol A results in decreased expression of DKK1 mRNA CTD PMID:38866337 NCBI chr26:35,697,428...35,701,596
Ensembl chr26:35,697,618...35,701,496
JBrowse link
G DKK2 dickkopf WNT signaling pathway inhibitor 2 increases expression EXP bisphenol A results in increased expression of DKK2 mRNA CTD PMID:38866337 NCBI chr32:27,548,877...27,647,039
Ensembl chr32:27,550,833...27,713,838
JBrowse link
G DLA-DOB major histocompatibility complex, class II, DO beta increases expression EXP bisphenol A results in increased expression of DLA-DOB mRNA CTD PMID:38866337 NCBI chr12:2,376,957...2,384,179
Ensembl chr12:2,378,126...2,432,303
JBrowse link
G DLST dihydrolipoamide S-succinyltransferase increases expression EXP bisphenol A results in increased expression of DLST mRNA CTD PMID:38866337 NCBI chr 8:48,003,730...48,025,001
Ensembl chr 8:48,002,211...48,024,999
JBrowse link
G DMXL2 Dmx like 2 increases expression EXP bisphenol A results in increased expression of DMXL2 mRNA CTD PMID:38866337 NCBI chr30:17,156,077...17,308,641
Ensembl chr30:17,156,791...17,308,803
JBrowse link
G DNAAF8 dynein axonemal assembly factor 8 increases expression EXP bisphenol A results in increased expression of DNAAF8 mRNA CTD PMID:38866337 NCBI chr 6:36,665,193...36,678,860
Ensembl chr 6:36,665,455...36,678,680
JBrowse link
G DNAJB13 DnaJ heat shock protein family (Hsp40) member B13 increases expression EXP bisphenol A results in increased expression of DNAJB13 mRNA CTD PMID:38866337 NCBI chr21:24,314,242...24,326,605
Ensembl chr21:24,314,248...24,338,253
JBrowse link
G DNAJB5 DnaJ heat shock protein family (Hsp40) member B5 decreases expression EXP bisphenol A results in decreased expression of DNAJB5 mRNA CTD PMID:38866337 NCBI chr11:51,587,728...51,596,911
Ensembl chr11:51,587,295...51,595,839
JBrowse link
G DNAJC13 DnaJ heat shock protein family (Hsp40) member C13 increases expression EXP bisphenol A results in increased expression of DNAJC13 mRNA CTD PMID:38866337 NCBI chr23:29,389,120...29,506,339
Ensembl chr23:29,389,979...29,506,343
JBrowse link
G DNAJC17 DnaJ heat shock protein family (Hsp40) member C17 decreases expression EXP bisphenol A results in decreased expression of DNAJC17 mRNA CTD PMID:38866337 NCBI chr30:7,904,519...7,945,222
Ensembl chr30:7,904,517...7,945,125
JBrowse link
G DNAL4 dynein axonemal light chain 4 increases expression EXP bisphenol A results in increased expression of DNAL4 mRNA CTD PMID:38866337 NCBI chr10:26,023,706...26,037,883
Ensembl chr10:26,030,850...26,035,690
JBrowse link
G DOCK9 dedicator of cytokinesis 9 increases expression EXP bisphenol A results in increased expression of DOCK9 mRNA CTD PMID:38866337 NCBI chr22:48,880,335...49,159,395
Ensembl chr22:48,880,972...49,159,711
JBrowse link
G DSE dermatan sulfate epimerase decreases expression EXP bisphenol A results in decreased expression of DSE mRNA CTD PMID:38866337 NCBI chr 1:56,787,809...56,868,037
Ensembl chr 1:56,787,256...56,867,716
JBrowse link
G DSEL dermatan sulfate epimerase like decreases expression EXP bisphenol A results in decreased expression of DSEL mRNA CTD PMID:38866337 NCBI chr 1:10,344,468...10,366,936 JBrowse link
G DSTYK dual serine/threonine and tyrosine protein kinase increases expression EXP bisphenol A results in increased expression of DSTYK mRNA CTD PMID:38866337 NCBI chr38:1,669,721...1,716,407
Ensembl chr38:1,669,726...1,716,254
JBrowse link
G DUSP13B dual specificity phosphatase 13B decreases expression EXP bisphenol A results in decreased expression of DUSP13 mRNA CTD PMID:38866337 NCBI chr 4:25,360,291...25,373,299
Ensembl chr 4:25,360,294...25,373,238
JBrowse link
G DUSP14 dual specificity phosphatase 14 decreases expression EXP bisphenol A results in decreased expression of DUSP14 mRNA CTD PMID:38866337 NCBI chr 9:37,253,305...37,277,320
Ensembl chr 9:37,276,084...37,276,680
JBrowse link
G DUSP6 dual specificity phosphatase 6 increases expression EXP bisphenol A results in increased expression of DUSP6 mRNA CTD PMID:38866337 NCBI chr15:30,322,472...30,327,221
Ensembl chr15:30,323,697...30,326,508
JBrowse link
G DYNC2H1 dynein cytoplasmic 2 heavy chain 1 increases expression EXP bisphenol A results in increased expression of DYNC2H1 mRNA CTD PMID:38866337 NCBI chr 5:28,566,604...28,727,416
Ensembl chr 5:28,388,664...28,727,334
JBrowse link
G DYNLT2 dynein light chain Tctex-type 2 increases expression EXP bisphenol A results in increased expression of DYNLT2 mRNA CTD PMID:38866337
G DYNLT4 dynein light chain Tctex-type 4 increases expression EXP bisphenol A results in increased expression of DYNLT4 mRNA CTD PMID:38866337 NCBI chr15:15,516,950...15,519,137
Ensembl chr15:15,518,369...15,519,028
JBrowse link
G EBF1 EBF transcription factor 1 increases expression EXP bisphenol A results in increased expression of EBF1 mRNA CTD PMID:38866337 NCBI chr 4:51,378,314...51,765,768
Ensembl chr 4:51,379,233...51,763,035
JBrowse link
G ECHDC2 enoyl-CoA hydratase domain containing 2 increases expression EXP bisphenol A results in increased expression of ECHDC2 mRNA CTD PMID:38866337 NCBI chr 5:55,972,116...55,991,573
Ensembl chr 5:55,972,004...55,991,531
JBrowse link
G EDN1 endothelin 1 decreases expression EXP bisphenol A results in decreased expression of EDN1 mRNA CTD PMID:38866337 NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
JBrowse link
G EDNRA endothelin receptor type A decreases expression EXP bisphenol A results in decreased expression of EDNRA mRNA CTD PMID:38866337 NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463
JBrowse link
G EEF2K eukaryotic elongation factor 2 kinase increases expression EXP bisphenol A results in increased expression of EEF2K mRNA CTD PMID:38866337 NCBI chr 6:23,368,296...23,433,853
Ensembl chr 6:23,371,546...23,433,929
JBrowse link
G EFEMP1 EGF containing fibulin extracellular matrix protein 1 increases expression EXP bisphenol A results in increased expression of EFEMP1 mRNA CTD PMID:38866337 NCBI chr10:56,632,801...56,694,872
Ensembl chr10:56,579,899...56,787,187
JBrowse link
G EGLN3 egl-9 family hypoxia inducible factor 3 decreases expression EXP bisphenol A results in decreased expression of EGLN3 mRNA CTD PMID:38866337 NCBI chr 8:12,873,755...12,901,728
Ensembl chr 8:12,875,387...12,901,709
JBrowse link
G EIF2B5 eukaryotic translation initiation factor 2B subunit epsilon increases expression EXP bisphenol A results in increased expression of EIF2B5 mRNA CTD PMID:38866337 NCBI chr34:17,038,163...17,047,390
Ensembl chr34:17,038,203...17,046,928
JBrowse link
G EIF5B eukaryotic translation initiation factor 5B increases expression EXP bisphenol A results in increased expression of EIF5B mRNA CTD PMID:38866337 NCBI chr10:43,247,536...43,342,754
Ensembl chr10:43,244,704...43,342,575
JBrowse link
G ELK4 ETS transcription factor ELK4 increases expression EXP bisphenol A results in increased expression of ELK4 mRNA CTD PMID:38866337 NCBI chr38:2,069,829...2,085,381
Ensembl chr38:2,078,008...2,125,069
JBrowse link
G ELOB elongin B decreases expression EXP bisphenol A results in decreased expression of ELOB mRNA CTD PMID:38866337 NCBI chr 6:38,311,082...38,314,502
Ensembl chr 6:38,311,082...38,314,508
JBrowse link
G ELOVL7 ELOVL fatty acid elongase 7 decreases expression EXP bisphenol A results in decreased expression of ELOVL7 mRNA CTD PMID:38866337 NCBI chr 2:47,406,323...47,482,113
Ensembl chr 2:47,296,656...47,482,064
JBrowse link
G EMC9 ER membrane protein complex subunit 9 increases expression EXP bisphenol A results in increased expression of EMC9 mRNA CTD PMID:38866337 NCBI chr 8:4,133,997...4,136,144
Ensembl chr 8:4,134,020...4,136,290
JBrowse link
G EML1 EMAP like 1 increases expression EXP bisphenol A results in increased expression of EML1 mRNA CTD PMID:38866337 NCBI chr 8:68,139,741...68,295,363
Ensembl chr 8:68,216,857...68,294,080
JBrowse link
G EMP1 epithelial membrane protein 1 decreases expression EXP bisphenol A results in decreased expression of EMP1 mRNA CTD PMID:38866337 NCBI chr27:33,177,874...33,199,048
Ensembl chr27:33,179,576...33,206,634
JBrowse link
G ENO1 enolase 1 decreases expression EXP bisphenol A results in decreased expression of ENO1 mRNA CTD PMID:38866337 NCBI chr 5:62,300,805...62,314,508
Ensembl chr 5:62,300,808...62,304,093
JBrowse link
G ENO3 enolase 3 decreases expression EXP bisphenol A results in decreased expression of ENO3 mRNA CTD PMID:38866337 NCBI chr 5:31,662,284...31,667,498
Ensembl chr 5:31,662,285...31,834,968
JBrowse link
G ENPP5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 increases expression EXP bisphenol A results in increased expression of ENPP5 mRNA CTD PMID:38866337 NCBI chr12:14,376,278...14,387,883
Ensembl chr12:14,377,565...14,385,171
JBrowse link
G ENTPD3 ectonucleoside triphosphate diphosphohydrolase 3 decreases expression EXP bisphenol A results in decreased expression of ENTPD3 mRNA CTD PMID:38866337 NCBI chr23:9,858,328...9,891,244
Ensembl chr23:9,858,764...9,890,483
JBrowse link
G EPB42 erythrocyte membrane protein band 4.2 increases expression EXP bisphenol A results in increased expression of EPB42 mRNA CTD PMID:38866337 NCBI chr30:10,065,352...10,085,021
Ensembl chr30:10,065,469...10,084,976
JBrowse link
G EPHX2 epoxide hydrolase 2 increases expression EXP bisphenol A results in increased expression of EPHX2 mRNA CTD PMID:38866337 NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
JBrowse link
G ERAP1 endoplasmic reticulum aminopeptidase 1 increases expression EXP bisphenol A results in increased expression of ERAP1 mRNA CTD PMID:38866337 NCBI chr 3:12,879,823...12,920,710
Ensembl chr 3:12,879,477...12,919,634
JBrowse link
G EREG epiregulin decreases expression EXP bisphenol A results in decreased expression of EREG mRNA CTD PMID:38866337 NCBI chr13:62,857,325...62,877,831
Ensembl chr13:62,856,709...62,877,760
JBrowse link
G ERLIN2 ER lipid raft associated 2 increases expression EXP bisphenol A results in increased expression of ERLIN2 mRNA CTD PMID:38866337 NCBI chr16:27,622,549...27,639,807
Ensembl chr16:27,625,417...27,639,202
JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha decreases expression EXP bisphenol A results in decreased expression of ERO1A mRNA CTD PMID:38866337 NCBI chr 8:28,864,642...28,913,864
Ensembl chr 8:28,864,925...28,914,368
JBrowse link
G EXTL3 exostosin like glycosyltransferase 3 increases expression EXP bisphenol A results in increased expression of EXTL3 mRNA CTD PMID:38866337 NCBI chr25:28,788,803...28,833,964
Ensembl chr25:28,790,506...28,937,647
JBrowse link
G F11R F11 receptor increases expression EXP bisphenol A results in increased expression of F11R mRNA CTD PMID:38866337 NCBI chr38:21,433,819...21,456,722
Ensembl chr38:21,451,952...21,454,959
JBrowse link
G F13A1 coagulation factor XIII A chain decreases expression EXP bisphenol A results in decreased expression of F13A1 mRNA CTD PMID:38866337 NCBI chr35:6,186,750...6,347,522
Ensembl chr35:6,187,235...6,349,773
JBrowse link
G F2RL1 F2R like trypsin receptor 1 decreases expression EXP bisphenol A results in decreased expression of F2RL1 mRNA CTD PMID:38866337 NCBI chr 3:29,801,119...29,810,006
Ensembl chr 3:29,800,211...29,810,180
JBrowse link
G F3 coagulation factor III, tissue factor decreases expression EXP bisphenol A results in decreased expression of F3 mRNA CTD PMID:38866337 NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
JBrowse link
G FABP4 fatty acid binding protein 4 increases expression EXP bisphenol A results in increased expression of FABP4 mRNA CTD PMID:38866337 NCBI chr29:28,651,550...28,656,255
Ensembl chr29:28,652,146...28,656,228
JBrowse link
G FABP5 fatty acid binding protein 5 increases expression EXP bisphenol A results in increased expression of FABP5 mRNA CTD PMID:38866337 NCBI chr29:28,488,818...28,492,698 JBrowse link
G FAH fumarylacetoacetate hydrolase decreases expression EXP bisphenol A results in decreased expression of FAH mRNA CTD PMID:38866337 NCBI chr 3:57,300,422...57,326,546
Ensembl chr 3:57,300,441...57,326,486
JBrowse link
G FAM107A family with sequence similarity 107 member A increases expression EXP bisphenol A results in increased expression of FAM107A mRNA CTD PMID:38866337 NCBI chr20:32,047,132...32,099,815
Ensembl chr20:32,047,625...32,097,585
JBrowse link
G FAM13C family with sequence similarity 13 member C decreases expression EXP bisphenol A results in decreased expression of FAM13C mRNA CTD PMID:38866337 NCBI chr 4:11,461,024...11,607,901
Ensembl chr 4:11,452,422...11,608,088
JBrowse link
G FAM180A family with sequence similarity 180 member A increases expression EXP bisphenol A results in increased expression of FAM180A mRNA CTD PMID:38866337 NCBI chr16:12,523,407...12,535,510
Ensembl chr16:12,523,467...12,535,885
JBrowse link
G FAM228B family with sequence similarity 228, member B increases expression EXP bisphenol A results in increased expression of FAM228B mRNA CTD PMID:38866337 NCBI chr17:18,579,700...18,615,602 JBrowse link
G FAM229A family with sequence similarity 229 member A increases expression EXP bisphenol A results in increased expression of FAM229A mRNA CTD PMID:38866337 NCBI chr 2:68,876,345...68,877,498
Ensembl chr 2:68,874,679...68,877,498
JBrowse link
G FAM234B family with sequence similarity 234 member B increases expression EXP bisphenol A results in increased expression of FAM234B mRNA CTD PMID:38866337 NCBI chr27:33,302,816...33,337,751
Ensembl chr27:33,305,231...33,337,577
JBrowse link
G FAM72A family with sequence similarity 72 member A decreases expression EXP bisphenol A results in decreased expression of FAM72A mRNA CTD PMID:38866337 NCBI chr38:2,495,180...2,505,313 JBrowse link
G FAM98A family with sequence similarity 98 member A increases expression EXP bisphenol A results in increased expression of FAM98A mRNA CTD PMID:38866337 NCBI chr17:26,671,254...26,687,808
Ensembl chr17:26,671,948...26,688,447
JBrowse link
G FANK1 fibronectin type III and ankyrin repeat domains 1 decreases expression EXP bisphenol A results in decreased expression of FANK1 mRNA CTD PMID:38866337 NCBI chr28:35,042,045...35,152,282
Ensembl chr28:35,095,689...35,152,276
JBrowse link
G FAXDC2 fatty acid hydroxylase domain containing 2 increases expression EXP bisphenol A results in increased expression of FAXDC2 mRNA CTD PMID:38866337 NCBI chr 4:54,962,585...54,988,756
Ensembl chr 4:54,970,733...54,991,204
JBrowse link
G FBH1 F-box DNA helicase 1 increases expression EXP bisphenol A results in increased expression of FBH1 mRNA CTD PMID:38866337 NCBI chr 2:30,047,994...30,095,761
Ensembl chr 2:30,048,567...30,095,696
JBrowse link
G FBLL1 fibrillarin like 1 increases expression EXP bisphenol A results in increased expression of FBLL1 mRNA CTD PMID:38866337 NCBI chr 4:43,214,112...43,216,772 JBrowse link
G FBXO21 F-box protein 21 increases expression EXP bisphenol A results in increased expression of FBXO21 mRNA CTD PMID:38866337 NCBI chr26:13,722,301...13,769,273
Ensembl chr26:13,725,137...13,769,234
JBrowse link
G FBXW12 F-box and WD repeat domain containing 12 decreases expression EXP bisphenol A results in decreased expression of FBXW12 mRNA CTD PMID:38866337 NCBI chr20:40,696,434...40,711,177
Ensembl chr20:40,696,502...40,710,720
JBrowse link
G FBXW2 F-box and WD repeat domain containing 2 increases expression EXP bisphenol A results in increased expression of FBXW2 mRNA CTD PMID:38866337 NCBI chr11:73,825,191...73,848,361
Ensembl chr11:73,824,590...73,849,249
JBrowse link
G FDFT1 farnesyl-diphosphate farnesyltransferase 1 increases expression EXP bisphenol A results in increased expression of FDFT1 mRNA CTD PMID:38866337 NCBI chr25:26,060,031...26,093,515
Ensembl chr25:26,060,386...26,093,582
JBrowse link
G FFAR3 free fatty acid receptor 3 increases expression EXP bisphenol A results in increased expression of FFAR3 mRNA CTD PMID:38866337 NCBI chr 1:117,251,604...117,257,048 JBrowse link
G FGD6 FYVE, RhoGEF and PH domain containing 6 increases expression EXP bisphenol A results in increased expression of FGD6 mRNA CTD PMID:38866337 NCBI chr15:35,050,993...35,162,421
Ensembl chr15:35,055,469...35,162,224
JBrowse link
G FGL1 fibrinogen like 1 increases expression EXP bisphenol A results in increased expression of FGL1 mRNA CTD PMID:38866337 NCBI chr16:41,161,314...41,191,282
Ensembl chr16:41,161,394...41,179,791
JBrowse link
G FHOD3 formin homology 2 domain containing 3 decreases expression EXP bisphenol A results in decreased expression of FHOD3 mRNA CTD PMID:38866337 NCBI chr 7:53,477,273...53,933,532
Ensembl chr 7:53,478,930...53,934,331
JBrowse link
G FICD FIC domain protein adenylyltransferase decreases expression EXP bisphenol A results in decreased expression of FICD mRNA CTD PMID:38866337 NCBI chr26:18,347,393...18,353,081
Ensembl chr26:18,348,526...18,353,665
JBrowse link
G FKBP11 FKBP prolyl isomerase 11 decreases expression EXP bisphenol A results in decreased expression of FKBP11 mRNA CTD PMID:38866337 NCBI chr27:5,636,643...5,639,521
Ensembl chr27:5,636,627...5,639,509
JBrowse link
G FKBP5 FKBP prolyl isomerase 5 increases expression EXP bisphenol A results in increased expression of FKBP5 mRNA CTD PMID:38866337 NCBI chr12:4,724,668...4,833,691
Ensembl chr12:4,727,497...4,833,323
JBrowse link
G FRMD3 FERM domain containing 3 increases expression EXP bisphenol A results in increased expression of FRMD3 mRNA CTD PMID:38866337 NCBI chr 1:75,893,014...76,183,234
Ensembl chr 1:75,893,008...76,183,228
JBrowse link
G FRYL FRY like transcription coactivator increases expression EXP bisphenol A results in increased expression of FRYL mRNA CTD PMID:38866337 NCBI chr13:44,307,293...44,565,449
Ensembl chr13:44,307,859...44,527,170
JBrowse link
G FXYD4 FXYD domain containing ion transport regulator 4 decreases expression EXP bisphenol A results in decreased expression of FXYD4 mRNA CTD PMID:38866337 NCBI chr28:3,685,057...3,690,388
Ensembl chr28:3,685,151...3,687,652
JBrowse link
G FZD6 frizzled class receptor 6 decreases expression EXP bisphenol A results in decreased expression of FZD6 mRNA CTD PMID:38866337 NCBI chr13:4,732,541...4,771,294
Ensembl chr13:4,733,017...4,772,115
JBrowse link
G GADD45B growth arrest and DNA damage inducible beta decreases expression EXP bisphenol A results in decreased expression of GADD45B mRNA CTD PMID:38866337 NCBI chr20:56,627,915...56,629,960
Ensembl chr20:56,628,485...56,629,730
JBrowse link
G GAP43 growth associated protein 43 decreases expression EXP bisphenol A results in decreased expression of GAP43 mRNA CTD PMID:38866337 NCBI chr33:19,668,491...19,770,509
Ensembl chr33:19,656,835...19,770,408
JBrowse link
G GAPVD1 GTPase activating protein and VPS9 domains 1 increases expression EXP bisphenol A results in increased expression of GAPVD1 mRNA CTD PMID:38866337 NCBI chr 9:57,751,988...57,836,526
Ensembl chr 9:57,756,234...57,802,174
JBrowse link
G GAR1 GAR1 ribonucleoprotein increases expression EXP bisphenol A results in increased expression of GAR1 mRNA CTD PMID:38866337 NCBI chr32:29,995,710...30,004,545
Ensembl chr32:29,996,148...30,004,536
JBrowse link
G GARS1 glycyl-tRNA synthetase 1 decreases expression EXP bisphenol A results in decreased expression of GARS1 mRNA CTD PMID:38866337 NCBI chr14:43,308,274...43,351,999
Ensembl chr14:43,308,152...43,396,487
JBrowse link
G GCNT1 glucosaminyl (N-acetyl) transferase 1 decreases expression EXP bisphenol A results in decreased expression of GCNT1 mRNA CTD PMID:38866337 NCBI chr 1:81,985,519...82,017,420 JBrowse link
G GCNT4 glucosaminyl (N-acetyl) transferase 4 decreases expression EXP bisphenol A results in decreased expression of GCNT4 mRNA CTD PMID:38866337 NCBI chr 3:31,198,656...31,222,523
Ensembl chr 3:31,217,562...31,218,926
JBrowse link
G GDA guanine deaminase increases expression EXP bisphenol A results in increased expression of GDA mRNA CTD PMID:38866337 NCBI chr 1:85,506,598...85,586,212
Ensembl chr 1:85,444,917...85,586,163
JBrowse link
G GEMIN5 gem nuclear organelle associated protein 5 increases expression EXP bisphenol A results in increased expression of GEMIN5 mRNA CTD PMID:38866337 NCBI chr 4:54,894,747...54,934,869
Ensembl chr 4:54,894,784...54,934,986
JBrowse link
G GGA2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 increases expression EXP bisphenol A results in increased expression of GGA2 mRNA CTD PMID:38866337 NCBI chr 6:22,309,565...22,342,469
Ensembl chr 6:22,309,537...22,341,632
JBrowse link
G GLB1L galactosidase beta 1 like increases expression EXP bisphenol A results in increased expression of GLB1L mRNA CTD PMID:38866337 NCBI chr37:25,783,837...25,793,968
Ensembl chr37:25,783,816...25,792,589
JBrowse link
G GLCE glucuronic acid epimerase increases expression EXP bisphenol A results in increased expression of GLCE mRNA CTD PMID:38866337 NCBI chr30:33,093,318...33,208,754
Ensembl chr30:33,110,947...33,206,095
JBrowse link
G GLS glutaminase decreases expression EXP bisphenol A results in decreased expression of GLS mRNA CTD PMID:38866337 NCBI chr37:1,433,640...1,508,347
Ensembl chr37:1,433,398...1,508,146
JBrowse link
G GLS2 glutaminase 2 increases expression EXP bisphenol A results in increased expression of GLS2 mRNA CTD PMID:38866337 NCBI chr10:722,105...737,857
Ensembl chr10:722,202...737,753
JBrowse link
G GLUL glutamate-ammonia ligase increases expression EXP bisphenol A results in increased expression of GLUL mRNA CTD PMID:38866337 NCBI chr 7:15,730,898...15,740,241
Ensembl chr 7:15,730,898...15,740,241
JBrowse link
G GMPR guanosine monophosphate reductase decreases expression EXP bisphenol A results in decreased expression of GMPR mRNA CTD PMID:38866337 NCBI chr35:15,400,937...15,449,157
Ensembl chr35:15,401,003...15,448,022
JBrowse link
G GNG2 G protein subunit gamma 2 decreases expression EXP bisphenol A results in decreased expression of GNG2 mRNA CTD PMID:38866337 NCBI chr 8:28,080,699...28,194,464
Ensembl chr 8:28,049,195...28,191,358
JBrowse link
G GNG3 G protein subunit gamma 3 increases expression EXP bisphenol A results in increased expression of GNG3 mRNA CTD PMID:38866337 NCBI chr18:53,958,798...53,960,363
Ensembl chr18:53,958,804...53,960,284
JBrowse link
G GNG8 G protein subunit gamma 8 decreases expression EXP bisphenol A results in decreased expression of GNG8 mRNA CTD PMID:38866337 NCBI chr 1:109,266,884...109,268,515
Ensembl chr 1:109,268,056...109,268,453
JBrowse link
G GNGT1 G protein subunit gamma transducin 1 decreases expression EXP bisphenol A results in decreased expression of GNGT1 mRNA CTD PMID:38866337 NCBI chr14:19,081,676...19,420,261
Ensembl chr14:19,415,510...19,420,255
JBrowse link
G GNMT glycine N-methyltransferase increases expression EXP bisphenol A results in increased expression of GNMT mRNA CTD PMID:38866337 NCBI chr12:11,500,363...11,503,075
Ensembl chr12:11,500,392...11,503,481
JBrowse link
G GOLGA2 golgin A2 increases expression EXP bisphenol A results in increased expression of GOLGA2 mRNA CTD PMID:38866337 NCBI chr 9:55,234,836...55,251,698 JBrowse link
G GOLIM4 golgi integral membrane protein 4 increases expression EXP bisphenol A results in increased expression of GOLIM4 mRNA CTD PMID:38866337 NCBI chr34:32,800,297...32,879,065
Ensembl chr34:32,801,676...32,879,515
JBrowse link
G GPD1L glycerol-3-phosphate dehydrogenase 1 like increases expression EXP bisphenol A results in increased expression of GPD1L mRNA CTD PMID:38866337 NCBI chr23:12,568,914...12,631,903
Ensembl chr23:12,522,398...12,632,447
JBrowse link
G GPNMB glycoprotein nmb increases expression EXP bisphenol A results in increased expression of GPNMB mRNA CTD PMID:38866337 NCBI chr14:36,919,184...36,947,023
Ensembl chr14:36,919,296...36,946,643
JBrowse link
G GPR137B G protein-coupled receptor 137B increases expression EXP bisphenol A results in increased expression of GPR137B mRNA CTD PMID:38866337 NCBI chr 4:3,819,338...3,864,690
Ensembl chr 4:3,825,602...3,864,780
JBrowse link
G GPR20 G protein-coupled receptor 20 increases expression EXP bisphenol A results in increased expression of GPR20 mRNA CTD PMID:38866337 NCBI chr13:35,820,979...35,835,553 JBrowse link
G GPR85 G protein-coupled receptor 85 decreases expression EXP bisphenol A results in decreased expression of GPR85 mRNA CTD PMID:38866337 NCBI chr14:52,567,685...52,572,600
Ensembl chr14:52,569,632...52,570,744
JBrowse link
G GREM1 gremlin 1, DAN family BMP antagonist decreases expression EXP bisphenol A results in decreased expression of GREM1 mRNA CTD PMID:38866337 NCBI chr30:2,219,535...2,231,868
Ensembl chr30:2,222,898...2,225,418
JBrowse link
G GSAP gamma-secretase activating protein decreases expression EXP bisphenol A results in decreased expression of GSAP mRNA CTD PMID:38866337 NCBI chr18:17,406,903...17,479,429
Ensembl chr18:17,407,532...17,484,688
JBrowse link
G GSS glutathione synthetase increases expression EXP bisphenol A results in increased expression of GSS mRNA CTD PMID:38866337 NCBI chr24:23,973,807...24,000,281
Ensembl chr24:23,901,045...23,997,286
JBrowse link
G GSTT2B glutathione S-transferase theta 2B increases expression EXP bisphenol A results in increased expression of GSTT2B mRNA CTD PMID:38866337 NCBI chr26:28,573,435...28,580,846 JBrowse link
G GTF3C4 general transcription factor IIIC subunit 4 increases expression EXP bisphenol A results in increased expression of GTF3C4 mRNA CTD PMID:38866337 NCBI chr 9:51,602,025...51,630,139
Ensembl chr 9:51,606,235...51,630,637
JBrowse link
G GYPC glycophorin C increases expression EXP bisphenol A results in increased expression of GYPC mRNA CTD PMID:38866337 NCBI chr19:23,946,413...23,988,970
Ensembl chr19:23,946,494...23,988,415
JBrowse link
G H1-5 H1.5 linker histone, cluster member increases expression EXP bisphenol A results in increased expression of H1-5 mRNA CTD PMID:38866337 NCBI chr35:25,045,883...25,046,775
Ensembl chr35:25,046,023...25,046,703
JBrowse link
G H2AC13 H2A clustered histone 13 increases expression EXP bisphenol A results in increased expression of H2AC11 mRNA CTD PMID:38866337 NCBI chr35:25,000,243...25,001,749
Ensembl chr35:25,000,401...25,000,793
JBrowse link
G H2AC19 H2A clustered histone 19 decreases expression EXP bisphenol A results in decreased expression of H2AC15 mRNA CTD PMID:38866337 NCBI chr17:59,156,821...59,157,523
Ensembl chr17:59,147,111...59,147,503
JBrowse link
G H2AC25 H2A clustered histone 25 increases expression EXP bisphenol A results in increased expression of H2AC25 mRNA CTD PMID:38866337 NCBI chr14:604,444...605,584
Ensembl chr14:604,505...604,897
JBrowse link
G HACD1 3-hydroxyacyl-CoA dehydratase 1 decreases expression EXP bisphenol A results in decreased expression of HACD1 mRNA CTD PMID:38866337 NCBI chr 2:19,362,488...19,383,090
Ensembl chr 2:19,362,403...19,383,090
JBrowse link
G HACD2 3-hydroxyacyl-CoA dehydratase 2 decreases expression EXP bisphenol A results in decreased expression of HACD2 mRNA CTD PMID:38866337 NCBI chr33:26,530,221...26,643,477
Ensembl chr33:26,533,114...26,637,035
JBrowse link
G HAUS8 HAUS augmin like complex subunit 8 decreases expression EXP bisphenol A results in decreased expression of HAUS8 mRNA CTD PMID:38866337 NCBI chr20:45,600,120...45,622,569
Ensembl chr20:45,600,135...45,622,566
JBrowse link
G HCAR1 hydroxycarboxylic acid receptor 1 increases expression EXP bisphenol A results in increased expression of HCAR1 mRNA CTD PMID:38866337 NCBI chr26:6,734,818...6,735,906
Ensembl chr26:6,734,818...6,735,906
JBrowse link
G HCAR2 hydroxycarboxylic acid receptor 2 increases expression EXP bisphenol A results in increased expression of HCAR2 mRNA CTD PMID:38866337 NCBI chr26:6,748,415...6,750,509 JBrowse link
G HCN3 hyperpolarization activated cyclic nucleotide gated potassium channel 3 increases expression EXP bisphenol A results in increased expression of HCN3 mRNA CTD PMID:38866337 NCBI chr 7:42,272,756...42,282,770
Ensembl chr 7:42,273,571...42,282,595
JBrowse link
G HDHD3 haloacid dehalogenase like hydrolase domain containing 3 decreases expression EXP bisphenol A results in decreased expression of HDHD3 mRNA CTD PMID:38866337 NCBI chr11:67,729,133...67,731,956
Ensembl chr11:67,729,275...67,730,030
JBrowse link
G HEATR1 HEAT repeat containing 1 increases expression EXP bisphenol A results in increased expression of HEATR1 mRNA CTD PMID:38866337 NCBI chr 4:3,501,191...3,547,212
Ensembl chr 4:3,501,571...3,547,100
JBrowse link
G HECTD1 HECT domain E3 ubiquitin protein ligase 1 increases expression EXP bisphenol A results in increased expression of HECTD1 mRNA CTD PMID:38866337 NCBI chr 8:10,399,183...10,493,074
Ensembl chr 8:10,400,604...10,491,247
JBrowse link
G HEPHL1 hephaestin like 1 decreases expression EXP bisphenol A results in decreased expression of HEPHL1 mRNA CTD PMID:38866337 NCBI chr21:6,720,472...6,813,946
Ensembl chr21:6,716,562...6,814,486
JBrowse link
G HIF3A hypoxia inducible factor 3 subunit alpha increases expression EXP bisphenol A results in increased expression of HIF3A mRNA CTD PMID:38866337 NCBI chr 1:109,479,456...109,504,271
Ensembl chr 1:109,479,128...109,504,274
JBrowse link
G HILPDA hypoxia inducible lipid droplet associated decreases expression EXP bisphenol A results in decreased expression of HILPDA mRNA CTD PMID:38866337 NCBI chr14:7,957,811...7,959,878 JBrowse link
G HLF HLF transcription factor, PAR bZIP family member increases expression EXP bisphenol A results in increased expression of HLF mRNA CTD PMID:38866337 NCBI chr 9:30,321,090...30,380,480
Ensembl chr 9:30,327,495...30,377,175
JBrowse link
G HMG20A high mobility group 20A increases expression EXP bisphenol A results in increased expression of HMG20A mRNA CTD PMID:38866337 NCBI chr30:38,839,520...38,916,952
Ensembl chr30:38,845,415...38,864,148
JBrowse link
G HMGA2 high mobility group AT-hook 2 increases expression EXP bisphenol A results in increased expression of HMGA2 mRNA CTD PMID:38866337 NCBI chr10:8,348,101...8,491,435 JBrowse link
G HMGB3 high mobility group box 3 increases expression EXP bisphenol A results in increased expression of HMGB3 mRNA CTD PMID:38866337 NCBI chr  X:119,152,166...119,159,803
Ensembl chr  X:119,155,786...119,159,814
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression EXP bisphenol A results in increased expression of HMGCS1 mRNA CTD PMID:38866337 NCBI chr 4:66,633,706...66,654,005
Ensembl chr 4:66,633,572...66,652,196
JBrowse link
G HNF4A hepatocyte nuclear factor 4 alpha increases expression EXP bisphenol A results in increased expression of HNF4A mRNA CTD PMID:38866337 NCBI chr24:31,847,864...31,908,337
Ensembl chr24:31,847,961...31,905,916
JBrowse link
G HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 increases expression EXP bisphenol A results in increased expression of HNRNPA2B1 mRNA CTD PMID:38866337 NCBI chr14:39,498,805...39,509,034
Ensembl chr14:39,500,897...39,508,952
JBrowse link
G HNRNPA3 heterogeneous nuclear ribonucleoprotein A3 increases expression EXP bisphenol A results in increased expression of HNRNPA3 mRNA CTD PMID:38866337 NCBI chr36:20,974,541...20,983,972
Ensembl chr36:20,974,648...20,980,137
JBrowse link
G HNRNPH2 heterogeneous nuclear ribonucleoprotein H2 increases expression EXP bisphenol A results in increased expression of HNRNPH2 mRNA CTD PMID:38866337 NCBI chr  X:75,320,505...75,326,651
Ensembl chr  X:75,324,481...75,325,830
JBrowse link
G HOMEZ homeobox and leucine zipper encoding decreases expression EXP bisphenol A results in decreased expression of HOMEZ mRNA CTD PMID:38866337 NCBI chr 8:3,545,434...3,558,923
Ensembl chr 8:3,545,472...3,558,440
JBrowse link
G HOXA1 homeobox A1 increases expression EXP bisphenol A results in increased expression of HOXA1 mRNA CTD PMID:38866337 NCBI chr14:40,267,033...40,272,212
Ensembl chr14:40,267,528...40,269,681
JBrowse link
G HOXA2 homeobox A2 increases expression EXP bisphenol A results in increased expression of HOXA2 mRNA CTD PMID:38866337 NCBI chr14:40,273,992...40,276,975
Ensembl chr14:40,274,469...40,276,239
JBrowse link
G HOXA3 homeobox A3 increases expression EXP bisphenol A results in increased expression of HOXA3 mRNA CTD PMID:38866337 NCBI chr14:40,280,866...40,326,559
Ensembl chr14:40,280,861...40,296,147
JBrowse link
G HOXA9 homeobox A9 increases expression EXP bisphenol A results in increased expression of HOXA9 mRNA CTD PMID:38866337 NCBI chr14:40,336,829...40,340,533
Ensembl chr14:40,337,999...40,339,923
JBrowse link
G HOXD8 homeobox D8 increases expression EXP bisphenol A results in increased expression of HOXD8 mRNA CTD PMID:38866337 NCBI chr36:19,938,916...19,941,092 JBrowse link
G HPS5 HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 increases expression EXP bisphenol A results in increased expression of HPS5 mRNA CTD PMID:38866337 NCBI chr21:40,725,089...40,770,665
Ensembl chr21:40,726,274...40,770,112
JBrowse link
G HRCT1 histidine rich carboxyl terminus 1 increases expression EXP bisphenol A results in increased expression of HRCT1 mRNA CTD PMID:38866337 NCBI chr11:52,420,070...52,421,097
Ensembl chr11:52,420,011...52,420,629
JBrowse link
G HSD17B4 hydroxysteroid 17-beta dehydrogenase 4 increases expression EXP bisphenol A results in increased expression of HSD17B4 mRNA CTD PMID:38866337 NCBI chr11:8,717,182...8,810,716
Ensembl chr11:8,717,349...8,824,594
JBrowse link
G HSD17B7 hydroxysteroid 17-beta dehydrogenase 7 increases expression EXP bisphenol A results in increased expression of HSD17B7 mRNA CTD PMID:38866337 NCBI chr38:19,975,935...19,999,077
Ensembl chr38:19,977,086...19,999,010
JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 increases expression EXP bisphenol A results in increased expression of HSP90AA1 mRNA CTD PMID:38866337 NCBI chr 8:70,091,203...70,096,107
Ensembl chr 8:70,092,217...70,095,243
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 increases expression EXP bisphenol A results in increased expression of HSPA8 mRNA CTD PMID:38866337 NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
JBrowse link
G HSPA9 heat shock protein family A (Hsp70) member 9 increases expression EXP bisphenol A results in increased expression of HSPA9 mRNA CTD PMID:38866337 NCBI chr11:26,122,917...26,142,458
Ensembl chr11:26,121,499...26,142,434
JBrowse link
G HTATSF1 HIV-1 Tat specific factor 1 increases expression EXP bisphenol A results in increased expression of HTATSF1 mRNA CTD PMID:38866337 NCBI chr  X:106,848,455...106,866,540
Ensembl chr  X:106,848,455...106,866,540
JBrowse link
G HVCN1 hydrogen voltage gated channel 1 increases expression EXP bisphenol A results in increased expression of HVCN1 mRNA CTD PMID:38866337 NCBI chr26:8,437,032...8,474,831
Ensembl chr26:8,419,269...8,466,523
JBrowse link
G ID1 inhibitor of DNA binding 1 increases expression EXP bisphenol A results in increased expression of ID1 mRNA CTD PMID:38866337 NCBI chr24:21,094,339...21,096,276
Ensembl chr24:21,094,755...21,096,276
JBrowse link
G ID4 inhibitor of DNA binding 4, HLH protein increases expression EXP bisphenol A results in increased expression of ID4 mRNA CTD PMID:38866337 NCBI chr35:18,358,518...18,360,767
Ensembl chr35:18,357,826...18,359,011
Ensembl chr35:18,357,826...18,359,011
JBrowse link
G IDH1 isocitrate dehydrogenase (NADP(+)) 1 increases expression EXP bisphenol A results in increased expression of IDH1 mRNA CTD PMID:38866337 NCBI chr37:16,512,027...16,531,269
Ensembl chr37:16,512,770...16,531,219
JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 decreases expression EXP bisphenol A results in decreased expression of IDH2 mRNA CTD PMID:38866337 NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
JBrowse link
G IFNAR2 interferon alpha and beta receptor subunit 2 decreases expression EXP bisphenol A results in decreased expression of IFNAR2 mRNA CTD PMID:38866337 NCBI chr31:27,860,094...27,891,361 JBrowse link
G IFT122 intraflagellar transport 122 increases expression EXP bisphenol A results in increased expression of IFT122 mRNA CTD PMID:38866337 NCBI chr20:5,644,002...5,716,702
Ensembl chr20:5,644,089...5,715,906
JBrowse link
G IFT70B intraflagellar transport 70B decreases expression EXP bisphenol A results in decreased expression of IFT70B mRNA CTD PMID:38866337 NCBI chr36:21,270,467...21,273,878 JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 increases expression EXP bisphenol A results in increased expression of IGFBP3 mRNA CTD PMID:38866337 NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
JBrowse link
G IKZF2 IKAROS family zinc finger 2 increases expression EXP bisphenol A results in increased expression of IKZF2 mRNA CTD PMID:38866337 NCBI chr37:20,508,647...20,662,549
Ensembl chr37:20,516,239...20,661,298
JBrowse link
G IL10RB interleukin 10 receptor subunit beta decreases expression EXP bisphenol A results in decreased expression of IL10RB mRNA CTD PMID:38866337 NCBI chr31:28,791,541...28,815,163
Ensembl chr31:27,892,394...27,915,637
JBrowse link
G IL11 interleukin 11 decreases expression EXP bisphenol A results in decreased expression of IL11 mRNA CTD PMID:38866337 NCBI chr 1:102,311,960...102,319,102
Ensembl chr 1:102,316,105...102,318,653
JBrowse link
G IL13RA1 interleukin 13 receptor subunit alpha 1 decreases expression EXP bisphenol A results in decreased expression of IL13RA1 mRNA CTD PMID:38866337 NCBI chr  X:90,925,497...90,981,855
Ensembl chr  X:90,924,801...90,979,963
JBrowse link
G IL18R1 interleukin 18 receptor 1 increases expression EXP bisphenol A results in increased expression of IL18R1 mRNA CTD PMID:38866337 NCBI chr10:40,614,336...40,653,300
Ensembl chr10:40,615,312...40,653,454
JBrowse link
G IL1R1 interleukin 1 receptor type 1 increases expression EXP bisphenol A results in increased expression of IL1R1 mRNA CTD PMID:38866337 NCBI chr10:40,825,986...40,897,898
Ensembl chr10:40,827,377...40,897,596
JBrowse link
G IL1RL1 interleukin 1 receptor like 1 increases expression EXP bisphenol A results in increased expression of IL1RL1 mRNA CTD PMID:38866337 NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
JBrowse link
G IL37 interleukin 37 decreases expression EXP bisphenol A results in decreased expression of IL37 mRNA CTD PMID:38866337 NCBI chr17:36,964,857...37,101,005
Ensembl chr17:36,977,063...37,100,801
JBrowse link
G INHBA inhibin subunit beta A decreases expression EXP bisphenol A results in decreased expression of INHBA mRNA CTD PMID:38866337 NCBI chr18:8,272,978...8,288,432
Ensembl chr18:8,272,872...8,283,794
JBrowse link
G INO80C INO80 complex subunit C decreases expression EXP bisphenol A results in decreased expression of INO80C mRNA CTD PMID:38866337 NCBI chr 7:54,569,954...54,586,902
Ensembl chr 7:54,569,972...54,586,782
JBrowse link
G INSIG1 insulin induced gene 1 increases expression EXP bisphenol A results in increased expression of INSIG1 mRNA CTD PMID:38866337 NCBI chr16:18,260,456...18,271,855
Ensembl chr16:18,259,935...18,271,378
JBrowse link
G INTS6L integrator complex subunit 6 like decreases expression EXP bisphenol A results in decreased expression of INTS6L mRNA CTD PMID:38866337 NCBI chr  X:105,996,058...106,052,347
Ensembl chr  X:105,995,434...106,080,535
JBrowse link
G IRAK2 interleukin 1 receptor associated kinase 2 decreases expression EXP bisphenol A results in decreased expression of IRAK2 mRNA CTD PMID:38866337 NCBI chr20:8,133,987...8,197,009
Ensembl chr20:8,134,970...8,196,910
JBrowse link
G ISG15 ISG15 ubiquitin like modifier decreases expression EXP bisphenol A results in decreased expression of ISG15 mRNA CTD PMID:38866337 NCBI chr 5:56,230,879...56,237,354
Ensembl chr 5:56,236,318...56,404,695
JBrowse link
G ITGB1BP2 integrin subunit beta 1 binding protein 2 decreases expression EXP bisphenol A results in decreased expression of ITGB1BP2 mRNA CTD PMID:38866337 NCBI chr  X:55,632,566...55,652,801
Ensembl chr  X:55,633,060...55,636,868
JBrowse link
G IZUMO4 IZUMO family member 4 decreases expression EXP bisphenol A results in decreased expression of IZUMO4 mRNA CTD PMID:38866337 NCBI chr20:56,933,644...56,936,171
Ensembl chr20:56,933,646...56,936,163
JBrowse link
G JAK1 Janus kinase 1 increases expression EXP bisphenol A results in increased expression of JAK1 mRNA CTD PMID:38866337 NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
JBrowse link
G JAZF1 JAZF zinc finger 1 decreases expression EXP bisphenol A results in decreased expression of JAZF1 mRNA CTD PMID:38866337 NCBI chr14:40,939,680...41,275,981
Ensembl chr14:40,941,677...41,234,384
JBrowse link
G KAZALD1 Kazal type serine peptidase inhibitor domain 1 increases expression EXP bisphenol A results in increased expression of KAZALD1 mRNA CTD PMID:38866337 NCBI chr28:13,741,085...13,745,426
Ensembl chr28:13,742,322...13,745,119
JBrowse link
G KCNE4 potassium voltage-gated channel subfamily E regulatory subunit 4 decreases expression EXP bisphenol A results in decreased expression of KCNE4 mRNA CTD PMID:38866337 NCBI chr37:28,994,797...28,998,596
Ensembl chr37:28,996,105...28,996,990
JBrowse link
G KCNIP1 potassium voltage-gated channel interacting protein 1 decreases expression EXP bisphenol A results in decreased expression of KCNIP1 mRNA CTD PMID:38866337 NCBI chr 4:41,220,128...41,566,841
Ensembl chr 4:41,223,369...41,431,510
JBrowse link
G KCNJ15 potassium inwardly rectifying channel subfamily J member 15 decreases expression EXP bisphenol A results in decreased expression of KCNJ15 mRNA CTD PMID:38866337 NCBI chr31:33,314,061...33,388,165
Ensembl chr31:33,384,630...33,386,885
JBrowse link
G KCNK16 potassium two pore domain channel subfamily K member 16 decreases expression EXP bisphenol A results in decreased expression of KCNK16 mRNA CTD PMID:38866337 NCBI chr12:8,210,498...8,232,269
Ensembl chr12:8,224,518...8,232,758
JBrowse link
G KCTD1 potassium channel tetramerization domain containing 1 increases expression EXP bisphenol A results in increased expression of KCTD1 mRNA CTD PMID:38866337 NCBI chr 7:62,119,658...62,214,365
Ensembl chr 7:62,118,600...62,213,593
JBrowse link
G KCTD13 potassium channel tetramerization domain containing 13 increases expression EXP bisphenol A results in increased expression of KCTD13 mRNA CTD PMID:38866337 NCBI chr 6:17,945,541...17,959,421
Ensembl chr 6:17,946,062...17,959,232
JBrowse link
G KCTD7 potassium channel tetramerization domain containing 7 increases expression EXP bisphenol A results in increased expression of KCTD7 mRNA CTD PMID:38866337
G KDELR2 KDEL endoplasmic reticulum protein retention receptor 2 decreases expression EXP bisphenol A results in decreased expression of KDELR2 mRNA CTD PMID:38866337 NCBI chr 6:11,796,586...11,815,765
Ensembl chr 6:11,798,377...11,815,760
JBrowse link
G KDM5A lysine demethylase 5A increases expression EXP bisphenol A results in increased expression of KDM5A mRNA CTD PMID:38866337 NCBI chr27:42,364,606...42,447,839
Ensembl chr27:42,360,456...42,447,821
JBrowse link
G KHK ketohexokinase increases expression EXP bisphenol A results in increased expression of KHK mRNA CTD PMID:38866337 NCBI chr17:21,079,907...21,092,510
Ensembl chr17:21,079,907...21,092,510
JBrowse link
G KIDINS220 kinase D interacting substrate 220 increases expression EXP bisphenol A results in increased expression of KIDINS220 mRNA CTD PMID:38866337 NCBI chr17:5,983,208...6,077,609
Ensembl chr17:5,982,938...6,071,165
JBrowse link
G KLF1 KLF transcription factor 1 decreases expression EXP bisphenol A results in decreased expression of KLF1 mRNA CTD PMID:38866337 NCBI chr20:49,295,097...49,298,668
Ensembl chr20:49,295,195...49,298,602
JBrowse link
G KLF3 KLF transcription factor 3 increases expression EXP bisphenol A results in increased expression of KLF3 mRNA CTD PMID:38866337 NCBI chr 3:73,627,112...73,663,702
Ensembl chr 3:73,629,312...73,664,182
JBrowse link
G KLHL12 kelch like family member 12 increases expression EXP bisphenol A results in increased expression of KLHL12 mRNA CTD PMID:38866337 NCBI chr 7:256,814...284,132 JBrowse link
G KLK14 kallikrein related peptidase 14 decreases expression EXP bisphenol A results in decreased expression of KLK14 mRNA CTD PMID:38866337 NCBI chr 1:105,811,435...105,816,625
Ensembl chr 1:105,812,224...105,816,625
JBrowse link
G KNCN kinocilin decreases expression EXP bisphenol A results in decreased expression of KNCN mRNA CTD PMID:38866337 NCBI chr15:13,900,881...13,907,964
Ensembl chr15:13,903,036...13,907,967
JBrowse link
G KPNA6 karyopherin subunit alpha 6 increases expression EXP bisphenol A results in increased expression of KPNA6 mRNA CTD PMID:38866337 NCBI chr 2:69,025,409...69,078,635
Ensembl chr 2:69,030,228...69,077,912
JBrowse link
G KRT16 keratin 16 increases expression EXP bisphenol A results in increased expression of KRT16 mRNA CTD PMID:38866337 NCBI chr 9:21,167,714...21,170,650 JBrowse link
G KRT7 keratin 7 decreases expression EXP bisphenol A results in decreased expression of KRT7 mRNA CTD PMID:38866337 NCBI chr27:2,812,709...2,827,451 JBrowse link
G LACTB lactamase beta increases expression EXP bisphenol A results in increased expression of LACTB mRNA CTD PMID:38866337 NCBI chr30:27,720,255...27,738,213
Ensembl chr30:27,719,821...27,737,959
JBrowse link
G LAMC2 laminin subunit gamma 2 increases expression EXP bisphenol A results in increased expression of LAMC2 mRNA CTD PMID:38866337 NCBI chr 7:16,543,541...16,625,304
Ensembl chr 7:16,569,086...16,624,085
JBrowse link
G LATS2 large tumor suppressor kinase 2 increases expression EXP bisphenol A results in increased expression of LATS2 mRNA CTD PMID:38866337 NCBI chr25:17,110,620...17,169,826
Ensembl chr25:17,110,637...17,169,291
JBrowse link
G LBH LBH regulator of WNT signaling pathway increases expression EXP bisphenol A results in increased expression of LBH mRNA CTD PMID:38866337 NCBI chr17:23,939,135...23,969,611
Ensembl chr17:23,938,772...24,022,140
JBrowse link
G LCN8 lipocalin 8 increases expression EXP bisphenol A results in increased expression of LCN8 mRNA CTD PMID:38866337 NCBI chr 9:48,789,948...48,796,002
Ensembl chr 9:48,769,526...48,794,188
JBrowse link
G LCNL1 lipocalin like 1 decreases expression EXP bisphenol A results in decreased expression of LCNL1 mRNA CTD PMID:38866337 NCBI chr 9:48,643,845...48,647,187 JBrowse link
G LCP1 lymphocyte cytosolic protein 1 decreases expression EXP bisphenol A results in decreased expression of LCP1 mRNA CTD PMID:38866337 NCBI chr22:4,955,453...5,059,654
Ensembl chr22:4,992,347...5,059,636
JBrowse link
G LENG9 leukocyte receptor cluster member 9 increases expression EXP bisphenol A results in increased expression of LENG9 mRNA CTD PMID:38866337 NCBI chr 1:102,842,997...102,844,194 JBrowse link
G LEP leptin decreases expression EXP bisphenol A results in decreased expression of LEP mRNA CTD PMID:38866337 NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
JBrowse link
G LEPR leptin receptor decreases expression EXP bisphenol A results in decreased expression of LEPR mRNA CTD PMID:38866337 NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
JBrowse link
G LGALS12 galectin 12 increases expression EXP bisphenol A results in increased expression of LGALS12 mRNA CTD PMID:38866337 NCBI chr18:53,428,894...53,446,767
Ensembl chr18:53,437,562...53,447,013
JBrowse link
G LGR4 leucine rich repeat containing G protein-coupled receptor 4 increases expression EXP bisphenol A results in increased expression of LGR4 mRNA CTD PMID:38866337 NCBI chr21:47,952,019...47,995,530
Ensembl chr21:47,952,890...47,996,288
JBrowse link
G LHFPL6 LHFPL tetraspan subfamily member 6 increases expression EXP bisphenol A results in increased expression of LHFPL6 mRNA CTD PMID:38866337 NCBI chr25:1,567,799...1,805,030
Ensembl chr25:1,567,335...1,804,535
JBrowse link
G LIN7A lin-7 homolog A, crumbs cell polarity complex component decreases expression EXP bisphenol A results in decreased expression of LIN7A mRNA CTD PMID:38866337 NCBI chr15:23,101,524...23,186,343
Ensembl chr15:23,111,944...23,187,354
JBrowse link
G LMO2 LIM domain only 2 increases expression EXP bisphenol A results in increased expression of LMO2 mRNA CTD PMID:38866337
G LOC100687713 BUB3-interacting and GLEBS motif-containing protein ZNF207 increases expression EXP bisphenol A results in increased expression of ZNF207 mRNA CTD PMID:38866337 NCBI chr11:1,027,387...1,029,505 JBrowse link
G LONRF3 LON peptidase N-terminal domain and ring finger 3 increases expression EXP bisphenol A results in increased expression of LONRF3 mRNA CTD PMID:38866337 NCBI chr  X:91,105,938...91,146,468
Ensembl chr  X:91,106,496...91,141,790
JBrowse link
G LPIN1 lipin 1 increases expression EXP bisphenol A results in increased expression of LPIN1 mRNA CTD PMID:38866337 NCBI chr17:8,348,860...8,480,447
Ensembl chr17:8,348,886...8,478,863
JBrowse link
G LRBA LPS responsive beige-like anchor protein increases expression EXP bisphenol A results in increased expression of LRBA mRNA CTD PMID:38866337 NCBI chr15:48,273,866...48,996,546
Ensembl chr15:48,274,881...48,995,697
JBrowse link
G LRIG3 leucine rich repeats and immunoglobulin like domains 3 increases expression EXP bisphenol A results in increased expression of LRIG3 mRNA CTD PMID:38866337 NCBI chr10:2,723,836...2,772,630
Ensembl chr10:2,724,951...2,772,636
JBrowse link
G LRIT3 leucine rich repeat, Ig-like and transmembrane domains 3 decreases expression EXP bisphenol A results in decreased expression of LRIT3 mRNA CTD PMID:38866337 NCBI chr32:30,024,765...30,044,845
Ensembl chr32:30,026,897...30,041,996
JBrowse link
G LRP12 LDL receptor related protein 12 decreases expression EXP bisphenol A results in decreased expression of LRP12 mRNA CTD PMID:38866337 NCBI chr13:5,670,932...5,754,076
Ensembl chr13:5,674,649...5,744,740
JBrowse link
G LRP6 LDL receptor related protein 6 increases expression EXP bisphenol A results in increased expression of LRP6 mRNA CTD PMID:38866337 NCBI chr27:34,003,334...34,166,334
Ensembl chr27:34,003,539...34,161,437
JBrowse link
G LRRC59 leucine rich repeat containing 59 decreases expression EXP bisphenol A results in decreased expression of LRRC59 mRNA CTD PMID:38866337 NCBI chr 9:26,350,300...26,364,021
Ensembl chr 9:26,351,734...26,364,082
JBrowse link
G LRRN4CL LRRN4 C-terminal like increases expression EXP bisphenol A results in increased expression of LRRN4CL mRNA CTD PMID:38866337 NCBI chr18:53,971,590...53,973,958
Ensembl chr18:53,972,490...53,973,203
JBrowse link
G LST1 leukocyte specific transcript 1 increases expression EXP bisphenol A results in increased expression of LST1 mRNA CTD PMID:38866337 NCBI chr12:1,084,739...1,086,182 JBrowse link
G LYVE1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression EXP bisphenol A results in decreased expression of LYVE1 mRNA CTD PMID:38866337 NCBI chr21:33,716,138...33,727,470
Ensembl chr21:33,716,581...33,727,297
JBrowse link
G MAN1A1 mannosidase alpha class 1A member 1 increases expression EXP bisphenol A results in increased expression of MAN1A1 mRNA CTD PMID:38866337 NCBI chr 1:59,106,834...59,274,936
Ensembl chr 1:59,109,366...59,275,399
JBrowse link
G MAOA monoamine oxidase A increases expression EXP bisphenol A results in increased expression of MAOA mRNA CTD PMID:38866337 NCBI chr  X:37,678,933...37,744,757
Ensembl chr  X:37,677,493...37,744,757
JBrowse link
G MAP10 microtubule associated protein 10 increases expression EXP bisphenol A results in increased expression of MAP10 mRNA CTD PMID:38866337 NCBI chr 4:6,867,323...6,870,177
Ensembl chr 4:6,867,326...6,870,063
JBrowse link
G MAP2K6 mitogen-activated protein kinase kinase 6 increases expression EXP bisphenol A results in increased expression of MAP2K6 mRNA CTD PMID:38866337 NCBI chr 9:15,840,714...15,962,400
Ensembl chr 9:15,840,983...15,952,026
JBrowse link
G MAP3K5 mitogen-activated protein kinase kinase kinase 5 increases expression EXP bisphenol A results in increased expression of MAP3K5 mRNA CTD PMID:38866337 NCBI chr 1:29,107,813...29,306,437
Ensembl chr 1:29,108,591...29,306,503
JBrowse link
G MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 increases expression EXP bisphenol A results in increased expression of MAP4K4 mRNA CTD PMID:38866337 NCBI chr10:41,088,020...41,276,801
Ensembl chr10:41,089,371...41,276,891
JBrowse link
G MAPK13 mitogen-activated protein kinase 13 decreases expression EXP bisphenol A results in decreased expression of MAPK13 mRNA CTD PMID:38866337 NCBI chr12:5,239,783...5,248,197
Ensembl chr12:5,239,750...5,248,196
JBrowse link
G MARF1 meiosis regulator and mRNA stability factor 1 increases expression EXP bisphenol A results in increased expression of MARF1 mRNA CTD PMID:38866337 NCBI chr 6:28,194,771...28,231,908
Ensembl chr 6:28,041,318...28,262,184
JBrowse link
G MAT2A methionine adenosyltransferase 2A increases expression EXP bisphenol A results in increased expression of MAT2A mRNA CTD PMID:38866337 NCBI chr17:39,525,635...39,532,512
Ensembl chr17:39,525,626...39,532,512
JBrowse link
G MBOAT2 membrane bound O-acyltransferase domain containing 2 decreases expression EXP bisphenol A results in decreased expression of MBOAT2 mRNA CTD PMID:38866337 NCBI chr17:6,090,746...6,217,139
Ensembl chr17:6,094,900...6,213,142
JBrowse link
G MC1R melanocortin 1 receptor increases expression EXP bisphenol A results in increased expression of MC1R mRNA CTD PMID:38866337 NCBI chr 5:63,694,296...63,695,249 JBrowse link
G MCL1 MCL1 apoptosis regulator, BCL2 family member increases expression EXP bisphenol A results in increased expression of MCL1 mRNA CTD PMID:38866337 NCBI chr17:59,759,605...59,763,111
Ensembl chr17:59,759,605...59,763,111
JBrowse link
G MCUR1 mitochondrial calcium uniporter regulator 1 increases expression EXP bisphenol A results in increased expression of MCUR1 mRNA CTD PMID:38866337 NCBI chr35:13,188,002...13,229,444 JBrowse link
G MDH2 malate dehydrogenase 2 increases expression EXP bisphenol A results in increased expression of MDH2 mRNA CTD PMID:38866337 NCBI chr 6:7,389,266...7,405,311 JBrowse link
G ME3 malic enzyme 3 decreases expression EXP bisphenol A results in decreased expression of ME3 mRNA CTD PMID:38866337 NCBI chr21:12,813,052...13,105,805
Ensembl chr21:12,813,047...13,105,804
JBrowse link
G MED13 mediator complex subunit 13 increases expression EXP bisphenol A results in increased expression of MED13 mRNA CTD PMID:38866337 NCBI chr 9:34,638,892...34,742,235
Ensembl chr 9:34,641,601...34,738,352
JBrowse link
G MEIS1 Meis homeobox 1 increases expression EXP bisphenol A results in increased expression of MEIS1 mRNA CTD PMID:38866337 NCBI chr10:65,765,498...65,898,714
Ensembl chr10:65,683,560...65,897,573
JBrowse link
G MERTK MER proto-oncogene, tyrosine kinase increases expression EXP bisphenol A results in increased expression of MERTK mRNA CTD PMID:38866337 NCBI chr17:36,336,787...36,445,796
Ensembl chr17:36,336,861...36,445,380
JBrowse link
G METTL1 methyltransferase 1, tRNA methylguanosine decreases expression EXP bisphenol A results in decreased expression of METTL1 mRNA CTD PMID:38866337 NCBI chr10:1,831,088...1,833,818
Ensembl chr10:1,831,091...1,833,868
JBrowse link
G MFAP1 microfibril associated protein 1 increases expression EXP bisphenol A results in increased expression of MFAP1 mRNA CTD PMID:38866337 NCBI chr30:10,545,987...10,559,507
Ensembl chr30:10,546,369...10,559,414
JBrowse link
G MGRH mas-related G-protein coupled receptor member X2 decreases expression EXP bisphenol A results in decreased expression of MGRH mRNA CTD PMID:38866337 NCBI chr18:47,212,903...47,215,195 JBrowse link
G MIF macrophage migration inhibitory factor decreases expression EXP bisphenol A results in decreased expression of MIF mRNA CTD PMID:38866337
G MINAR2 membrane integral NOTCH2 associated receptor 2 decreases expression EXP bisphenol A results in decreased expression of MINAR2 mRNA CTD PMID:38866337 NCBI chr11:18,506,042...18,531,187
Ensembl chr11:18,507,059...18,524,589
JBrowse link
G MIR29C-1 microRNA mir-29c-1 decreases expression EXP bisphenol A results in decreased expression of MIR29C-1 mRNA CTD PMID:38866337 NCBI chr 7:6,588,010...6,588,067 JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor decreases expression EXP bisphenol A results in decreased expression of MLLT11 mRNA CTD PMID:38866337 NCBI chr17:60,142,411...60,153,650
Ensembl chr17:60,152,378...60,152,650
JBrowse link
G MMP13 matrix metallopeptidase 13 decreases expression EXP bisphenol A results in decreased expression of MMP13 mRNA CTD PMID:38866337 NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
JBrowse link
G MOB3B MOB kinase activator 3B increases expression EXP bisphenol A results in increased expression of MOB3B mRNA CTD PMID:38866337 NCBI chr11:45,456,049...45,574,034
Ensembl chr11:45,460,901...45,574,034
JBrowse link
G MON2 MON2 homolog, regulator of endosome-to-Golgi trafficking increases expression EXP bisphenol A results in increased expression of MON2 mRNA CTD PMID:38866337 NCBI chr10:5,670,388...5,776,533
Ensembl chr10:5,670,388...5,774,134
JBrowse link
G MPEG1 macrophage expressed 1 decreases expression EXP bisphenol A results in decreased expression of MPEG1 mRNA CTD PMID:38866337 NCBI chr18:37,530,895...37,535,334
Ensembl chr18:37,531,032...37,533,179
JBrowse link
G MPLKIP M-phase specific PLK1 interacting protein decreases expression EXP bisphenol A results in decreased expression of MPLKIP mRNA CTD PMID:38866337 NCBI chr18:9,766,369...9,768,831
Ensembl chr18:9,765,972...9,768,833
JBrowse link
G MRM3 mitochondrial rRNA methyltransferase 3 increases expression EXP bisphenol A results in increased expression of MRM3 mRNA CTD PMID:38866337 NCBI chr 9:45,004,382...45,011,834
Ensembl chr 9:45,005,145...45,011,811
JBrowse link
G MT1E metallothionein 1E increases expression EXP bisphenol A results in increased expression of MT1E mRNA CTD PMID:38866337
G MTARC1 mitochondrial amidoxime reducing component 1 increases expression EXP bisphenol A results in increased expression of MTARC1 mRNA CTD PMID:38866337 NCBI chr38:15,460,548...15,490,941
Ensembl chr38:15,463,548...15,532,241
JBrowse link
G MTARC2 mitochondrial amidoxime reducing component 2 increases expression EXP bisphenol A results in increased expression of MTARC2 mRNA CTD PMID:38866337 NCBI chr38:15,426,884...15,451,701
Ensembl chr38:15,426,666...15,451,136
JBrowse link
G MTURN maturin, neural progenitor differentiation regulator homolog increases expression EXP bisphenol A results in increased expression of MTURN mRNA CTD PMID:38866337 NCBI chr14:42,890,343...42,928,985
Ensembl chr14:42,899,944...42,930,117
JBrowse link
G MX2 MX dynamin like GTPase 2 decreases expression EXP bisphenol A results in decreased expression of MX2 mRNA CTD PMID:38866337 NCBI chr31:35,860,596...35,883,607
Ensembl chr31:35,860,590...35,951,350
JBrowse link
G MYBPH myosin binding protein H increases expression EXP bisphenol A results in increased expression of MYBPH mRNA CTD PMID:38866337 NCBI chr 7:34,181...44,479
Ensembl chr 7:36,428...43,803
JBrowse link
G MYL5 myosin light chain 5 increases expression EXP bisphenol A results in increased expression of MYL5 mRNA CTD PMID:38866337 NCBI chr 3:91,738,518...91,743,619
Ensembl chr 3:91,738,523...91,744,297
JBrowse link
G MYL6B myosin light chain 6B decreases expression EXP bisphenol A results in decreased expression of MYL6B mRNA CTD PMID:38866337 NCBI chr10:472,415...476,738
Ensembl chr10:472,515...476,719
JBrowse link
G MYOM1 myomesin 1 decreases expression EXP bisphenol A results in decreased expression of MYOM1 mRNA CTD PMID:38866337 NCBI chr 7:69,703,057...69,837,987
Ensembl chr 7:69,703,540...69,857,740
JBrowse link
G NAA10 N-alpha-acetyltransferase 10, NatA catalytic subunit decreases expression EXP bisphenol A results in decreased expression of NAA10 mRNA CTD PMID:38866337 NCBI chr  X:121,777,658...121,782,097
Ensembl chr  X:121,727,573...121,788,860
JBrowse link
G NADK NAD kinase increases expression EXP bisphenol A results in increased expression of NADK mRNA CTD PMID:38866337 NCBI chr 5:56,743,920...56,774,578
Ensembl chr 5:56,745,869...56,774,529
JBrowse link
G NANS N-acetylneuraminate synthase decreases expression EXP bisphenol A results in decreased expression of NANS mRNA CTD PMID:38866337 NCBI chr11:55,286,290...55,310,904
Ensembl chr11:55,243,854...55,350,194
JBrowse link
G NAT9 N-acetyltransferase 9 decreases expression EXP bisphenol A results in decreased expression of NAT9 mRNA CTD PMID:38866337 NCBI chr 9:5,655,178...5,660,068
Ensembl chr 9:5,655,125...5,660,046
JBrowse link
G NCL nucleolin increases expression EXP bisphenol A results in increased expression of NCL mRNA CTD PMID:38866337 NCBI chr25:43,330,524...43,384,909
Ensembl chr25:43,330,799...43,384,258
JBrowse link
G NCOR1 nuclear receptor corepressor 1 increases expression EXP bisphenol A results in increased expression of NCOR1 mRNA CTD PMID:38866337 NCBI chr 5:39,687,530...39,837,003
Ensembl chr 5:39,687,543...39,836,464
JBrowse link
G NDRG2 NDRG family member 2 increases expression EXP bisphenol A results in increased expression of NDRG2 mRNA CTD PMID:38866337 NCBI chr15:18,106,651...18,115,026
Ensembl chr15:18,106,654...18,113,970
JBrowse link
G NDUFAF8 NADH:ubiquinone oxidoreductase complex assembly factor 8 increases expression EXP bisphenol A results in increased expression of NDUFAF8 mRNA CTD PMID:38866337 NCBI chr 9:851,903...854,005
Ensembl chr 9:851,923...854,005
JBrowse link
G NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 decreases expression EXP bisphenol A results in decreased expression of NDUFV3 mRNA CTD PMID:38866337 NCBI chr31:37,118,201...37,131,035
Ensembl chr31:37,118,247...37,130,810
JBrowse link
G NEK2 NIMA related kinase 2 decreases expression EXP bisphenol A results in decreased expression of NEK2 mRNA CTD PMID:38866337 NCBI chr 7:10,039,617...10,052,511
Ensembl chr 7:10,040,187...10,052,512
JBrowse link
G NEK9 NIMA related kinase 9 increases expression EXP bisphenol A results in increased expression of NEK9 mRNA CTD PMID:38866337 NCBI chr 8:48,180,203...48,218,430
Ensembl chr 8:48,183,071...48,257,646
JBrowse link
G NFATC2IP nuclear factor of activated T cells 2 interacting protein increases expression EXP bisphenol A results in increased expression of NFATC2IP mRNA CTD PMID:38866337 NCBI chr 6:18,433,421...18,444,148
Ensembl chr 6:18,432,809...18,443,922
JBrowse link
G NFIA nuclear factor I A increases expression EXP bisphenol A results in increased expression of NFIA mRNA CTD PMID:38866337 NCBI chr 5:48,489,521...49,064,867
Ensembl chr 5:48,496,773...49,064,848
JBrowse link
G NGF nerve growth factor decreases expression EXP bisphenol A results in decreased expression of NGF mRNA CTD PMID:38866337 NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
JBrowse link
G NIM1K NIM1 serine/threonine protein kinase increases expression EXP bisphenol A results in increased expression of NIM1K mRNA CTD PMID:38866337 NCBI chr 4:66,662,920...66,726,675
Ensembl chr 4:66,662,951...66,705,908
JBrowse link
G NIN ninein increases expression EXP bisphenol A results in increased expression of NIN mRNA CTD PMID:38866337 NCBI chr 8:27,100,740...27,199,269
Ensembl chr 8:27,104,262...27,189,463
JBrowse link
G NIPAL2 NIPA like domain containing 2 decreases expression EXP bisphenol A results in decreased expression of NIPAL2 mRNA CTD PMID:38866337 NCBI chr13:427,216...493,861
Ensembl chr13:428,752...493,817
JBrowse link
G NIPAL3 NIPA like domain containing 3 increases expression EXP bisphenol A results in increased expression of NIPAL3 mRNA CTD PMID:38866337 NCBI chr 2:75,182,820...75,236,487
Ensembl chr 2:75,184,578...75,232,897
JBrowse link
G NKX3-2 NK3 homeobox 2 increases expression EXP bisphenol A results in increased expression of NKX3-2 mRNA CTD PMID:38866337 NCBI chr 3:66,543,046...66,546,779
Ensembl chr 3:66,543,046...66,545,580
JBrowse link
G NMB neuromedin B decreases expression EXP bisphenol A results in decreased expression of NMB mRNA CTD PMID:38866337 NCBI chr 3:53,927,891...53,931,129
Ensembl chr 3:53,927,900...53,931,069
JBrowse link
G NMS neuromedin S decreases expression EXP bisphenol A results in decreased expression of NMS mRNA CTD PMID:38866337 NCBI chr10:42,260,542...42,310,397
Ensembl chr10:42,260,540...42,274,613
JBrowse link
G NOLC1 nucleolar and coiled-body phosphoprotein 1 increases expression EXP bisphenol A results in increased expression of NOLC1 mRNA CTD PMID:38866337 NCBI chr28:14,686,001...14,699,082
Ensembl chr28:14,686,090...14,697,980
JBrowse link
G NONO non-POU domain containing octamer binding increases expression EXP bisphenol A results in increased expression of NONO mRNA CTD PMID:38866337 NCBI chr  X:55,618,032...55,632,237
Ensembl chr  X:55,618,095...55,631,388
JBrowse link
G NOX4 NADPH oxidase 4 decreases expression EXP bisphenol A results in decreased expression of NOX4 mRNA CTD PMID:38866337 NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
JBrowse link
G NPAT nuclear protein, coactivator of histone transcription increases expression EXP bisphenol A results in increased expression of NPAT mRNA CTD PMID:38866337 NCBI chr 5:24,297,419...24,360,461
Ensembl chr 5:24,296,653...24,346,935
JBrowse link
G NPB neuropeptide B decreases expression EXP bisphenol A results in decreased expression of NPB mRNA CTD PMID:38866337 NCBI chr 9:390,493...392,339
Ensembl chr 9:391,781...392,314
JBrowse link
G NPNT nephronectin increases expression EXP bisphenol A results in increased expression of NPNT mRNA CTD PMID:38866337 NCBI chr32:26,706,147...26,781,792
Ensembl chr32:26,705,476...26,781,275
JBrowse link
G NPTX2 neuronal pentraxin 2 decreases expression EXP bisphenol A results in decreased expression of NPTX2 mRNA CTD PMID:38866337 NCBI chr 6:10,805,564...10,816,587
Ensembl chr 6:10,806,696...10,816,572
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression EXP bisphenol A results in increased expression of NQO1 mRNA CTD PMID:38866337 NCBI chr 5:79,979,593...79,990,875
Ensembl chr 5:79,978,865...79,989,860
JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 increases expression EXP bisphenol A results in increased expression of NR4A2 mRNA CTD PMID:38866337 NCBI chr36:2,546,237...2,554,559
Ensembl chr36:2,547,421...2,552,780
JBrowse link
G NREP neuronal regeneration related protein decreases expression EXP bisphenol A results in decreased expression of NREP mRNA CTD PMID:38866337 NCBI chr 3:997,142...1,025,215
Ensembl chr 3:997,234...1,024,087
JBrowse link
G NRP1 neuropilin 1 increases expression EXP bisphenol A results in increased expression of NRP1 mRNA CTD PMID:38866337 NCBI chr 2:3,416,062...3,553,929
Ensembl chr 2:3,413,821...3,552,483
JBrowse link
G NSDHL NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL decreases expression EXP bisphenol A results in decreased expression of NSDHL mRNA CTD PMID:38866337 NCBI chr  X:120,720,118...120,754,573
Ensembl chr  X:120,720,183...120,754,143
JBrowse link
G NT5C1B 5'-nucleotidase, cytosolic IB increases expression EXP bisphenol A results in increased expression of NT5C1B mRNA CTD PMID:38866337 NCBI chr17:13,848,736...13,870,933 JBrowse link
G NTRK2 neurotrophic receptor tyrosine kinase 2 increases expression EXP bisphenol A results in increased expression of NTRK2 mRNA CTD PMID:38866337 NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
JBrowse link
G NUP93 nucleoporin 93 increases expression EXP bisphenol A results in increased expression of NUP93 mRNA CTD PMID:38866337 NCBI chr 2:59,465,482...59,573,871
Ensembl chr 2:59,465,487...59,574,033
JBrowse link
G NVL nuclear VCP like increases expression EXP bisphenol A results in increased expression of NVL mRNA CTD PMID:38866337 NCBI chr 7:40,041,692...40,131,984
Ensembl chr 7:40,041,394...40,131,823
JBrowse link
G NWD1 NACHT and WD repeat domain containing 1 decreases expression EXP bisphenol A results in decreased expression of NWD1 mRNA CTD PMID:38866337 NCBI chr20:45,792,745...45,854,889
Ensembl chr20:45,794,306...45,852,100
JBrowse link
G NXPH2 neurexophilin 2 increases expression EXP bisphenol A results in increased expression of NXPH2 mRNA CTD PMID:38866337 NCBI chr19:41,316,391...41,321,165
Ensembl chr19:41,318,149...41,318,904
JBrowse link
G OCRL OCRL inositol polyphosphate-5-phosphatase increases expression EXP bisphenol A results in increased expression of OCRL mRNA CTD PMID:38866337 NCBI chr  X:100,760,302...100,817,673
Ensembl chr  X:100,757,373...100,831,500
JBrowse link
G OGA O-GlcNAcase increases expression EXP bisphenol A results in increased expression of OGA mRNA CTD PMID:38866337 NCBI chr28:14,376,824...14,405,409
Ensembl chr28:14,373,452...14,404,541
JBrowse link
G OGFOD2 2-oxoglutarate and iron dependent oxygenase domain containing 2 increases expression EXP bisphenol A results in increased expression of OGFOD2 mRNA CTD PMID:38866337 NCBI chr26:6,525,655...6,530,333
Ensembl chr26:6,526,304...6,530,286
JBrowse link
G OLFML1 olfactomedin like 1 increases expression EXP bisphenol A results in increased expression of OLFML1 mRNA CTD PMID:38866337 NCBI chr21:31,136,218...31,162,405
Ensembl chr21:30,986,521...31,162,414
JBrowse link
G OOEP oocyte expressed protein decreases expression EXP bisphenol A results in decreased expression of OOEP mRNA CTD PMID:38866337 NCBI chr12:35,431,562...35,449,540
Ensembl chr12:35,448,015...35,449,511
JBrowse link
G OR4D9D olfactory receptor family 4 subfamily D member 9D decreases expression EXP bisphenol A results in decreased expression of OR4D9D mRNA CTD PMID:38866337 NCBI chr18:37,212,362...37,215,456
Ensembl chr18:37,214,518...37,215,453
JBrowse link
G OR4S7 olfactory receptor family 4 subfamily S member 7 decreases expression EXP bisphenol A results in decreased expression of OR4S7 mRNA CTD PMID:38866337 NCBI chr18:41,570,757...41,571,773
Ensembl chr18:41,570,757...41,571,773
JBrowse link
G OR5AN1 olfactory receptor family 5 subfamily AN member 1 decreases expression EXP bisphenol A results in decreased expression of OR5AN1 mRNA CTD PMID:38866337 NCBI chr18:37,329,690...37,330,628
Ensembl chr18:37,329,690...37,330,744
JBrowse link
G OR5AN5P olfactory receptor family 5 subfamily AN member 5, pseudogene decreases expression EXP bisphenol A results in decreased expression of OR5AN5P mRNA CTD PMID:38866337
G OR6Q1 olfactory receptor family 6 subfamily Q member 1 decreases expression EXP bisphenol A results in decreased expression of OR6AE1 mRNA CTD PMID:38866337 NCBI chr18:38,284,202...38,285,308
Ensembl chr18:38,284,202...38,285,155
JBrowse link
G OSR1 odd-skipped related transcription factor 1 increases expression EXP bisphenol A results in increased expression of OSR1 mRNA CTD PMID:38866337 NCBI chr17:14,508,543...14,515,657
Ensembl chr17:14,509,333...14,589,228
JBrowse link
G PAK1 p21 (RAC1) activated kinase 1 decreases expression EXP bisphenol A results in decreased expression of PAK1 mRNA CTD PMID:38866337 NCBI chr21:21,341,530...21,409,535
Ensembl chr21:21,265,484...21,408,416
JBrowse link
G PANK2 pantothenate kinase 2 increases expression EXP bisphenol A results in increased expression of PANK2 mRNA CTD PMID:38866337 NCBI chr24:17,461,406...17,475,248
Ensembl chr24:17,463,447...17,490,360
JBrowse link
G PARD3 par-3 family cell polarity regulator increases expression EXP bisphenol A results in increased expression of PARD3 mRNA CTD PMID:38866337 NCBI chr 2:2,252,262...2,791,459
Ensembl chr 2:2,076,502...2,789,886
JBrowse link
G PARP15 poly(ADP-ribose) polymerase family member 15 decreases expression EXP bisphenol A results in decreased expression of PARP15 mRNA CTD PMID:38866337 NCBI chr33:25,689,618...25,737,179
Ensembl chr33:25,700,353...25,735,540
JBrowse link
G PARP2 poly(ADP-ribose) polymerase 2 increases expression EXP bisphenol A results in increased expression of PARP2 mRNA CTD PMID:38866337 NCBI chr15:17,705,966...17,716,743
Ensembl chr15:17,705,975...17,716,094
JBrowse link
G PCDH20 protocadherin 20 increases expression EXP bisphenol A results in increased expression of PCDH20 mRNA CTD PMID:38866337 NCBI chr22:17,150,498...17,156,091
Ensembl chr22:17,151,913...17,155,892
JBrowse link
G PCK1 phosphoenolpyruvate carboxykinase 1 increases expression EXP bisphenol A results in increased expression of PCK1 mRNA CTD PMID:38866337 NCBI chr24:42,538,858...42,544,200
Ensembl chr24:42,538,882...42,544,198
JBrowse link
G PCSK1 proprotein convertase subtilisin/kexin type 1 decreases expression EXP bisphenol A results in decreased expression of PCSK1 mRNA CTD PMID:38866337 NCBI chr 3:13,233,342...13,276,921
Ensembl chr 3:13,233,594...13,274,094
JBrowse link
G PDCD7 programmed cell death 7 increases expression EXP bisphenol A results in increased expression of PDCD7 mRNA CTD PMID:38866337 NCBI chr30:29,498,290...29,510,991
Ensembl chr30:29,475,498...29,510,575
JBrowse link
G PDGFRA platelet derived growth factor receptor alpha increases expression EXP bisphenol A results in increased expression of PDGFRA mRNA CTD PMID:38866337 NCBI chr13:46,729,722...46,775,828
Ensembl chr13:46,730,703...46,773,278
JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 increases expression EXP bisphenol A results in increased expression of PDK4 mRNA CTD PMID:38866337 NCBI chr14:20,825,861...20,839,290
Ensembl chr14:20,827,831...20,839,256
JBrowse link
G PDLIM5 PDZ and LIM domain 5 decreases expression EXP bisphenol A results in decreased expression of PDLIM5 mRNA CTD PMID:38866337 NCBI chr32:17,294,023...17,505,212
Ensembl chr32:17,294,073...17,502,409
JBrowse link
G PEG3 paternally expressed 3 increases expression EXP bisphenol A results in increased expression of PEG3 mRNA CTD PMID:38866337 NCBI chr 1:101,091,161...101,123,552
Ensembl chr 1:101,098,669...101,121,032
JBrowse link
G PELI1 pellino E3 ubiquitin protein ligase 1 increases expression EXP bisphenol A results in increased expression of PELI1 mRNA CTD PMID:38866337 NCBI chr10:63,727,905...63,863,599
Ensembl chr10:63,729,604...63,743,303
JBrowse link
G PFDN2 prefoldin subunit 2 decreases expression EXP bisphenol A results in decreased expression of PFDN2 mRNA CTD PMID:38866337 NCBI chr38:21,355,622...21,367,623
Ensembl chr38:21,355,678...21,367,619
JBrowse link
G PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 increases expression EXP bisphenol A results in increased expression of PFKFB2 mRNA CTD PMID:38866337 NCBI chr 7:6,193,519...6,220,034
Ensembl chr 7:6,196,656...6,218,397
JBrowse link
G PFN4 profilin family member 4 decreases expression EXP bisphenol A results in decreased expression of PFN4 mRNA CTD PMID:38866337 NCBI chr17:18,571,201...18,579,593
Ensembl chr17:18,573,445...18,578,818
JBrowse link
G PGAM1 phosphoglycerate mutase 1 decreases expression EXP bisphenol A results in decreased expression of PGAM1 mRNA CTD PMID:38866337 NCBI chr28:10,720,235...10,727,709
Ensembl chr28:10,720,094...10,930,286
JBrowse link
G PGK1 phosphoglycerate kinase 1 decreases expression EXP bisphenol A results in decreased expression of PGK1 mRNA CTD PMID:38866337 NCBI chr  X:60,374,743...60,396,244
Ensembl chr  X:60,374,754...60,423,947
JBrowse link
G PGR progesterone receptor decreases expression EXP bisphenol A results in decreased expression of PGR mRNA CTD PMID:38866337 NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
JBrowse link
G PHKA1 phosphorylase kinase regulatory subunit alpha 1 increases expression EXP bisphenol A results in increased expression of PHKA1 mRNA CTD PMID:38866337 NCBI chr  X:56,579,538...56,758,293
Ensembl chr  X:56,581,435...56,757,905
JBrowse link
G PIAS1 protein inhibitor of activated STAT 1 increases expression EXP bisphenol A results in increased expression of PIAS1 mRNA CTD PMID:38866337 NCBI chr30:32,116,363...32,232,530
Ensembl chr30:32,119,311...32,228,945
JBrowse link
G PIF1 PIF1 5'-to-3' DNA helicase increases expression EXP bisphenol A results in increased expression of PIF1 mRNA CTD PMID:38866337 NCBI chr30:29,223,507...29,232,584
Ensembl chr30:29,157,119...29,232,043
JBrowse link
G PIK3IP1 phosphoinositide-3-kinase interacting protein 1 increases expression EXP bisphenol A results in increased expression of PIK3IP1 mRNA CTD PMID:38866337 NCBI chr26:24,243,195...24,255,335
Ensembl chr26:24,244,772...24,255,131
JBrowse link
G PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 increases expression EXP bisphenol A results in increased expression of PIK3R1 mRNA CTD PMID:38866337 NCBI chr 2:53,447,802...53,527,563
Ensembl chr 2:53,448,286...53,524,970
JBrowse link
G PIKFYVE phosphoinositide kinase, FYVE-type zinc finger containing increases expression EXP bisphenol A results in increased expression of PIKFYVE mRNA CTD PMID:38866337 NCBI chr37:16,537,095...16,620,427
Ensembl chr37:16,541,562...16,619,554
JBrowse link
G PIP4K2C phosphatidylinositol-5-phosphate 4-kinase type 2 gamma increases expression EXP bisphenol A results in increased expression of PIP4K2C mRNA CTD PMID:38866337 NCBI chr10:1,670,076...1,680,975
Ensembl chr10:1,672,380...1,680,840
JBrowse link
G PJA1 praja ring finger ubiquitin ligase 1 decreases expression EXP bisphenol A results in decreased expression of PJA1 mRNA CTD PMID:38866337 NCBI chr  X:53,608,459...53,614,270 JBrowse link
G PKD2 polycystin 2, transient receptor potential cation channel increases expression EXP bisphenol A results in increased expression of PKD2 mRNA CTD PMID:38866337 NCBI chr32:11,383,441...11,437,603
Ensembl chr32:11,383,424...11,435,438
JBrowse link
G PKDREJ polycystin family receptor for egg jelly increases expression EXP bisphenol A results in increased expression of PKDREJ mRNA CTD PMID:38866337 NCBI chr10:19,914,217...19,921,766
Ensembl chr10:19,914,721...19,920,822
JBrowse link
G PKP2 plakophilin 2 decreases expression EXP bisphenol A results in decreased expression of PKP2 mRNA CTD PMID:38866337 NCBI chr27:16,023,186...16,109,978
Ensembl chr27:16,023,224...16,109,603
JBrowse link
G PLAA phospholipase A2 activating protein increases expression EXP bisphenol A results in increased expression of PLAA mRNA CTD PMID:38866337 NCBI chr11:45,121,423...45,159,093
Ensembl chr11:45,121,588...45,159,098
JBrowse link
G PLAGL1 PLAG1 like zinc finger 1 decreases expression EXP bisphenol A results in decreased expression of PLAGL1 mRNA CTD PMID:38866337 NCBI chr 1:35,418,470...35,529,230
Ensembl chr 1:35,419,577...35,528,530
JBrowse link
G PLD4 phospholipase D family member 4 increases expression EXP bisphenol A results in increased expression of PLD4 mRNA CTD PMID:38866337 NCBI chr 8:72,410,076...72,417,681
Ensembl chr 8:72,416,637...72,417,384
JBrowse link
G PLEKHA2 pleckstrin homology domain containing A2 decreases expression EXP bisphenol A results in decreased expression of PLEKHA2 mRNA CTD PMID:38866337 NCBI chr16:26,570,466...26,644,971
Ensembl chr16:26,572,641...26,629,495
JBrowse link
G PLIN1 perilipin 1 increases expression EXP bisphenol A results in increased expression of PLIN1 mRNA CTD PMID:38866337 NCBI chr 3:52,657,178...52,670,573
Ensembl chr 3:52,658,427...52,671,196
JBrowse link
G PLOD2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 decreases expression EXP bisphenol A results in decreased expression of PLOD2 mRNA CTD PMID:38866337 NCBI chr23:41,290,183...41,382,917
Ensembl chr23:41,290,567...41,382,807
JBrowse link
G PLSCR4 phospholipid scramblase 4 increases expression EXP bisphenol A results in increased expression of PLSCR4 mRNA CTD PMID:38866337 NCBI chr23:41,415,151...41,453,727
Ensembl chr23:41,415,079...41,450,001
JBrowse link
G PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 decreases expression EXP bisphenol A results in decreased expression of PMAIP1 mRNA CTD PMID:38866337 NCBI chr 1:16,469,793...16,472,910
Ensembl chr 1:16,469,793...16,472,910
JBrowse link
G PMEL premelanosome protein increases expression EXP bisphenol A results in increased expression of PMEL mRNA CTD PMID:38866337 NCBI chr10:292,595...327,618
Ensembl chr10:292,597...300,098
JBrowse link
G PNCK pregnancy up-regulated nonubiquitous CaM kinase decreases expression EXP bisphenol A results in decreased expression of PNCK mRNA CTD PMID:38866337 NCBI chr  X:121,489,041...121,491,356
Ensembl chr  X:121,489,040...121,491,431
JBrowse link
G PNMA8A PNMA family member 8A increases expression EXP bisphenol A results in increased expression of PNMA8A mRNA CTD PMID:38866337 NCBI chr 1:109,401,900...109,405,955 JBrowse link
G POC1B POC1 centriolar protein B increases expression EXP bisphenol A results in increased expression of POC1B mRNA CTD PMID:38866337 NCBI chr15:30,388,351...30,481,294
Ensembl chr15:30,382,033...30,483,135
JBrowse link
G POLA1 DNA polymerase alpha 1, catalytic subunit increases expression EXP bisphenol A results in increased expression of POLA1 mRNA CTD PMID:38866337 NCBI chr  X:20,227,808...20,537,893
Ensembl chr  X:20,227,886...20,537,902
JBrowse link
G POLR1B RNA polymerase I subunit B increases expression EXP bisphenol A results in increased expression of POLR1B mRNA CTD PMID:38866337 NCBI chr17:36,774,472...36,798,900
Ensembl chr17:36,774,541...36,797,525
JBrowse link
G POLR2L RNA polymerase II, I and III subunit L increases expression EXP bisphenol A results in increased expression of POLR2L mRNA CTD PMID:38866337 NCBI chr18:45,201,194...45,203,825 JBrowse link
G POLR3B RNA polymerase III subunit B increases expression EXP bisphenol A results in increased expression of POLR3B mRNA CTD PMID:38866337 NCBI chr10:32,202,188...32,309,775
Ensembl chr10:32,202,190...32,309,614
JBrowse link
G POSTN periostin decreases expression EXP bisphenol A results in decreased expression of POSTN mRNA CTD PMID:38866337 NCBI chr25:3,167,319...3,208,970
Ensembl chr25:3,167,359...3,208,411
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma increases expression EXP bisphenol A results in increased expression of PPARG mRNA CTD PMID:38866337 NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
JBrowse link
G PPFIA1 PTPRF interacting protein alpha 1 increases expression EXP bisphenol A results in increased expression of PPFIA1 mRNA CTD PMID:38866337 NCBI chr18:47,974,109...48,060,331
Ensembl chr18:47,975,441...48,058,377
JBrowse link
G PPFIBP2 PPFIA binding protein 2 increases expression EXP bisphenol A results in increased expression of PPFIBP2 mRNA CTD PMID:38866337 NCBI chr21:31,165,386...31,335,231
Ensembl chr21:31,165,194...31,334,973
JBrowse link
G PPM1B protein phosphatase, Mg2+/Mn2+ dependent 1B increases expression EXP bisphenol A results in increased expression of PPM1B mRNA CTD PMID:38866337 NCBI chr10:46,590,110...46,680,792
Ensembl chr10:46,590,079...46,665,866
JBrowse link
G PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D increases expression EXP bisphenol A results in increased expression of PPM1D mRNA CTD PMID:38866337 NCBI chr 9:35,856,277...35,914,096
Ensembl chr 9:35,856,765...35,913,884
JBrowse link
G PPM1J protein phosphatase, Mg2+/Mn2+ dependent 1J increases expression EXP bisphenol A results in increased expression of PPM1J mRNA CTD PMID:38866337 NCBI chr17:62,858,620...62,863,869
Ensembl chr17:62,858,338...62,863,884
JBrowse link
G PPP1R14A protein phosphatase 1 regulatory inhibitor subunit 14A decreases expression EXP bisphenol A results in decreased expression of PPP1R14A mRNA CTD PMID:38866337 NCBI chr 1:114,739,823...114,743,663
Ensembl chr 1:114,740,117...114,741,910
JBrowse link
G PPP1R1A protein phosphatase 1 regulatory inhibitor subunit 1A decreases expression EXP bisphenol A results in decreased expression of PPP1R1A mRNA CTD PMID:38866337 NCBI chr27:766,757...770,994
Ensembl chr27:766,338...771,598
JBrowse link
G PPP1R3B protein phosphatase 1 regulatory subunit 3B decreases expression EXP bisphenol A results in decreased expression of PPP1R3B mRNA CTD PMID:38866337 NCBI chr16:35,372,928...35,384,640
Ensembl chr16:35,372,859...35,381,921
JBrowse link
G PPP2R1B protein phosphatase 2 scaffold subunit Abeta increases expression EXP bisphenol A results in increased expression of PPP2R1B mRNA CTD PMID:38866337 NCBI chr 5:21,323,956...21,356,835
Ensembl chr 5:21,322,059...21,394,193
JBrowse link
G PPP2R5A protein phosphatase 2 regulatory subunit B'alpha increases expression EXP bisphenol A results in increased expression of PPP2R5A mRNA CTD PMID:38866337 NCBI chr 7:10,502,959...10,566,475
Ensembl chr 7:10,502,930...10,565,404
JBrowse link
G PPP4R3A protein phosphatase 4 regulatory subunit 3A increases expression EXP bisphenol A results in increased expression of PPP4R3A mRNA CTD PMID:38866337 NCBI chr 8:62,304,805...62,344,232
Ensembl chr 8:62,305,947...62,344,147
JBrowse link
G PPTC7 protein phosphatase targeting COQ7 increases expression EXP bisphenol A results in increased expression of PPTC7 mRNA CTD PMID:38866337 NCBI chr26:8,345,690...8,383,902
Ensembl chr26:8,349,453...8,383,617
JBrowse link
G PRELID3A PRELI domain containing 3A increases expression EXP bisphenol A results in increased expression of PRELID3A mRNA CTD PMID:38866337 NCBI chr 7:77,826,003...77,873,568
Ensembl chr 7:77,832,134...77,836,987
JBrowse link
G PRKAG2 protein kinase AMP-activated non-catalytic subunit gamma 2 decreases expression EXP bisphenol A results in decreased expression of PRKAG2 mRNA CTD PMID:38866337 NCBI chr16:15,521,304...15,786,237
Ensembl chr16:15,522,111...15,785,854
JBrowse link
G PRKCZ protein kinase C zeta increases expression EXP bisphenol A results in increased expression of PRKCZ mRNA CTD PMID:38866337 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit increases expression EXP bisphenol A results in increased expression of PRKDC mRNA CTD PMID:38866337 NCBI chr29:24,904...243,926
Ensembl chr29:35,007...243,895
JBrowse link
G PRLR prolactin receptor increases expression EXP bisphenol A results in increased expression of PRLR mRNA CTD PMID:38866337 NCBI chr 4:73,147,919...73,280,970
Ensembl chr 4:73,110,858...73,273,916
JBrowse link
G PRPSAP2 phosphoribosyl pyrophosphate synthetase associated protein 2 decreases expression EXP bisphenol A results in decreased expression of PRPSAP2 mRNA CTD PMID:38866337 NCBI chr 5:41,118,591...41,167,647
Ensembl chr 5:41,039,015...41,167,568
JBrowse link
G PRR14L proline rich 14 like increases expression EXP bisphenol A results in increased expression of PRR14L mRNA CTD PMID:38866337 NCBI chr26:24,570,777...24,624,151
Ensembl chr26:24,570,880...24,622,166
JBrowse link
G PRSS23 serine protease 23 decreases expression EXP bisphenol A results in decreased expression of PRSS23 mRNA CTD PMID:38866337 NCBI chr21:12,792,212...12,813,067
Ensembl chr21:12,793,373...12,803,136
JBrowse link
G PRUNE1 prune exopolyphosphatase 1 increases expression EXP bisphenol A results in increased expression of PRUNE1 mRNA CTD PMID:38866337 NCBI chr17:60,104,724...60,125,899
Ensembl chr17:60,104,958...60,124,900
JBrowse link
G PSAT1 phosphoserine aminotransferase 1 decreases expression EXP bisphenol A results in decreased expression of PSAT1 mRNA CTD PMID:38866337 NCBI chr 1:80,376,469...80,408,177
Ensembl chr 1:80,377,115...80,408,162
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP bisphenol A results in decreased expression of PTGS2 mRNA CTD PMID:38866337 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
G PTHLH parathyroid hormone like hormone decreases expression EXP bisphenol A results in decreased expression of PTHLH mRNA CTD PMID:38866337 NCBI chr27:19,781,557...19,795,078
Ensembl chr27:19,781,557...19,795,078
JBrowse link
G PTPN13 protein tyrosine phosphatase non-receptor type 13 increases expression EXP bisphenol A results in increased expression of PTPN13 mRNA CTD PMID:38866337 NCBI chr32:10,125,447...10,328,764
Ensembl chr32:10,125,441...10,328,757
JBrowse link
G PXMP4 peroxisomal membrane protein 4 increases expression EXP bisphenol A results in increased expression of PXMP4 mRNA CTD PMID:38866337 NCBI chr24:22,916,336...22,930,082
Ensembl chr24:22,918,363...22,930,036
JBrowse link
G PYGL glycogen phosphorylase L increases expression EXP bisphenol A results in increased expression of PYGL mRNA CTD PMID:38866337 NCBI chr 8:27,264,778...27,307,977
Ensembl chr 8:27,223,273...27,307,977
JBrowse link
G QPCT glutaminyl-peptide cyclotransferase decreases expression EXP bisphenol A results in decreased expression of QPCT mRNA CTD PMID:38866337 NCBI chr17:29,700,422...29,741,652
Ensembl chr17:29,716,378...29,741,221
JBrowse link
G QRFP pyroglutamylated RFamide peptide increases expression EXP bisphenol A results in increased expression of QRFP mRNA CTD PMID:38866337 NCBI chr 9:53,110,763...53,113,743
Ensembl chr 9:53,112,586...53,112,996
JBrowse link
G RAB6A RAB6A, member RAS oncogene family decreases expression EXP bisphenol A results in decreased expression of RAB6A mRNA CTD PMID:38866337 NCBI chr21:24,489,653...24,578,212
Ensembl chr21:24,492,359...24,576,524
JBrowse link
G RABEP1 rabaptin, RAB GTPase binding effector protein 1 increases expression EXP bisphenol A results in increased expression of RABEP1 mRNA CTD PMID:38866337 NCBI chr 5:31,390,873...31,442,585
Ensembl chr 5:31,391,576...31,491,506
JBrowse link
G RABGAP1 RAB GTPase activating protein 1 increases expression EXP bisphenol A results in increased expression of RABGAP1 mRNA CTD PMID:38866337 NCBI chr 9:59,692,621...59,860,392
Ensembl chr 9:59,694,098...59,836,532
JBrowse link
G RAI14 retinoic acid induced 14 decreases expression EXP bisphenol A results in decreased expression of RAI14 mRNA CTD PMID:38866337 NCBI chr 4:73,460,728...73,599,070
Ensembl chr 4:73,461,523...73,585,173
JBrowse link
G RALGAPA1 Ral GTPase activating protein catalytic subunit alpha 1 increases expression EXP bisphenol A results in increased expression of RALGAPA1 mRNA CTD PMID:38866337 NCBI chr 8:14,221,516...14,463,481
Ensembl chr 8:14,222,749...14,462,998
JBrowse link
G RALGAPB Ral GTPase activating protein non-catalytic subunit beta increases expression EXP bisphenol A results in increased expression of RALGAPB mRNA CTD PMID:38866337 NCBI chr24:26,948,626...27,032,092
Ensembl chr24:26,961,628...27,070,850
JBrowse link
G RALGPS2 Ral GEF with PH domain and SH3 binding motif 2 decreases expression EXP bisphenol A results in decreased expression of RALGPS2 mRNA CTD PMID:38866337 NCBI chr 7:20,874,227...21,031,817
Ensembl chr 7:20,879,492...21,005,154
JBrowse link
G RAP2C RAP2C, member of RAS oncogene family decreases expression EXP bisphenol A results in decreased expression of RAP2C mRNA CTD PMID:38866337 NCBI chr  X:103,134,752...103,150,900
Ensembl chr  X:103,145,635...103,150,934
JBrowse link
G RAPGEF3 Rap guanine nucleotide exchange factor 3 increases expression EXP bisphenol A results in increased expression of RAPGEF3 mRNA CTD PMID:38866337 NCBI chr27:6,993,452...7,030,372
Ensembl chr27:6,993,452...7,017,316
JBrowse link
G RAPGEF5 Rap guanine nucleotide exchange factor 5 increases expression EXP bisphenol A results in increased expression of RAPGEF5 mRNA CTD PMID:38866337 NCBI chr14:35,979,393...36,208,849
Ensembl chr14:35,982,444...36,209,214
JBrowse link
G RASSF2 Ras association domain family member 2 increases expression EXP bisphenol A results in increased expression of RASSF2 mRNA CTD PMID:38866337 NCBI chr24:16,736,786...16,779,910
Ensembl chr24:16,736,962...16,781,569
JBrowse link
G RASSF4 Ras association domain family member 4 decreases expression EXP bisphenol A results in decreased expression of RASSF4 mRNA CTD PMID:38866337 NCBI chr28:2,450,935...2,473,461
Ensembl chr28:2,452,175...2,482,880
JBrowse link
G RBM11 RNA binding motif protein 11 decreases expression EXP bisphenol A results in decreased expression of RBM11 mRNA CTD PMID:38866337 NCBI chr31:11,204,273...11,217,526
Ensembl chr31:11,203,207...11,217,509
JBrowse link
G RBM6 RNA binding motif protein 6 increases expression EXP bisphenol A results in increased expression of RBM6 mRNA CTD PMID:38866337 NCBI chr20:39,235,301...39,359,784
Ensembl chr20:39,235,421...39,334,107
JBrowse link
G RBP4 retinol binding protein 4 decreases expression EXP bisphenol A results in decreased expression of RBP4 mRNA CTD PMID:38866337 NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
JBrowse link
G RBPJL recombination signal binding protein for immunoglobulin kappa J region like increases expression EXP bisphenol A results in increased expression of RBPJL mRNA CTD PMID:38866337 NCBI chr24:32,615,934...32,625,183
Ensembl chr24:32,612,386...32,624,567
JBrowse link
G RCN1 reticulocalbin 1 decreases expression EXP bisphenol A results in decreased expression of RCN1 mRNA CTD PMID:38866337 NCBI chr18:35,373,175...35,393,389
Ensembl chr18:35,374,116...35,395,528
JBrowse link
G REPS2 RALBP1 associated Eps domain containing 2 decreases expression EXP bisphenol A results in decreased expression of REPS2 mRNA CTD PMID:38866337 NCBI chr  X:13,088,980...13,320,534
Ensembl chr  X:13,088,349...13,307,402
JBrowse link
G RERG RAS like estrogen regulated growth inhibitor increases expression EXP bisphenol A results in increased expression of RERG mRNA CTD PMID:38866337 NCBI chr27:31,413,464...31,526,838
Ensembl chr27:31,417,487...31,525,496
JBrowse link
G RETREG3 reticulophagy regulator family member 3 increases expression EXP bisphenol A results in increased expression of RETREG3 mRNA CTD PMID:38866337 NCBI chr 9:20,363,729...20,385,580
Ensembl chr 9:20,363,823...20,385,592
JBrowse link
G REV3L REV3 like, DNA directed polymerase zeta catalytic subunit increases expression EXP bisphenol A results in increased expression of REV3L mRNA CTD PMID:38866337 NCBI chr12:67,776,285...67,953,337
Ensembl chr12:67,756,924...67,953,553
JBrowse link
G RHOBTB1 Rho related BTB domain containing 1 increases expression EXP bisphenol A results in increased expression of RHOBTB1 mRNA CTD PMID:38866337 NCBI chr 4:12,971,624...13,089,520
Ensembl chr 4:12,973,412...13,035,505
JBrowse link
G RHOQ ras homolog family member Q decreases expression EXP bisphenol A results in decreased expression of RHOQ mRNA CTD PMID:38866337 NCBI chr10:48,766,623...48,807,198
Ensembl chr10:48,768,191...48,804,129
JBrowse link
G RHOU ras homolog family member U increases expression EXP bisphenol A results in increased expression of RHOU mRNA CTD PMID:38866337 NCBI chr 4:10,395,033...10,406,239
Ensembl chr 4:10,396,111...10,406,244
JBrowse link
G RIBC2 RIB43A domain with coiled-coils 2 decreases expression EXP bisphenol A results in decreased expression of RIBC2 mRNA CTD PMID:38866337 NCBI chr10:20,625,423...20,640,266
Ensembl chr10:20,625,447...20,640,468
JBrowse link
G RILPL2 Rab interacting lysosomal protein like 2 increases expression EXP bisphenol A results in increased expression of RILPL2 mRNA CTD PMID:38866337 NCBI chr26:6,145,571...6,168,750
Ensembl chr26:6,145,937...6,168,625
JBrowse link
G RIMOC1 RAB7A interacting MON1-CCZ1 complex subunit 1 increases expression EXP bisphenol A results in increased expression of RIMOC1 mRNA CTD PMID:38866337 NCBI chr 4:67,668,727...67,688,509
Ensembl chr 4:67,672,923...67,688,451
JBrowse link
G RMND5A required for meiotic nuclear division 5 homolog A increases expression EXP bisphenol A results in increased expression of RMND5A mRNA CTD PMID:38866337 NCBI chr17:38,408,946...38,472,342
Ensembl chr17:38,412,967...38,472,395
JBrowse link
G RNASEL ribonuclease L increases expression EXP bisphenol A results in increased expression of RNASEL mRNA CTD PMID:38866337 NCBI chr 7:15,978,055...16,001,604
Ensembl chr 7:15,856,151...16,001,569
JBrowse link
G RNASET2 ribonuclease T2 increases expression EXP bisphenol A results in increased expression of RNASET2 mRNA CTD PMID:38866337 NCBI chr 1:54,779,453...54,820,697 JBrowse link
G RND1 Rho family GTPase 1 decreases expression EXP bisphenol A results in decreased expression of RND1 mRNA CTD PMID:38866337 NCBI chr27:5,679,629...5,686,657
Ensembl chr27:5,679,658...5,687,428
JBrowse link
G RND3 Rho family GTPase 3 decreases expression EXP bisphenol A results in decreased expression of RND3 mRNA CTD PMID:38866337 NCBI chr19:51,889,693...51,909,028
Ensembl chr19:51,891,494...51,909,033
JBrowse link
G RNF144B ring finger protein 144B decreases expression EXP bisphenol A results in decreased expression of RNF144B mRNA CTD PMID:38866337 NCBI chr35:17,056,189...17,226,254
Ensembl chr35:17,150,835...17,238,566
JBrowse link
G RNF169 ring finger protein 169 increases expression EXP bisphenol A results in increased expression of RNF169 mRNA CTD PMID:38866337 NCBI chr21:23,574,478...23,655,305
Ensembl chr21:23,579,370...23,655,290
JBrowse link
G RORB RAR related orphan receptor B increases expression EXP bisphenol A results in increased expression of RORB mRNA CTD PMID:38866337 NCBI chr 1:83,470,569...83,666,200
Ensembl chr 1:83,476,816...83,666,061
JBrowse link
G RRAD RRAD, Ras related glycolysis inhibitor and calcium channel regulator decreases expression EXP bisphenol A results in decreased expression of RRAD mRNA CTD PMID:38866337 NCBI chr 5:82,392,608...82,395,574
Ensembl chr 5:82,392,557...82,395,561
JBrowse link
G RRAS2 RAS related 2 decreases expression EXP bisphenol A results in decreased expression of RRAS2 mRNA CTD PMID:38866337 NCBI chr21:37,037,576...37,119,733
Ensembl chr21:37,038,334...37,112,662
JBrowse link
G RSPO1 R-spondin 1 increases expression EXP bisphenol A results in increased expression of RSPO1 mRNA CTD PMID:38866337 NCBI chr15:4,857,887...4,876,077
Ensembl chr15:4,856,853...4,876,800
JBrowse link
G RSPO3 R-spondin 3 decreases expression EXP bisphenol A results in decreased expression of RSPO3 mRNA CTD PMID:38866337 NCBI chr 1:65,858,822...65,936,160
Ensembl chr 1:65,858,794...65,936,322
JBrowse link
G RTF1 RTF1 homolog, Paf1/RNA polymerase II complex component increases expression EXP bisphenol A results in increased expression of RTF1 mRNA CTD PMID:38866337 NCBI chr30:8,468,001...8,524,712
Ensembl chr30:8,467,761...8,522,874
JBrowse link
G RUFY1 RUN and FYVE domain containing 1 increases expression EXP bisphenol A results in increased expression of RUFY1 mRNA CTD PMID:38866337 NCBI chr11:2,062,623...2,127,613
Ensembl chr11:2,052,901...2,127,746
JBrowse link
G RUNDC1 RUN domain containing 1 increases expression EXP bisphenol A results in increased expression of RUNDC1 mRNA CTD PMID:38866337 NCBI chr 9:20,071,040...20,080,597
Ensembl chr 9:20,072,446...20,080,528
JBrowse link
G S100A10 S100 calcium binding protein A10 increases expression EXP bisphenol A results in increased expression of S100A10 mRNA CTD PMID:38866337 NCBI chr17:60,984,138...60,994,915 JBrowse link
G SAP30L SAP30 like increases expression EXP bisphenol A results in increased expression of SAP30L mRNA CTD PMID:38866337 NCBI chr 4:55,247,912...55,261,655
Ensembl chr 4:55,252,938...55,262,207
JBrowse link
G SBF2 SET binding factor 2 increases expression EXP bisphenol A results in increased expression of SBF2 mRNA CTD PMID:38866337 NCBI chr21:33,005,921...33,461,258
Ensembl chr21:33,007,380...33,461,115
JBrowse link
G SCD stearoyl-CoA desaturase increases expression EXP bisphenol A results in increased expression of SCD mRNA CTD PMID:38866337 NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
JBrowse link
G SCUBE2 signal peptide, CUB domain and EGF like domain containing 2 increases expression EXP bisphenol A results in increased expression of SCUBE2 mRNA CTD PMID:38866337 NCBI chr21:32,370,361...32,435,608
Ensembl chr21:32,370,913...32,574,588
JBrowse link
G SDHA succinate dehydrogenase complex flavoprotein subunit A increases expression EXP bisphenol A results in increased expression of SDHA mRNA CTD PMID:38866337 NCBI chr34:11,935,684...11,965,094
Ensembl chr34:11,935,941...11,965,189
JBrowse link
G SEC16B SEC16 homolog B, endoplasmic reticulum export factor decreases expression EXP bisphenol A results in decreased expression of SEC16B mRNA CTD PMID:38866337 NCBI chr 7:21,683,310...21,739,914
Ensembl chr 7:21,698,411...21,738,954
JBrowse link
G SEMA3C semaphorin 3C decreases expression EXP bisphenol A results in decreased expression of SEMA3C mRNA CTD PMID:38866337 NCBI chr18:20,457,683...20,748,008
Ensembl chr18:20,459,925...20,635,276
JBrowse link
G SEMA3D semaphorin 3D decreases expression EXP bisphenol A results in decreased expression of SEMA3D mRNA CTD PMID:38866337 NCBI chr18:24,254,113...24,429,767
Ensembl chr18:24,262,125...24,394,155
JBrowse link
G SEMA6D semaphorin 6D increases expression EXP bisphenol A results in increased expression of SEMA6D mRNA CTD PMID:38866337 NCBI chr30:13,489,896...14,059,623
Ensembl chr30:14,005,124...14,057,202
JBrowse link
G SENP1 SUMO specific peptidase 1 increases expression EXP bisphenol A results in increased expression of SENP1 mRNA CTD PMID:38866337 NCBI chr27:6,664,750...6,719,257
Ensembl chr27:6,664,818...6,714,479
JBrowse link
G SEPHS1 selenophosphate synthetase 1 increases expression EXP bisphenol A results in increased expression of SEPHS1 mRNA CTD PMID:38866337 NCBI chr 2:23,147,303...23,178,808
Ensembl chr 2:23,146,353...23,177,174
JBrowse link
G SEPTIN11 septin 11 increases expression EXP bisphenol A results in increased expression of SEPTIN11 mRNA CTD PMID:38866337 NCBI chr32:1,553,208...1,608,132
Ensembl chr32:1,475,748...1,607,107
JBrowse link
G SERPINE2 serpin family E member 2 decreases expression EXP bisphenol A results in decreased expression of SERPINE2 mRNA CTD PMID:38866337 NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228
JBrowse link
G SERPINF1 serpin family F member 1 decreases expression EXP bisphenol A results in decreased expression of SERPINF1 mRNA CTD PMID:38866337 NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
JBrowse link
G SERPINI1 serpin family I member 1 decreases expression EXP bisphenol A results in decreased expression of SERPINI1 mRNA CTD PMID:38866337 NCBI chr34:32,553,876...32,624,708
Ensembl chr34:32,553,902...32,624,526
JBrowse link
G SERTAD3 SERTA domain containing 3 increases expression EXP bisphenol A results in increased expression of SERTAD3 mRNA CTD PMID:38866337 NCBI chr 1:113,258,274...113,264,013
Ensembl chr 1:113,261,354...113,263,899
JBrowse link
G SESN1 sestrin 1 increases expression EXP bisphenol A results in increased expression of SESN1 mRNA CTD PMID:38866337 NCBI chr12:65,958,995...66,057,369
Ensembl chr12:65,960,066...66,057,035
JBrowse link
G SETD2 SET domain containing 2, histone lysine methyltransferase increases expression EXP bisphenol A results in increased expression of SETD2 mRNA CTD PMID:38866337 NCBI chr20:41,675,539...41,800,697
Ensembl chr20:41,675,599...41,800,612
JBrowse link
G SFRP4 secreted frizzled related protein 4 decreases expression EXP bisphenol A results in decreased expression of SFRP4 mRNA CTD PMID:38866337 NCBI chr18:12,018,049...12,028,123
Ensembl chr18:12,017,978...12,027,788
JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 increases expression EXP bisphenol A results in increased expression of SGK1 mRNA CTD PMID:38866337 NCBI chr 1:27,086,431...27,196,601
Ensembl chr 1:27,087,361...27,196,521
JBrowse link
G SH2D4A SH2 domain containing 4A increases expression EXP bisphenol A results in increased expression of SH2D4A mRNA CTD PMID:38866337 NCBI chr16:22,138,555...22,209,326
Ensembl chr16:22,143,602...22,209,341
JBrowse link
G SH3D19 SH3 domain containing 19 increases expression EXP bisphenol A results in increased expression of SH3D19 mRNA CTD PMID:38866337 NCBI chr15:49,076,194...49,244,691
Ensembl chr15:49,081,803...49,168,312
JBrowse link
G SHC2 SHC adaptor protein 2 decreases expression EXP bisphenol A results in decreased expression of SHC2 mRNA CTD PMID:38866337 NCBI chr20:58,001,442...58,023,201 JBrowse link
G SIX4 SIX homeobox 4 decreases expression EXP bisphenol A results in decreased expression of SIX4 mRNA CTD PMID:38866337 NCBI chr 8:35,735,893...35,748,976
Ensembl chr 8:35,737,058...35,748,893
JBrowse link
G SLC16A12 solute carrier family 16 member 12 decreases expression EXP bisphenol A results in decreased expression of SLC16A12 mRNA CTD PMID:38866337 NCBI chr28:4,343,773...4,430,653
Ensembl chr28:4,345,546...4,421,234
JBrowse link
G SLC22A3 solute carrier family 22 member 3 increases expression EXP bisphenol A results in increased expression of SLC22A3 mRNA CTD PMID:38866337 NCBI chr 1:49,407,949...49,496,627
Ensembl chr 1:49,407,966...49,496,620
JBrowse link
G SLC23A2 solute carrier family 23 member 2 increases expression EXP bisphenol A results in increased expression of SLC23A2 mRNA CTD PMID:38866337 NCBI chr24:16,573,616...16,709,296
Ensembl chr24:16,574,168...16,709,296
JBrowse link
G SLC25A34 solute carrier family 25 member 34 increases expression EXP bisphenol A results in increased expression of SLC25A34 mRNA CTD PMID:38866337 NCBI chr 2:81,859,294...81,864,808
Ensembl chr 2:81,860,234...81,863,494
JBrowse link
G SLC25A47 solute carrier family 25 member 47 increases expression EXP bisphenol A results in increased expression of SLC25A47 mRNA CTD PMID:38866337 NCBI chr 8:68,602,525...68,607,364
Ensembl chr 8:68,602,662...68,606,875
JBrowse link
G SLC27A6 solute carrier family 27 member 6 increases expression EXP bisphenol A results in increased expression of SLC27A6 mRNA CTD PMID:38866337 NCBI chr11:17,899,270...17,968,940
Ensembl chr11:17,899,556...17,968,910
JBrowse link
G SLC38A1 solute carrier family 38 member 1 decreases expression EXP bisphenol A results in decreased expression of SLC38A1 mRNA CTD PMID:38866337 NCBI chr27:8,110,327...8,179,394
Ensembl chr27:8,130,823...8,174,936
JBrowse link
G SLC40A1 solute carrier family 40 member 1 increases expression EXP bisphenol A results in increased expression of SLC40A1 mRNA CTD PMID:38866337 NCBI chr37:308,054...329,037
Ensembl chr37:303,104...368,865
JBrowse link
G SLC44A1 solute carrier family 44 member 1 increases expression EXP bisphenol A results in increased expression of SLC44A1 mRNA CTD PMID:38866337 NCBI chr11:61,120,858...61,313,250
Ensembl chr11:61,120,176...61,312,590
JBrowse link
G SLMAP sarcolemma associated protein decreases expression EXP bisphenol A results in decreased expression of SLMAP mRNA CTD PMID:38866337 NCBI chr20:32,592,576...32,738,515
Ensembl chr20:32,594,417...32,738,823
JBrowse link
G SMAGP small cell adhesion glycoprotein decreases expression EXP bisphenol A results in decreased expression of SMAGP mRNA CTD PMID:38866337 NCBI chr27:3,614,888...3,616,519
Ensembl chr27:3,614,963...3,615,929
JBrowse link
G SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 increases expression EXP bisphenol A results in increased expression of SMCHD1 mRNA CTD PMID:38866337 NCBI chr 7:69,359,286...69,505,067
Ensembl chr 7:69,358,447...69,621,067
JBrowse link
G SMG8 SMG8 nonsense mediated mRNA decay factor increases expression EXP bisphenol A results in increased expression of SMG8 mRNA CTD PMID:38866337 NCBI chr 9:33,759,020...33,763,767
Ensembl chr 9:33,759,132...33,935,412
JBrowse link
G SMIM1 small integral membrane protein 1 decreases expression EXP bisphenol A results in decreased expression of SMIM1 mRNA CTD PMID:38866337 NCBI chr 5:58,281,962...58,285,071
Ensembl chr 5:58,282,347...58,284,616
JBrowse link
G SMIM2 small integral membrane protein 2 increases expression EXP bisphenol A results in increased expression of SMIM2 mRNA CTD PMID:38866337 NCBI chr22:6,741,203...6,742,866
Ensembl chr22:6,741,504...6,757,691
JBrowse link
G SNRK SNF related kinase increases expression EXP bisphenol A results in increased expression of SNRK mRNA CTD PMID:38866337 NCBI chr23:2,909,311...2,966,098
Ensembl chr23:2,909,298...2,965,508
JBrowse link
G SOCS2 suppressor of cytokine signaling 2 increases expression EXP bisphenol A results in increased expression of SOCS2 mRNA CTD PMID:38866337 NCBI chr15:33,761,434...33,788,973
Ensembl chr15:33,785,545...33,877,869
JBrowse link
G SP1 Sp1 transcription factor increases expression EXP bisphenol A results in increased expression of SP1 mRNA CTD PMID:38866337 NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226
JBrowse link
G SPAAR small regulatory polypeptide of amino acid response increases expression EXP bisphenol A results in increased expression of SPAAR mRNA CTD PMID:38866337 NCBI chr11:52,424,607...52,427,288
Ensembl chr11:52,426,076...52,426,303
JBrowse link
G SPACA9 sperm acrosome associated 9 increases expression EXP bisphenol A results in increased expression of SPACA9 mRNA CTD PMID:38866337 NCBI chr 9:51,460,359...51,470,612
Ensembl chr 9:51,460,623...51,468,902
JBrowse link
G SPATA20 spermatogenesis associated 20 decreases expression EXP bisphenol A results in decreased expression of SPATA20 mRNA CTD PMID:38866337 NCBI chr 9:26,468,931...26,476,218
Ensembl chr 9:26,468,208...26,476,211
JBrowse link
G SPATS2L spermatogenesis associated serine rich 2 like decreases expression EXP bisphenol A results in decreased expression of SPATS2L mRNA CTD PMID:38866337 NCBI chr37:9,403,557...9,564,466
Ensembl chr37:9,407,101...9,586,913
JBrowse link
G SPG11 SPG11 vesicle trafficking associated, spatacsin increases expression EXP bisphenol A results in increased expression of SPG11 mRNA CTD PMID:38866337 NCBI chr30:11,233,709...11,305,454
Ensembl chr30:11,233,718...11,305,485
JBrowse link
G SPINT3 serine peptidase inhibitor, Kunitz type 3 increases expression EXP bisphenol A results in increased expression of SPINT3 mRNA CTD PMID:38866337 NCBI chr24:32,721,798...32,724,433
Ensembl chr24:32,721,798...32,724,408
JBrowse link
G SPRY2 sprouty RTK signaling antagonist 2 increases expression EXP bisphenol A results in increased expression of SPRY2 mRNA CTD PMID:38866337 NCBI chr22:33,366,139...33,371,102
Ensembl chr22:33,366,931...33,367,878
JBrowse link
G SPRYD4 SPRY domain containing 4 increases expression EXP bisphenol A results in increased expression of SPRYD4 mRNA CTD PMID:38866337 NCBI chr10:720,099...722,139
Ensembl chr10:720,046...722,119
JBrowse link
G SQOR sulfide quinone oxidoreductase decreases expression EXP bisphenol A results in decreased expression of SQOR mRNA CTD PMID:38866337 NCBI chr30:11,956,335...12,004,770
Ensembl chr30:11,956,366...12,004,765
JBrowse link
G SRSF5 serine and arginine rich splicing factor 5 increases expression EXP bisphenol A results in increased expression of SRSF5 mRNA CTD PMID:38866337 NCBI chr 8:43,514,048...43,519,019
Ensembl chr 8:43,514,076...43,518,481
JBrowse link
G SSH2 slingshot protein phosphatase 2 increases expression EXP bisphenol A results in increased expression of SSH2 mRNA CTD PMID:38866337 NCBI chr 9:43,726,726...43,907,199
Ensembl chr 9:43,731,635...43,907,220
JBrowse link
G SSR3 signal sequence receptor subunit 3 decreases expression EXP bisphenol A results in decreased expression of SSR3 mRNA CTD PMID:38866337 NCBI chr23:50,136,591...50,150,424
Ensembl chr23:50,138,909...50,150,415
JBrowse link
G ST6GALNAC5 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 decreases expression EXP bisphenol A results in decreased expression of ST6GALNAC5 mRNA CTD PMID:38866337 NCBI chr 6:69,706,717...69,867,760
Ensembl chr 6:69,709,114...69,867,648
JBrowse link
G STARD10 StAR related lipid transfer domain containing 10 decreases expression EXP bisphenol A results in decreased expression of STARD10 mRNA CTD PMID:38866337 NCBI chr21:25,439,189...25,466,614
Ensembl chr21:25,433,208...25,466,583
JBrowse link
G STAT2 signal transducer and activator of transcription 2 increases expression EXP bisphenol A results in increased expression of STAT2 mRNA CTD PMID:38866337 NCBI chr10:641,543...660,882
Ensembl chr10:642,718...658,546
JBrowse link
G STON1 stonin 1 decreases expression EXP bisphenol A results in decreased expression of STON1 mRNA CTD PMID:38866337 NCBI chr10:50,421,635...50,470,302
Ensembl chr10:50,436,715...50,467,878
JBrowse link
G STRADA STE20 related adaptor alpha decreases expression EXP bisphenol A results in decreased expression of STRADA mRNA CTD PMID:38866337 NCBI chr 9:11,684,905...11,712,515
Ensembl chr 9:11,684,663...11,712,432
JBrowse link
G STRBP spermatid perinuclear RNA binding protein increases expression EXP bisphenol A results in increased expression of STRBP mRNA CTD PMID:38866337 NCBI chr 9:59,543,172...59,689,035
Ensembl chr 9:59,614,129...59,689,032
JBrowse link
G STRIT1 small transmembrane regulator of ion transport 1 decreases expression EXP bisphenol A results in decreased expression of STRIT1 mRNA CTD PMID:38866337 NCBI chr23:49,131,218...49,134,728
Ensembl chr23:49,131,221...49,134,942
JBrowse link
G STX11 syntaxin 11 decreases expression EXP bisphenol A results in decreased expression of STX11 mRNA CTD PMID:38866337 NCBI chr 1:35,600,440...35,645,421
Ensembl chr 1:35,601,133...35,644,819
JBrowse link
G STXBP6 syntaxin binding protein 6 decreases expression EXP bisphenol A results in decreased expression of STXBP6 mRNA CTD PMID:38866337 NCBI chr 8:4,638,376...4,877,589
Ensembl chr 8:4,641,460...4,877,030
JBrowse link
G SULF2 sulfatase 2 increases expression EXP bisphenol A results in increased expression of SULF2 mRNA CTD PMID:38866337 NCBI chr24:34,732,000...34,850,347
Ensembl chr24:34,732,037...34,828,569
JBrowse link
G SULT1A1 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 increases expression EXP bisphenol A results in increased expression of SULT1A1 mRNA CTD PMID:38866337 NCBI chr 6:18,176,156...18,179,492
Ensembl chr 6:18,176,355...18,179,489
JBrowse link
G SUMF1 sulfatase modifying factor 1 increases expression EXP bisphenol A results in increased expression of SUMF1 mRNA CTD PMID:38866337 NCBI chr20:13,093,427...13,190,621
Ensembl chr20:13,092,901...13,299,314
JBrowse link
G SYCE2 synaptonemal complex central element protein 2 increases expression EXP bisphenol A results in increased expression of SYCE2 mRNA CTD PMID:38866337 NCBI chr20:49,267,985...49,285,986
Ensembl chr20:49,281,773...49,283,880
JBrowse link
G SYNE4 spectrin repeat containing nuclear envelope family member 4 increases expression EXP bisphenol A results in increased expression of SYNE4 mRNA CTD PMID:38866337 NCBI chr 1:116,676,365...116,686,911
Ensembl chr 1:116,670,841...116,680,515
JBrowse link
G SYTL2 synaptotagmin like 2 decreases expression EXP bisphenol A results in decreased expression of SYTL2 mRNA CTD PMID:38866337 NCBI chr21:13,639,054...13,756,332
Ensembl chr21:13,688,338...13,755,414
JBrowse link
G TACC3 transforming acidic coiled-coil containing protein 3 increases expression EXP bisphenol A results in increased expression of TACC3 mRNA CTD PMID:38866337 NCBI chr 3:62,368,641...62,380,898
Ensembl chr 3:62,368,642...62,381,024
JBrowse link
G TAF1 TATA-box binding protein associated factor 1 increases expression EXP bisphenol A results in increased expression of TAF1 mRNA CTD PMID:38866337 NCBI chr  X:55,693,091...55,764,268
Ensembl chr  X:55,693,194...55,763,683
JBrowse link
G TAF4B TATA-box binding protein associated factor 4b increases expression EXP bisphenol A results in increased expression of TAF4B mRNA CTD PMID:38866337 NCBI chr 7:62,276,885...62,402,838
Ensembl chr 7:62,278,061...62,402,375
JBrowse link
G TAOK1 TAO kinase 1 increases expression EXP bisphenol A results in increased expression of TAOK1 mRNA CTD PMID:38866337 NCBI chr 9:43,501,752...43,660,077
Ensembl chr 9:43,559,708...43,651,377
JBrowse link
G TBC1D20 TBC1 domain family member 20 increases expression EXP bisphenol A results in increased expression of TBC1D20 mRNA CTD PMID:38866337 NCBI chr24:20,400,647...20,419,652
Ensembl chr24:20,400,791...20,419,655
JBrowse link
G TBC1D22B TBC1 domain family member 22B increases expression EXP bisphenol A results in increased expression of TBC1D22B mRNA CTD PMID:38866337 NCBI chr12:6,289,704...6,367,643
Ensembl chr12:6,292,459...6,415,382
JBrowse link
G TBC1D8 TBC1 domain family member 8 increases expression EXP bisphenol A results in increased expression of TBC1D8 mRNA CTD PMID:38866337 NCBI chr10:41,718,975...41,831,950
Ensembl chr10:41,729,623...41,835,075
JBrowse link
G TBX5 T-box transcription factor 5 increases expression EXP bisphenol A results in increased expression of TBX5 mRNA CTD PMID:38866337 NCBI chr26:11,462,541...11,549,699
Ensembl chr26:11,463,653...11,506,446
JBrowse link
G TCEA3 transcription elongation factor A3 decreases expression EXP bisphenol A results in decreased expression of TCEA3 mRNA CTD PMID:38866337 NCBI chr 2:75,998,154...76,040,461
Ensembl chr 2:75,998,214...76,040,413
JBrowse link
G TCEAL3 transcription elongation factor A like 3 decreases expression EXP bisphenol A results in decreased expression of TCEAL3 mRNA CTD PMID:38866337 NCBI chr  X:77,021,480...77,023,881 JBrowse link
G TCEAL4 transcription elongation factor A (SII)-like 4 increases expression EXP bisphenol A results in increased expression of TCEAL4 mRNA CTD PMID:38866337 NCBI chr  X:77,010,138...77,012,431 JBrowse link
G TCP11 t-complex 11 increases expression EXP bisphenol A results in increased expression of TCP11 mRNA CTD PMID:38866337 NCBI chr12:4,286,863...4,306,152
Ensembl chr12:4,286,876...4,306,273
JBrowse link
G TCTN1 tectonic family member 1 increases expression EXP bisphenol A results in increased expression of TCTN1 mRNA CTD PMID:38866337 NCBI chr26:8,411,429...8,444,640
Ensembl chr26:8,407,105...8,437,027
JBrowse link
G TCTN3 tectonic family member 3 increases expression EXP bisphenol A results in increased expression of TCTN3 mRNA CTD PMID:38866337 NCBI chr28:9,155,758...9,181,721
Ensembl chr28:9,156,797...9,181,731
JBrowse link
G TDRP testis development related protein decreases expression EXP bisphenol A results in decreased expression of TDRP mRNA CTD PMID:38866337 NCBI chr25:37,484,952...37,525,672
Ensembl chr25:37,485,566...37,525,726
JBrowse link
G TERF2 telomeric repeat binding factor 2 increases expression EXP bisphenol A results in increased expression of TERF2 mRNA CTD PMID:38866337 NCBI chr 5:80,278,224...80,305,315
Ensembl chr 5:80,277,505...80,306,342
JBrowse link
G TEX28 testis expressed 28 decreases expression EXP bisphenol A results in decreased expression of TEX28 mRNA CTD PMID:38866337 NCBI chr  X:121,987,726...122,030,718
Ensembl chr  X:121,986,906...121,996,306
JBrowse link
G TFDP2 transcription factor Dp-2 increases expression EXP bisphenol A results in increased expression of TFDP2 mRNA CTD PMID:38866337 NCBI chr23:37,757,858...37,871,632
Ensembl chr23:37,757,685...37,871,612
JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 increases expression EXP bisphenol A results in increased expression of TGFBR2 mRNA CTD PMID:38866337 NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
JBrowse link
G TGFBR3 transforming growth factor beta receptor 3 increases expression EXP bisphenol A results in increased expression of TGFBR3 mRNA CTD PMID:38866337 NCBI chr 6:57,025,096...57,220,240
Ensembl chr 6:57,025,112...57,217,121
JBrowse link
G THADA THADA armadillo repeat containing increases expression EXP bisphenol A results in increased expression of THADA mRNA CTD PMID:38866337 NCBI chr10:45,754,873...46,084,496
Ensembl chr10:45,755,985...46,081,896
JBrowse link
G THAP11 THAP domain containing 11 increases expression EXP bisphenol A results in increased expression of THAP11 mRNA CTD PMID:38866337 NCBI chr 5:81,635,251...81,637,379
Ensembl chr 5:81,635,970...81,636,902
JBrowse link
G THEM5 thioesterase superfamily member 5 decreases expression EXP bisphenol A results in decreased expression of THEM5 mRNA CTD PMID:38866337 NCBI chr17:60,857,348...60,865,789
Ensembl chr17:60,857,350...60,865,579
JBrowse link
G THOC3 THO complex subunit 3 decreases expression EXP bisphenol A results in decreased expression of THOC3 mRNA CTD PMID:38866337 NCBI chr 4:37,130,944...37,151,479
Ensembl chr 4:37,057,940...37,199,448
Ensembl chr 4:37,057,940...37,199,448
JBrowse link
G THRAP3 thyroid hormone receptor associated protein 3 increases expression EXP bisphenol A results in increased expression of THRAP3 mRNA CTD PMID:38866337 NCBI chr15:5,955,469...6,022,442
Ensembl chr15:5,956,316...6,021,875
JBrowse link
G TMC7 transmembrane channel like 7 decreases expression EXP bisphenol A results in decreased expression of TMC7 mRNA CTD PMID:38866337 NCBI chr 6:25,855,162...25,917,214
Ensembl chr 6:25,855,223...25,907,762
JBrowse link
G TMCO2 transmembrane and coiled-coil domains 2 decreases expression EXP bisphenol A results in decreased expression of TMCO2 mRNA CTD PMID:38866337 NCBI chr15:2,714,751...2,717,545
Ensembl chr15:2,714,744...2,717,434
JBrowse link
G TMEM138 transmembrane protein 138 decreases expression EXP bisphenol A results in decreased expression of TMEM138 mRNA CTD PMID:38866337 NCBI chr18:55,033,586...55,040,001
Ensembl chr18:55,033,589...55,039,325
JBrowse link
G TMEM182 transmembrane protein 182 increases expression EXP bisphenol A results in increased expression of TMEM182 mRNA CTD PMID:38866337 NCBI chr10:40,227,230...40,283,747
Ensembl chr10:40,102,097...40,283,703
JBrowse link
G TMEM200B transmembrane protein 200B increases expression EXP bisphenol A results in increased expression of TMEM200B mRNA CTD PMID:38866337 NCBI chr 2:71,469,123...71,472,913 JBrowse link
G TMEM210 transmembrane protein 210 increases expression EXP bisphenol A results in increased expression of TMEM210 mRNA CTD PMID:38866337 NCBI chr 9:48,488,897...48,490,044
Ensembl chr 9:48,471,584...48,609,303
JBrowse link
G TMEM30B transmembrane protein 30B increases expression EXP bisphenol A results in increased expression of TMEM30B mRNA CTD PMID:38866337
G TMEM35A transmembrane protein 35A increases expression EXP bisphenol A results in increased expression of TMEM35A mRNA CTD PMID:38866337 NCBI chr  X:75,020,157...75,033,714
Ensembl chr  X:75,020,238...75,032,525
JBrowse link
G TMEM42 transmembrane protein 42 increases expression EXP bisphenol A results in increased expression of TMEM42 mRNA CTD PMID:38866337 NCBI chr20:43,446,963...43,451,241
Ensembl chr20:43,447,894...43,451,751
JBrowse link
G TMEM45A transmembrane protein 45A decreases expression EXP bisphenol A results in decreased expression of TMEM45A mRNA CTD PMID:38866337 NCBI chr33:7,075,693...7,141,013
Ensembl chr33:7,075,752...7,140,982
JBrowse link
G TMEM65 transmembrane protein 65 decreases expression EXP bisphenol A results in decreased expression of TMEM65 mRNA CTD PMID:38866337 NCBI chr13:22,426,487...22,494,520
Ensembl chr13:22,426,793...22,494,520
JBrowse link
G TMEM69 transmembrane protein 69 decreases expression EXP bisphenol A results in decreased expression of TMEM69 mRNA CTD PMID:38866337 NCBI chr15:14,666,926...14,671,839
Ensembl chr15:14,667,231...14,671,622
JBrowse link
G TMEM97 transmembrane protein 97 increases expression EXP bisphenol A results in increased expression of TMEM97 mRNA CTD PMID:38866337 NCBI chr 9:42,572,855...42,581,012
Ensembl chr 9:42,572,889...42,579,947
JBrowse link
G TMSB10 thymosin beta 10 decreases expression EXP bisphenol A results in decreased expression of TMSB10 mRNA CTD PMID:38866337 NCBI chr17:40,048,823...40,049,508
Ensembl chr17:40,048,828...40,049,470
JBrowse link
G TMT1A thiol methyltransferase 1A increases expression EXP bisphenol A results in increased expression of METTL7A mRNA CTD PMID:38866337 NCBI chr27:3,858,792...3,866,350
Ensembl chr27:3,857,454...3,866,448
JBrowse link
G TMTC1 transmembrane O-mannosyltransferase targeting cadherins 1 increases expression EXP bisphenol A results in increased expression of TMTC1 mRNA CTD PMID:38866337 NCBI chr27:18,252,642...18,519,802
Ensembl chr27:18,191,118...18,518,974
JBrowse link
G TNFAIP8L3 TNF alpha induced protein 8 like 3 decreases expression EXP bisphenol A results in decreased expression of TNFAIP8L3 mRNA CTD PMID:38866337 NCBI chr30:16,822,069...16,840,284
Ensembl chr30:16,822,969...16,823,529
JBrowse link
G TNFRSF21 TNF receptor superfamily member 21 increases expression EXP bisphenol A results in increased expression of TNFRSF21 mRNA CTD PMID:38866337 NCBI chr12:15,343,953...15,408,230 JBrowse link
G TOGARAM1 TOG array regulator of axonemal microtubules 1 increases expression EXP bisphenol A results in increased expression of TOGARAM1 mRNA CTD PMID:38866337 NCBI chr 8:22,420,718...22,499,435
Ensembl chr 8:22,420,584...22,497,671
JBrowse link
G TOP2A DNA topoisomerase II alpha increases expression EXP bisphenol A results in increased expression of TOP2A mRNA CTD PMID:38866337 NCBI chr 9:22,207,501...22,237,497
Ensembl chr 9:22,207,638...22,237,496
JBrowse link
G TPI1 triosephosphate isomerase 1 decreases expression EXP bisphenol A results in decreased expression of TPI1 mRNA CTD PMID:38866337 NCBI chr27:38,154,519...38,157,900
Ensembl chr27:38,154,519...38,158,137
JBrowse link
G TPM2 tropomyosin 2 decreases expression EXP bisphenol A results in decreased expression of TPM2 mRNA CTD PMID:38866337 NCBI chr11:52,212,372...52,219,947
Ensembl chr11:52,212,401...52,219,923
JBrowse link
G TPM4 tropomyosin 4 decreases expression EXP bisphenol A results in decreased expression of TPM4 mRNA CTD PMID:38866337 NCBI chr20:46,354,808...46,376,489
Ensembl chr20:46,355,736...46,376,425
JBrowse link
G TPR translocated promoter region, nuclear basket protein increases expression EXP bisphenol A results in increased expression of TPR mRNA CTD PMID:38866337 NCBI chr 7:19,376,951...19,442,368
Ensembl chr 7:19,376,975...19,442,303
JBrowse link
G TRARG1 trafficking regulator of GLUT4 (SLC2A4) 1 increases expression EXP bisphenol A results in increased expression of TRARG1 mRNA CTD PMID:38866337 NCBI chr 9:44,560,962...44,577,418
Ensembl chr 9:44,563,419...44,576,972
JBrowse link
G TRIM63 tripartite motif containing 63 increases expression EXP bisphenol A results in increased expression of TRIM63 mRNA CTD PMID:38866337 NCBI chr 2:73,841,868...73,918,371
Ensembl chr 2:73,888,689...73,909,414
JBrowse link
G TRNAC-GCA transfer RNA cysteine (anticodon GCA) decreases expression EXP bisphenol A results in decreased expression of TRNAC-GCA mRNA CTD PMID:38866337 NCBI chr16:14,451,086...14,451,157 JBrowse link
G TROAP trophinin associated protein increases expression EXP bisphenol A results in increased expression of TROAP mRNA CTD PMID:38866337 NCBI chr27:5,282,495...5,289,106
Ensembl chr27:5,282,497...5,289,124
JBrowse link
G TRPC2 transient receptor potential cation channel subfamily C member 2 increases expression EXP bisphenol A results in increased expression of TRPC2 mRNA CTD PMID:38866337 NCBI chr21:26,163,641...26,202,938 JBrowse link
G TSC22D1 TSC22 domain family member 1 increases expression EXP bisphenol A results in increased expression of TSC22D1 mRNA CTD PMID:38866337 NCBI chr22:6,375,585...6,506,511
Ensembl chr22:6,375,577...6,505,672
JBrowse link
G TSC22D3 TSC22 domain family member 3 increases expression EXP bisphenol A results in increased expression of TSC22D3 mRNA CTD PMID:38866337 NCBI chr  X:81,235,489...81,298,290
Ensembl chr  X:81,235,809...81,298,192
JBrowse link
G TSHZ2 teashirt zinc finger homeobox 2 increases expression EXP bisphenol A results in increased expression of TSHZ2 mRNA CTD PMID:38866337 NCBI chr24:39,124,993...39,354,202
Ensembl chr24:38,995,063...39,346,728
JBrowse link
G TSNAXIP1 translin associated factor X interacting protein 1 decreases expression EXP bisphenol A results in decreased expression of TSNAXIP1 mRNA CTD PMID:38866337 NCBI chr 5:81,647,135...81,662,106
Ensembl chr 5:81,647,141...81,661,562
JBrowse link
G TTC21A tetratricopeptide repeat domain 21A increases expression EXP bisphenol A results in increased expression of TTC21A mRNA CTD PMID:38866337 NCBI chr23:8,776,252...8,812,480
Ensembl chr23:8,781,582...8,811,031
JBrowse link
G TTC9C tetratricopeptide repeat domain 9C increases expression EXP bisphenol A results in increased expression of TTC9C mRNA CTD PMID:38866337 NCBI chr18:53,928,236...53,941,410
Ensembl chr18:53,932,696...53,940,930
JBrowse link
G TTLL5 tubulin tyrosine ligase like 5 increases expression EXP bisphenol A results in increased expression of TTLL5 mRNA CTD PMID:38866337 NCBI chr 8:48,651,766...48,920,733
Ensembl chr 8:48,651,814...48,920,039
JBrowse link
G TUFT1 tuftelin 1 decreases expression EXP bisphenol A results in decreased expression of TUFT1 mRNA CTD PMID:38866337 NCBI chr17:60,580,032...60,628,422
Ensembl chr17:60,580,082...60,627,174
JBrowse link
G TUT4 terminal uridylyl transferase 4 increases expression EXP bisphenol A results in increased expression of TUT4 mRNA CTD PMID:38866337 NCBI chr15:8,832,208...8,958,136
Ensembl chr15:8,832,199...9,047,152
JBrowse link
G TXNIP thioredoxin interacting protein increases expression EXP bisphenol A results in increased expression of TXNIP mRNA CTD PMID:38866337 NCBI chr17:58,775,588...58,779,730
Ensembl chr17:58,776,871...58,779,531
JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C decreases expression EXP bisphenol A results in decreased expression of UBE2C mRNA CTD PMID:38866337 NCBI chr24:33,128,300...33,133,637
Ensembl chr24:33,128,335...33,132,023
JBrowse link
G UBE2E2 ubiquitin conjugating enzyme E2 E2 decreases expression EXP bisphenol A results in decreased expression of UBE2E2 mRNA CTD PMID:38866337 NCBI chr23:20,110,128...20,593,767
Ensembl chr23:20,130,230...20,486,399
JBrowse link
G UBR1 ubiquitin protein ligase E3 component n-recognin 1 increases expression EXP bisphenol A results in increased expression of UBR1 mRNA CTD PMID:38866337 NCBI chr30:9,869,769...10,006,994
Ensembl chr30:9,870,021...10,006,947
JBrowse link
G UPP1 uridine phosphorylase 1 decreases expression EXP bisphenol A results in decreased expression of UPP1 mRNA CTD PMID:38866337 NCBI chr18:108,215...120,213 JBrowse link
G USP13 ubiquitin specific peptidase 13 increases expression EXP bisphenol A results in increased expression of USP13 mRNA CTD PMID:38866337 NCBI chr34:13,059,099...13,175,980
Ensembl chr34:13,059,092...13,171,234
JBrowse link
G USP18 ubiquitin specific peptidase 18 decreases expression EXP bisphenol A results in decreased expression of USP18 mRNA CTD PMID:38866337 NCBI chr27:45,739,845...45,814,668 JBrowse link
G USP24 ubiquitin specific peptidase 24 increases expression EXP bisphenol A results in increased expression of USP24 mRNA CTD PMID:38866337 NCBI chr 5:54,086,685...54,192,761
Ensembl chr 5:54,086,685...54,190,164
JBrowse link
G USP25 ubiquitin specific peptidase 25 increases expression EXP bisphenol A results in increased expression of USP25 mRNA CTD PMID:38866337 NCBI chr31:12,555,614...12,692,765
Ensembl chr31:12,555,595...12,691,694
JBrowse link
G USP34 ubiquitin specific peptidase 34 increases expression EXP bisphenol A results in increased expression of USP34 mRNA CTD PMID:38866337 NCBI chr10:61,264,605...61,459,603
Ensembl chr10:61,267,478...61,511,347
JBrowse link
G USP39 ubiquitin specific peptidase 39 increases expression EXP bisphenol A results in increased expression of USP39 mRNA CTD PMID:38866337 NCBI chr17:39,437,908...39,470,579
Ensembl chr17:39,438,329...39,470,549
JBrowse link
G USP4 ubiquitin specific peptidase 4 increases expression EXP bisphenol A results in increased expression of USP4 mRNA CTD PMID:38866337 NCBI chr20:39,899,880...39,952,959
Ensembl chr20:39,899,897...39,952,420
JBrowse link
G UST uronyl 2-sulfotransferase decreases expression EXP bisphenol A results in decreased expression of UST mRNA CTD PMID:38866337 NCBI chr 1:39,633,276...39,922,361
Ensembl chr 1:39,633,501...39,921,289
JBrowse link
G UTP20 UTP20 small subunit processome component increases expression EXP bisphenol A results in increased expression of UTP20 mRNA CTD PMID:38866337 NCBI chr15:40,291,344...40,387,200
Ensembl chr15:40,291,390...40,387,032
JBrowse link
G UTRN utrophin increases expression EXP bisphenol A results in increased expression of UTRN mRNA CTD PMID:38866337 NCBI chr 1:35,727,531...36,225,533
Ensembl chr 1:35,677,814...36,224,065
JBrowse link
G VAMP5 vesicle associated membrane protein 5 decreases expression EXP bisphenol A results in decreased expression of VAMP5 mRNA CTD PMID:38866337 NCBI chr17:39,488,877...39,495,795
Ensembl chr17:39,488,938...39,495,730
JBrowse link
G VAMP8 vesicle associated membrane protein 8 decreases expression EXP bisphenol A results in decreased expression of VAMP8 mRNA CTD PMID:38866337 NCBI chr17:39,497,628...39,501,734
Ensembl chr17:39,497,785...39,501,739
JBrowse link
G VDAC2 voltage dependent anion channel 2 decreases expression EXP bisphenol A results in decreased expression of VDAC2 mRNA CTD PMID:38866337 NCBI chr 4:25,449,926...25,462,147
Ensembl chr 4:25,449,442...25,462,335
JBrowse link
G VPS13B vacuolar protein sorting 13 homolog B increases expression EXP bisphenol A results in increased expression of VPS13B mRNA CTD PMID:38866337 NCBI chr13:1,101,226...1,834,933
Ensembl chr13:1,101,610...1,871,225
JBrowse link
G VRK3 VRK serine/threonine kinase 3 increases expression EXP bisphenol A results in increased expression of VRK3 mRNA CTD PMID:38866337 NCBI chr 1:106,564,151...106,601,321
Ensembl chr 1:106,564,110...106,598,332
JBrowse link
G VWA5A von Willebrand factor A domain containing 5A increases expression EXP bisphenol A results in increased expression of VWA5A mRNA CTD PMID:38866337 NCBI chr 5:10,337,879...10,362,299
Ensembl chr 5:10,325,266...10,362,641
JBrowse link
G VXN vexin decreases expression EXP bisphenol A results in decreased expression of VXN mRNA CTD PMID:38866337 NCBI chr29:16,078,154...16,101,873
Ensembl chr29:16,078,658...16,099,606
JBrowse link
G WASHC2C WASH complex subunit 2C decreases expression EXP bisphenol A results in decreased expression of WASHC2C mRNA CTD PMID:38866337 NCBI chr28:1,867,680...1,923,273 JBrowse link
G WDFY1 WD repeat and FYVE domain containing 1 increases expression EXP bisphenol A results in increased expression of WDFY1 mRNA CTD PMID:38866337 NCBI chr37:29,544,956...29,658,544
Ensembl chr37:29,444,082...29,677,312
JBrowse link
G WDR1 WD repeat domain 1 decreases expression EXP bisphenol A results in decreased expression of WDR1 mRNA CTD PMID:38866337 NCBI chr 3:69,305,731...69,348,183
Ensembl chr 3:69,305,731...69,348,177
JBrowse link
G WDR11 WD repeat domain 11 increases expression EXP bisphenol A results in increased expression of WDR11 mRNA CTD PMID:38866337 NCBI chr28:30,769,223...30,828,628
Ensembl chr28:30,769,219...30,828,049
JBrowse link
G WDR20 WD repeat domain 20 increases expression EXP bisphenol A results in increased expression of WDR20 mRNA CTD PMID:38866337 NCBI chr 8:70,150,090...70,208,683
Ensembl chr 8:70,146,967...70,199,975
JBrowse link
G WDR5 WD repeat domain 5 decreases expression EXP bisphenol A results in decreased expression of WDR5 mRNA CTD PMID:38866337 NCBI chr 9:50,352,600...50,371,224
Ensembl chr 9:50,352,472...50,371,236
JBrowse link
G WDR82 WD repeat domain 82 increases expression EXP bisphenol A results in increased expression of WDR82 mRNA CTD PMID:38866337 NCBI chr20:37,494,633...37,513,746
Ensembl chr20:37,355,494...37,511,125
JBrowse link
G XDH xanthine dehydrogenase increases expression EXP bisphenol A results in increased expression of XDH mRNA CTD PMID:38866337 NCBI chr17:24,900,708...24,960,748
Ensembl chr17:24,901,447...24,971,935
JBrowse link
G XRCC3 X-ray repair cross complementing 3 increases expression EXP bisphenol A results in increased expression of XRCC3 mRNA CTD PMID:38866337 NCBI chr 8:71,441,732...71,452,922
Ensembl chr 8:71,442,429...71,449,408
JBrowse link
G YIF1A Yip1 interacting factor homolog A, membrane trafficking protein decreases expression EXP bisphenol A results in decreased expression of YIF1A mRNA CTD PMID:38866337 NCBI chr18:51,015,575...51,019,909
Ensembl chr18:51,015,641...51,019,901
JBrowse link
G YIF1B Yip1 interacting factor homolog B, membrane trafficking protein decreases expression EXP bisphenol A results in decreased expression of YIF1B mRNA CTD PMID:38866337 NCBI chr 1:114,681,437...114,689,328
Ensembl chr 1:114,681,469...114,689,237
JBrowse link
G YPEL4 yippee like 4 increases expression EXP bisphenol A results in increased expression of YPEL4 mRNA CTD PMID:38866337 NCBI chr18:38,535,792...38,541,183
Ensembl chr18:38,539,190...38,540,303
JBrowse link
G ZAR1L zygote arrest 1 like increases expression EXP bisphenol A results in increased expression of ZAR1L mRNA CTD PMID:38866337 NCBI chr25:7,799,130...7,807,653
Ensembl chr25:7,799,615...7,856,230
JBrowse link
G ZC3H11A zinc finger CCCH-type containing 11A increases expression EXP bisphenol A results in increased expression of ZC3H11A mRNA CTD PMID:38866337 NCBI chr38:477,900...505,754 JBrowse link
G ZC3H12C zinc finger CCCH-type containing 12C decreases expression EXP bisphenol A results in decreased expression of ZC3H12C mRNA CTD PMID:38866337 NCBI chr 5:22,666,321...22,756,089
Ensembl chr 5:22,669,947...22,747,506
JBrowse link
G ZC3H6 zinc finger CCCH-type containing 6 increases expression EXP bisphenol A results in increased expression of ZC3H6 mRNA CTD PMID:38866337 NCBI chr17:36,620,959...36,688,438
Ensembl chr17:36,621,059...36,687,197
JBrowse link
G ZCCHC12 zinc finger CCHC-type containing 12 increases expression EXP bisphenol A results in increased expression of ZCCHC12 mRNA CTD PMID:38866337 NCBI chr  X:91,004,777...91,008,019 JBrowse link
G ZCCHC9 zinc finger CCHC-type containing 9 decreases expression EXP bisphenol A results in decreased expression of ZCCHC9 mRNA CTD PMID:38866337 NCBI chr 3:25,973,874...25,983,132
Ensembl chr 3:25,963,700...25,983,062
JBrowse link
G ZDHHC15 zinc finger DHHC-type palmitoyltransferase 15 increases expression EXP bisphenol A results in increased expression of ZDHHC15 mRNA CTD PMID:38866337 NCBI chr  X:58,641,182...58,812,671
Ensembl chr  X:58,645,650...58,812,671
JBrowse link
G ZDHHC3 zinc finger DHHC-type palmitoyltransferase 3 increases expression EXP bisphenol A results in increased expression of ZDHHC3 mRNA CTD PMID:38866337 NCBI chr20:43,379,669...43,433,101
Ensembl chr20:43,379,722...43,431,414
JBrowse link
G ZFAND5 zinc finger AN1-type containing 5 increases expression EXP bisphenol A results in increased expression of ZFAND5 mRNA CTD PMID:38866337 NCBI chr 1:85,420,091...85,429,843
Ensembl chr 1:85,420,127...85,428,424
JBrowse link
G ZKSCAN2 zinc finger with KRAB and SCAN domains 2 increases expression EXP bisphenol A results in increased expression of ZKSCAN2 mRNA CTD PMID:38866337 NCBI chr 6:20,958,058...20,977,182
Ensembl chr 6:20,958,395...20,973,507
JBrowse link
G ZKSCAN8 zinc finger with KRAB and SCAN domains 8 increases expression EXP bisphenol A results in increased expression of ZKSCAN8 mRNA CTD PMID:38866337 NCBI chr35:25,305,821...25,321,830
Ensembl chr35:25,305,610...25,317,780
JBrowse link
G ZNF445 zinc finger protein 445 increases expression EXP bisphenol A results in increased expression of ZNF445 mRNA CTD PMID:38866337 NCBI chr23:1,906,958...1,940,340
Ensembl chr23:1,927,625...1,939,382
JBrowse link
G ZNF556 zinc finger protein 556 increases expression EXP bisphenol A results in increased expression of ZNF556 mRNA CTD PMID:38866337 NCBI chr20:56,333,136...56,357,075
Ensembl chr20:56,336,162...56,347,541
JBrowse link
G ZNF622 zinc finger protein 622 increases expression EXP bisphenol A results in increased expression of ZNF622 mRNA CTD PMID:38866337 NCBI chr 4:86,929,947...86,943,711
Ensembl chr 4:86,826,892...86,951,542
JBrowse link
G ZNF81 zinc finger protein 81 decreases expression EXP bisphenol A results in decreased expression of ZNF81 mRNA CTD PMID:38866337 NCBI chr  X:41,353,241...41,460,082
Ensembl chr  X:41,353,440...41,593,082
JBrowse link
G ZSCAN22 zinc finger and SCAN domain containing 22 increases expression EXP bisphenol A results in increased expression of ZSCAN22 mRNA CTD PMID:38866337 NCBI chr 1:99,608,190...99,621,256
Ensembl chr 1:99,611,104...99,620,356
JBrowse link
blebbistatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 decreases localization EXP blebbistatin results in decreased localization of ABCB11 protein CTD PMID:15826951 NCBI chr36:13,742,895...13,835,312
Ensembl chr36:13,746,964...13,834,974
JBrowse link
bromosulfophthalein term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Sulfobromophthalein results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of Sulfobromophthalein CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
Butyrylcholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCHE butyrylcholinesterase increases hydrolysis
multiple interactions
EXP BCHE protein results in increased hydrolysis of butyrylcholine
Succinylcholine inhibits the reaction [BCHE protein results in increased hydrolysis of butyrylcholine]
CTD PMID:4631366 PMID:4985882 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
butyrylthiocholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCHE butyrylcholinesterase increases hydrolysis EXP BCHE protein results in increased hydrolysis of Butyrylthiocholine CTD PMID:22407886 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
calcein am term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC1 ATP binding cassette subfamily C member 1 affects export EXP ABCC1 protein affects the export of calcein AM CTD PMID:12516967 NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
JBrowse link
calcitriol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCL2 BCL2 apoptosis regulator affects expression EXP Calcitriol affects the expression of BCL2 protein CTD PMID:16080513 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
JBrowse link
calcium oxalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 multiple interactions
increases activity
EXP Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP3 protein] CTD PMID:25446497 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G CASP9 caspase 9 increases activity
multiple interactions
EXP Calcium Oxalate results in increased activity of CASP9 protein
Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein]
CTD PMID:25446497 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
JBrowse link
G TJP1 tight junction protein 1 multiple interactions
decreases expression
EXP Docetaxel inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein]; Phalloidine inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein] CTD PMID:34147488 PMID:36349591 NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
JBrowse link
calcium(0) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC8A1 solute carrier family 8 member A1 increases transport
multiple interactions
increases uptake
EXP SLC8A1 protein results in increased transport of Calcium
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [SLC8A1 protein results in increased transport of Calcium]; 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [SLC8A1 protein results in increased uptake of Calcium]; SEA 0400 inhibits the reaction [SLC8A1 protein results in increased uptake of Calcium]
CTD PMID:14660663 PMID:15375168 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
G TRPM8 transient receptor potential cation channel subfamily M member 8 multiple interactions EXP [icilin results in increased activity of TRPM8 protein] which results in increased transport of Calcium; [Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium; [mustard oil results in increased activity of TRPM8 protein] which results in increased transport of Calcium; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[icilin results in increased activity of TRPM8 protein] which results in increased transport of Calcium]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium]; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[mustard oil results in increased activity of TRPM8 protein] which results in increased transport of Calcium] CTD PMID:16386244 NCBI chr25:45,261,092...45,357,560
Ensembl chr25:45,261,107...45,353,282
JBrowse link
cannabidiol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CCL17 C-C motif chemokine ligand 17 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL17 promoter CTD PMID:33763461 NCBI chr 2:59,001,463...59,014,347
Ensembl chr 2:59,001,464...59,005,230
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL2 promoter CTD PMID:33763461 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G IL13 interleukin 13 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
JBrowse link
G IL31 interleukin 31 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr26:7,173,151...7,175,195
Ensembl chr26:7,172,451...7,175,195
JBrowse link
G IL31RA interleukin 31 receptor A multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of IL31RA promoter CTD PMID:33763461 NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293
JBrowse link
G IL4 interleukin 4 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
JBrowse link
G TSLP thymic stromal lymphopoietin multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of TSLP promoter CTD PMID:33763461 NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696
JBrowse link
capsaicin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HTR1B 5-hydroxytryptamine receptor 1B multiple interactions EXP HTR1B protein promotes the reaction [donitriptan results in decreased susceptibility to Capsaicin] CTD PMID:16880765 NCBI chr12:38,659,088...38,659,546 JBrowse link
G TRPV1 transient receptor potential cation channel subfamily V member 1 multiple interactions
increases activity
EXP JYL 1421 inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein] CTD PMID:17392452 NCBI chr 9:47,404,987...47,443,871
Ensembl chr 9:47,404,972...47,431,926
JBrowse link
carmustine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MGMT O-6-methylguanine-DNA methyltransferase decreases response to substance
multiple interactions
EXP MGMT protein mutant form results in decreased susceptibility to Carmustine; MGMT protein results in decreased susceptibility to Carmustine
MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine]
CTD PMID:14617759 PMID:15053863 NCBI chr28:38,204,611...38,427,482
Ensembl chr28:38,204,610...38,427,380
JBrowse link
carvacrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSP70 heat shock protein 70 multiple interactions EXP carvacrol promotes the reaction [sodium arsenite results in increased expression of HSP70 protein] CTD PMID:31940135 NCBI chr12:1,285,282...1,287,670 JBrowse link
carvedilol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 decreases activity EXP Carvedilol results in decreased activity of CASP3 protein CTD PMID:12875697 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G FAS Fas cell surface death receptor decreases expression EXP Carvedilol results in decreased expression of FAS CTD PMID:12875697 NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
JBrowse link
G FASLG Fas ligand decreases expression EXP Carvedilol results in decreased expression of FASLG CTD PMID:12875697 NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
JBrowse link
G NT5E 5'-nucleotidase ecto increases activity EXP Carvedilol results in increased activity of NT5E protein CTD PMID:15148268 NCBI chr12:45,491,028...45,520,019
Ensembl chr12:45,491,733...45,518,405
JBrowse link
G RYR2 ryanodine receptor 2 multiple interactions EXP Carvedilol results in decreased oxidation of and results in increased stability of RYR2 protein CTD PMID:17448375 NCBI chr 4:2,371,868...2,908,132
Ensembl chr 4:2,373,114...2,907,875
JBrowse link
Ceronapril term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE angiotensin I converting enzyme decreases activity EXP ceronapril results in decreased activity of ACE protein CTD PMID:1812274 NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
JBrowse link
ceruletide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SCT secretin multiple interactions EXP [Ceruletide co-treated with SCT protein] results in increased abundance of Bicarbonates CTD PMID:3562434
cholanic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP cholanic acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
cilazapril monohydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGT angiotensinogen decreases expression EXP Cilazapril results in decreased expression of AGT protein CTD PMID:2419701 NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
JBrowse link
G REN renin increases activity EXP Cilazapril results in increased activity of REN protein CTD PMID:2419701 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
cilostazol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MYC MYC proto-oncogene, bHLH transcription factor decreases expression EXP Cilostazol results in decreased expression of MYC mRNA CTD PMID:19545562 NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
JBrowse link
cimetidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP Cimetidine results in decreased activity of SLC22A2 protein CTD PMID:36669674 NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
JBrowse link
cisapride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KCNH2 potassium voltage-gated channel subfamily H member 2 multiple interactions EXP Cisapride binds to and results in decreased activity of KCNH2 protein CTD PMID:12388285 NCBI chr16:15,009,031...15,041,786
Ensembl chr16:15,009,031...15,041,504
JBrowse link
clofibrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACAA2 acetyl-CoA acyltransferase 2 increases expression EXP Clofibrate results in increased expression of ACAA2 mRNA CTD PMID:19952500 NCBI chr 7:79,028,636...79,057,720 JBrowse link
G ACADVL acyl-CoA dehydrogenase very long chain increases expression EXP Clofibrate results in increased expression of ACADVL protein CTD PMID:19952500 NCBI chr 5:32,189,191...32,194,255
Ensembl chr 5:32,186,502...32,327,990
JBrowse link
G AGXT alanine--glyoxylate and serine--pyruvate aminotransferase decreases expression EXP Clofibrate results in decreased expression of AGXT protein CTD PMID:19952500 NCBI chr25:50,968,291...50,976,089 JBrowse link
G AHCY adenosylhomocysteinase decreases expression EXP Clofibrate results in decreased expression of AHCY protein CTD PMID:19952500 NCBI chr24:23,410,553...23,423,494
Ensembl chr24:23,411,140...23,419,767
JBrowse link
G ASL argininosuccinate lyase increases expression EXP Clofibrate results in increased expression of ASL protein CTD PMID:19952500 NCBI chr 6:768,522...779,144
Ensembl chr 6:730,358...779,424
JBrowse link
G ASS1 argininosuccinate synthase 1 decreases expression EXP Clofibrate results in decreased expression of ASS1 protein CTD PMID:19952500 NCBI chr 9:53,425,228...53,478,007
Ensembl chr 9:53,425,448...53,477,904
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 increases expression EXP Clofibrate results in increased expression of CPS1 protein CTD PMID:19952500 NCBI chr37:18,308,164...18,428,487
Ensembl chr37:18,143,986...18,427,697
JBrowse link
G CPT2 carnitine palmitoyltransferase 2 increases expression EXP Clofibrate results in increased expression of CPT2 mRNA CTD PMID:19952500 NCBI chr 5:55,718,209...55,786,175
Ensembl chr 5:55,718,510...55,744,809
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 decreases expression EXP Clofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:19952500 NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
JBrowse link
G CYP2A13 cytochrome P450 family 2 subfamily A polypeptide 13 decreases expression EXP Clofibrate results in decreased expression of CYP2A13 mRNA CTD PMID:19952500 NCBI chr 1:112,932,246...112,938,248
Ensembl chr 1:112,931,985...112,938,350
JBrowse link
G CYP2B6 cytochrome P450 2B11 decreases expression EXP Clofibrate results in decreased expression of CYP2B6 mRNA CTD PMID:19952500 NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
JBrowse link
G CYP2C18 cytochrome P450 2C21 decreases expression EXP Clofibrate results in decreased expression of CYP2C18 mRNA CTD PMID:19952500 NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases expression EXP Clofibrate results in increased expression of CYP2E1 protein CTD PMID:19952500 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
G CYP3A12 cytochrome P-450 3A12 decreases expression EXP Clofibrate results in decreased expression of CYP3A12 mRNA CTD PMID:19952500
G CYP3A26 cytochrome P450 3A26 decreases expression EXP Clofibrate results in decreased expression of CYP3A26 mRNA CTD PMID:19952500 NCBI chr 6:9,777,663...9,815,345
Ensembl chr 6:9,777,659...9,869,352
JBrowse link
G CYP4A11 cytochrome P450, family 4, subfamily A, polypeptide 11 increases expression EXP Clofibrate results in increased expression of CYP4A11 mRNA CTD PMID:19952500 NCBI chr15:13,663,337...13,676,350
Ensembl chr15:13,604,130...13,676,344
JBrowse link
G DLST dihydrolipoamide S-succinyltransferase increases expression EXP Clofibrate results in increased expression of DLST protein CTD PMID:19952500 NCBI chr 8:48,003,730...48,025,001
Ensembl chr 8:48,002,211...48,024,999
JBrowse link
G ECHS1 enoyl-CoA hydratase, short chain 1 increases expression EXP Clofibrate results in increased expression of ECHS1 protein CTD PMID:19952500 NCBI chr28:40,939,856...40,947,694
Ensembl chr28:40,939,961...40,946,167
JBrowse link
G GDI1 GDP dissociation inhibitor 1 increases expression EXP Clofibrate results in increased expression of GDI1 protein CTD PMID:19952500 NCBI chr  X:122,141,633...122,146,724
Ensembl chr  X:122,141,566...122,146,824
JBrowse link
G GSTA4 glutathione S-transferase alpha 4 decreases expression EXP Clofibrate results in decreased expression of GSTA4 mRNA CTD PMID:19952500 NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
JBrowse link
G GSTK1 glutathione S-transferase kappa 1 decreases expression EXP Clofibrate results in decreased expression of GSTK1 mRNA CTD PMID:19952500 NCBI chr16:6,411,678...6,416,135 JBrowse link
G GSTO1 glutathione S-transferase omega 1 decreases expression EXP Clofibrate results in decreased expression of GSTO1 mRNA CTD PMID:19952500 NCBI chr28:16,569,421...16,579,239
Ensembl chr28:16,569,066...16,619,880
JBrowse link
G HADH hydroxyacyl-CoA dehydrogenase increases expression EXP Clofibrate results in increased expression of HADH mRNA CTD PMID:19952500 NCBI chr32:28,460,445...28,506,141
Ensembl chr32:28,460,193...28,531,280
JBrowse link
G HSPD1 heat shock protein family D (Hsp60) member 1 increases expression EXP Clofibrate results in increased expression of HSPD1 protein CTD PMID:19952500 NCBI chr37:7,010,421...7,025,912 JBrowse link
G KRT1 keratin 1 increases expression EXP Clofibrate results in increased expression of KRT1 protein CTD PMID:19952500 NCBI chr27:2,422,150...2,427,160 JBrowse link
G KRT18 keratin 18 decreases expression EXP Clofibrate results in decreased expression of KRT18 protein CTD PMID:19952500 NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
JBrowse link
G LOC474938 glutathione S-transferase A2 decreases expression EXP Clofibrate results in decreased expression of GSTA3 mRNA; Clofibrate results in decreased expression of GSTA3 protein CTD PMID:19952500 NCBI chr12:20,349,133...20,365,023 JBrowse link
G LOC479912 glutathione S-transferase Mu 1 decreases expression EXP Clofibrate results in decreased expression of GSTM1 mRNA CTD PMID:19952500 NCBI chr 6:42,201,697...42,207,886 JBrowse link
G MGST1 microsomal glutathione S-transferase 1 increases expression EXP Clofibrate results in increased expression of MGST1 mRNA CTD PMID:19952500 NCBI chr27:30,370,588...30,391,898
Ensembl chr27:30,370,594...30,391,778
JBrowse link
G PC pyruvate carboxylase increases expression EXP Clofibrate results in increased expression of PC protein CTD PMID:19952500 NCBI chr18:50,406,994...50,507,677
Ensembl chr18:50,412,272...50,507,669
JBrowse link
G PCK2 phosphoenolpyruvate carboxykinase 2, mitochondrial increases expression EXP Clofibrate results in increased expression of PCK2 protein CTD PMID:19952500 NCBI chr 8:4,099,016...4,107,870
Ensembl chr 8:4,098,671...4,107,865
JBrowse link
G PRDX6 peroxiredoxin 6 decreases expression EXP Clofibrate results in decreased expression of PRDX6 protein CTD PMID:19952500 NCBI chr 7:25,663,238...25,675,855
Ensembl chr 7:25,663,579...25,675,754
JBrowse link
G SELENBP1 selenium binding protein 1 decreases expression EXP Clofibrate results in decreased expression of SELENBP1 protein CTD PMID:19952500 NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
JBrowse link
G SHMT1 serine hydroxymethyltransferase 1 decreases expression EXP Clofibrate results in decreased expression of SHMT1 protein CTD PMID:19952500 NCBI chr 5:41,221,531...41,248,653
Ensembl chr 5:41,221,562...41,253,166
JBrowse link
G UGP2 UDP-glucose pyrophosphorylase 2 decreases expression EXP Clofibrate results in decreased expression of UGP2 protein CTD PMID:19952500 NCBI chr10:63,532,366...63,598,362
Ensembl chr10:63,533,171...63,597,452
JBrowse link
G UQCRC1 ubiquinol-cytochrome c reductase core protein 1 increases expression EXP Clofibrate results in increased expression of UQCRC1 protein CTD PMID:19952500 NCBI chr20:40,507,767...40,515,854
Ensembl chr20:40,506,907...40,520,110
JBrowse link
G UROC1 urocanate hydratase 1 decreases expression EXP Clofibrate results in decreased expression of UROC1 protein CTD PMID:19952500 NCBI chr20:676,624...717,109
Ensembl chr20:678,073...717,141
JBrowse link
clonidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA2A adrenoceptor alpha 2A multiple interactions
increases response to substance
EXP Clonidine binds to and results in increased activity of ADRA2A protein
ADRA2A protein results in increased susceptibility to Clonidine
CTD PMID:16814767 NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
JBrowse link
G ADRA2C adrenoceptor alpha 2C increases response to substance EXP ADRA2C protein results in increased susceptibility to Clonidine CTD PMID:16814767 NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
JBrowse link
G GH1 growth hormone increases secretion EXP Clonidine results in increased secretion of GH1 protein CTD PMID:6248808 NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
JBrowse link
G NISCH nischarin multiple interactions
affects binding
EXP Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein] CTD PMID:24120658 NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions
increases activity
EXP [Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein] CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
G PRKCZ protein kinase C zeta multiple interactions
increases phosphorylation
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
G REN renin multiple interactions
decreases activity
EXP Clonidine results in decreased secretion of and results in decreased activity of REN protein
Clonidine results in decreased activity of REN protein
CTD PMID:6248808 PMID:6991409 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
clonidine (amino form) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA2A adrenoceptor alpha 2A multiple interactions
increases response to substance
EXP Clonidine binds to and results in increased activity of ADRA2A protein
ADRA2A protein results in increased susceptibility to Clonidine
CTD PMID:16814767 NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
JBrowse link
G ADRA2C adrenoceptor alpha 2C increases response to substance EXP ADRA2C protein results in increased susceptibility to Clonidine CTD PMID:16814767 NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
JBrowse link
G GH1 growth hormone increases secretion EXP Clonidine results in increased secretion of GH1 protein CTD PMID:6248808 NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
JBrowse link
G NISCH nischarin affects binding
multiple interactions
EXP Clonidine binds to NISCH protein
Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein]
CTD PMID:24120658 NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma increases activity
multiple interactions
EXP Clonidine results in increased activity of PIK3CG protein
[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein]
CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
G PRKCZ protein kinase C zeta multiple interactions
increases phosphorylation
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
G REN renin multiple interactions
decreases activity
EXP Clonidine results in decreased secretion of and results in decreased activity of REN protein
Clonidine results in decreased activity of REN protein
CTD PMID:6248808 PMID:6991409 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
clonidine (imino form) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA2A adrenoceptor alpha 2A multiple interactions
increases response to substance
EXP Clonidine binds to and results in increased activity of ADRA2A protein
ADRA2A protein results in increased susceptibility to Clonidine
CTD PMID:16814767 NCBI chr28:22,366,989...22,392,163
Ensembl chr28:22,367,780...22,370,684
JBrowse link
G ADRA2C adrenoceptor alpha 2C increases response to substance EXP ADRA2C protein results in increased susceptibility to Clonidine CTD PMID:16814767 NCBI chr 3:60,608,632...60,648,112
Ensembl chr 3:60,646,132...60,647,722
JBrowse link
G GH1 growth hormone increases secretion EXP Clonidine results in increased secretion of GH1 protein CTD PMID:6248808 NCBI chr 9:11,832,265...11,834,123
Ensembl chr 9:11,832,265...11,834,123
JBrowse link
G NISCH nischarin affects binding
multiple interactions
EXP Clonidine binds to NISCH protein
Guanine Nucleotides inhibits the reaction [Clonidine binds to NISCH protein]
CTD PMID:24120658 NCBI chr20:37,278,660...37,312,549
Ensembl chr20:37,279,282...37,312,636
JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions
increases activity
EXP [Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein] CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
G PRKCZ protein kinase C zeta multiple interactions
increases phosphorylation
EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein]; Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
G REN renin multiple interactions
decreases activity
EXP Clonidine results in decreased secretion of and results in decreased activity of REN protein
Clonidine results in decreased activity of REN protein
CTD PMID:6248808 PMID:6991409 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
corticotropin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G INS insulin increases abundance EXP INS protein results in increased abundance of Adrenocorticotropic Hormone CTD PMID:1646414 NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
JBrowse link
cortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CRH corticotropin releasing hormone increases abundance EXP CRH protein results in increased abundance of Hydrocortisone CTD PMID:2831029 NCBI chr29:15,831,944...15,840,560
Ensembl chr29:15,831,944...15,834,384
JBrowse link
G INS insulin affects abundance
multiple interactions
EXP INS protein affects the abundance of Hydrocortisone
Sodium affects the reaction [INS protein affects the abundance of Hydrocortisone]
CTD PMID:1324617 NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
JBrowse link
G POMC proopiomelanocortin increases abundance EXP POMC protein results in increased abundance of Hydrocortisone CTD PMID:2831029 NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
JBrowse link
cyclophosphamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2B6 cytochrome P450 2B11 increases hydroxylation EXP CYP2B6 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:16546968 NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
JBrowse link
cytidine 5'-monophosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions EXP [delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate CTD PMID:2579070 NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
JBrowse link
D-glucitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation EXP Sorbitol results in increased phosphorylation of MAPK1 protein CTD PMID:12639917 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation EXP Sorbitol results in increased phosphorylation of MAPK3 protein CTD PMID:12639917 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
D-mannitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 increases expression EXP Mannitol results in increased expression of CLDN4 protein CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
delta-hexachlorocyclohexane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase decreases activity
multiple interactions
EXP delta-hexachlorocyclohexane results in decreased activity of CDIPT protein
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate
CTD PMID:2579070 NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
JBrowse link
desferrioxamine B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGT angiotensinogen multiple interactions EXP Deferoxamine inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin] CTD PMID:8021468 NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
JBrowse link
desipramine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2D15 cytochrome P450 family 2 subfamily D member 15 affects metabolic processing EXP CYP2D15 affects the metabolism of Desipramine CTD PMID:7786018 NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
JBrowse link
dexamethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AVP arginine vasopressin decreases expression EXP Dexamethasone results in decreased expression of AVP protein CTD PMID:1934541 NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
JBrowse link
G HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 increases expression EXP Dexamethasone results in increased expression of HSD11B1 mRNA CTD PMID:21798686 NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897
JBrowse link
G NPPA natriuretic peptide A increases expression EXP Dexamethasone results in increased expression of NPPA protein CTD PMID:1934541 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
JBrowse link
dichlorvos term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase decreases activity EXP Dichlorvos results in decreased activity of ACHE protein CTD PMID:89824 PMID:3627083 NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
JBrowse link
G BCHE butyrylcholinesterase decreases activity EXP Dichlorvos results in decreased activity of BCHE protein CTD PMID:3627083 PMID:4631366 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
diclofenac term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C41 cytochrome P450 2C41 affects metabolic processing
increases hydroxylation
EXP CYP2C9 protein affects the metabolism of Diclofenac
CYP2C19 protein results in increased hydroxylation of Diclofenac
CTD PMID:15677349 PMID:15801540
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Diclofenac results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
dihexadecanoyl phosphatidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLCG1 phospholipase C gamma 1 multiple interactions
increases activity
EXP dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein]
dipalmitoylphosphatidic acid results in increased activity of PLCG1 protein
CTD PMID:2001791 NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
JBrowse link
diisopropyl fluorophosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCHE butyrylcholinesterase decreases activity EXP Isoflurophate results in decreased activity of BCHE protein CTD PMID:4631366 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
dimyristoyl phosphatidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLCG1 phospholipase C gamma 1 increases activity EXP dimyristoylphosphatidic acid results in increased activity of PLCG1 protein CTD PMID:2001791 NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
JBrowse link
dioleoyl phosphatidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PLCG1 phospholipase C gamma 1 increases activity EXP dioleoylphosphatidic acid results in increased activity of PLCG1 protein CTD PMID:2001791 NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
JBrowse link
diosgenin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 multiple interactions EXP Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP3 protein] CTD PMID:25446497 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G CASP9 caspase 9 multiple interactions EXP Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein] CTD PMID:25446497 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
JBrowse link
doxorubicin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases expression
affects response to substance
multiple interactions
EXP Doxorubicin results in increased expression of ABCB1 protein
ABCB1 protein affects the susceptibility to Doxorubicin
valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]; valspodar inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]
CTD PMID:15492788 PMID:24975508 PMID:28093773 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G HGF hepatocyte growth factor decreases response to substance EXP HGF protein results in decreased susceptibility to Doxorubicin CTD PMID:15688034 NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
JBrowse link
G TNNT2 troponin T2, cardiac type affects expression EXP Doxorubicin affects the expression of TNNT2 protein CTD PMID:12322705 NCBI chr 7:1,598,306...1,620,531
Ensembl chr 7:1,598,306...1,613,741
JBrowse link
G VIP vasoactive intestinal peptide decreases expression EXP Doxorubicin results in decreased expression of VIP protein CTD PMID:3711722 NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
JBrowse link
G XIAP X-linked inhibitor of apoptosis affects response to substance EXP XIAP affects the susceptibility to Doxorubicin CTD PMID:16953886 NCBI chr  X:95,300,234...95,356,103
Ensembl chr  X:95,331,827...95,351,582
JBrowse link
DPDPE term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of Enkephalin, D-Penicillamine (2,5)- CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
emodepside term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 affects response to substance EXP ABCB1 protein affects the susceptibility to emodepside CTD PMID:25660379 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
enalapril term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions EXP [Ranolazine co-treated with Enalapril] affects the expression of ATP2A2 protein CTD PMID:18820026 NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
JBrowse link
G EGR1 early growth response 1 multiple interactions EXP [Ranolazine co-treated with Enalapril] affects the expression of EGR1 protein CTD PMID:18820026 NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
JBrowse link
G GATA4 GATA binding protein 4 multiple interactions EXP [Ranolazine co-treated with Enalapril] affects the expression of GATA4 protein CTD PMID:18820026 NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
JBrowse link
G KCND3 potassium voltage-gated channel subfamily D member 3 decreases expression EXP Enalapril results in decreased expression of KCND3 mRNA CTD PMID:19732978 NCBI chr17:63,470,829...63,668,354
Ensembl chr17:63,470,415...63,668,035
JBrowse link
G NAB1 NGFI-A binding protein 1 multiple interactions EXP [Ranolazine co-treated with Enalapril] affects the expression of NAB1 protein CTD PMID:18820026 NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
JBrowse link
G NOS3 nitric oxide synthase 3 multiple interactions
increases expression
EXP FR 173657 inhibits the reaction [Enalapril results in increased expression of NOS3 mRNA] CTD PMID:12019275 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
JBrowse link
G NPPA natriuretic peptide A decreases expression
multiple interactions
EXP Enalapril results in decreased expression of NPPA protein
FR 173657 inhibits the reaction [Enalapril results in decreased expression of NPPA protein]
CTD PMID:12019275 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
JBrowse link
G REN renin increases activity
multiple interactions
EXP Enalapril results in increased activity of REN protein
[Enalapril co-treated with FR 173657] results in increased activity of REN protein
CTD PMID:12019275 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
G SLC8A1 solute carrier family 8 member A1 multiple interactions EXP [Ranolazine co-treated with Enalapril] affects the expression of SLC8A1 protein CTD PMID:18820026 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
eplerenone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor multiple interactions EXP Eplerenone binds to and results in decreased activity of AR protein CTD PMID:23242577 NCBI chr24:34,713,390...34,731,461
NCBI chr  X:51,969,785...52,167,450
Ensembl chr  X:51,969,785...52,151,912
JBrowse link
estrone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALPI alkaline phosphatase, intestinal increases chemical synthesis EXP ALPI protein results in increased chemical synthesis of Estrone CTD PMID:1495895 NCBI chr25:44,107,418...44,110,947 JBrowse link
estrone 3-sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of estrone sulfate CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
etodolac term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP Etodolac results in decreased expression of PTGS2 mRNA CTD PMID:15198222 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
etoposide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC1 ATP binding cassette subfamily C member 1 decreases response to substance EXP ABCC1 protein results in decreased susceptibility to Etoposide CTD PMID:12516967 NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
JBrowse link
felodipine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Felodipine results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
JBrowse link
fenfluramine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G EDN1 endothelin 1 increases activity EXP Fenfluramine results in increased activity of EDN1 protein CTD PMID:9918753 NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
JBrowse link
flufenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Flufenamic Acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
fomepizole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions EXP Fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene] CTD PMID:8592870 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
gamma-hexachlorocyclohexane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions
affects activity
EXP [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate CTD PMID:2579070 NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
JBrowse link
ganglioside GM1 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GNAQ G protein subunit alpha q multiple interactions EXP G(M1) Ganglioside inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein] CTD PMID:21671308 NCBI chr 1:80,733,530...80,928,065
Ensembl chr 1:80,715,366...80,928,065
JBrowse link
G HEXB hexosaminidase subunit beta multiple interactions EXP G(M1) Ganglioside inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; G(M1) Ganglioside inhibits the reaction [Wasp Venoms results in increased secretion of HEXB protein] CTD PMID:21334356 PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
genistein term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator decreases activity EXP Genistein results in decreased activity of CFTR protein CTD PMID:15496164 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
JBrowse link
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Genistein results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
gentamycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CCL2 C-C motif chemokine ligand 2 increases expression EXP Gentamicins results in increased expression of CCL2 protein CTD PMID:33290828 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G CLU clusterin increases expression EXP Gentamicins results in increased expression of CLU mRNA; Gentamicins results in increased expression of CLU protein CTD PMID:25034533 PMID:33290828 NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
JBrowse link
G LCN2 lipocalin 2 increases expression EXP Gentamicins results in increased expression of LCN2 mRNA; Gentamicins results in increased expression of LCN2 protein CTD PMID:25034533 PMID:33290828 NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
JBrowse link
G LOC607874 cystatin-C-like increases expression EXP Gentamicins results in increased expression of CST3 protein CTD PMID:33290828 NCBI chr23:49,562...53,618 JBrowse link
G MIR15B microRNA mir-15b affects expression EXP Gentamicins affects the expression of MIR15B mRNA CTD PMID:33290828 NCBI chr34:26,460,663...26,460,722
Ensembl chr34:26,460,645...26,460,741
JBrowse link
G MIR30A microRNA mir-30a increases expression EXP Gentamicins results in increased expression of MIR30A mRNA CTD PMID:33290828 NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
JBrowse link
G SPP1 secreted phosphoprotein 1 increases expression EXP Gentamicins results in increased expression of SPP1 protein CTD PMID:33290828 NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
JBrowse link
glutathione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 multiple interactions EXP Glutathione inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] CTD PMID:23816505 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein] CTD PMID:23816505 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein] CTD PMID:23816505 NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions EXP Glutathione inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:23816505 NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
JBrowse link
glyburide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CFTR CF transmembrane conductance regulator decreases activity EXP Glyburide results in decreased activity of CFTR protein CTD PMID:15496164 NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
JBrowse link
hexaconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC47A1 solute carrier family 47 member 1 decreases activity EXP hexaconazole results in decreased activity of SLC47A1 protein CTD PMID:36669674 NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
JBrowse link
G SLC47A2 solute carrier family 47 member 2 decreases activity EXP hexaconazole results in decreased activity of SLC47A2 protein CTD PMID:36669674 NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
JBrowse link
hydrogen chloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATP5F1B ATP synthase F1 subunit beta multiple interactions
decreases expression
EXP [Hydrochloric Acid co-treated with Bile Acids and Salts] results in decreased expression of ATP5F1B mRNA
Hydrochloric Acid results in decreased expression of ATP5F1B mRNA
CTD PMID:15883737 NCBI chr10:870,405...876,937
Ensembl chr10:870,392...909,161
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression
multiple interactions
EXP Hydrochloric Acid results in increased expression of CXCL8 protein
Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of CXCL8 protein]
CTD PMID:18339021 NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
JBrowse link
G FGF7 fibroblast growth factor 7 increases expression EXP Hydrochloric Acid results in increased expression of FGF7 mRNA CTD PMID:15883737 NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
JBrowse link
G FGFR2 fibroblast growth factor receptor 2 increases expression EXP Hydrochloric Acid results in increased expression of FGFR2 mRNA CTD PMID:15883737 NCBI chr28:31,303,882...31,411,015
Ensembl chr28:31,303,894...31,411,621
JBrowse link
G MMP2 matrix metallopeptidase 2 increases expression
multiple interactions
EXP Hydrochloric Acid results in increased expression of MMP2 protein
Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP2 protein]
CTD PMID:18339021 NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
JBrowse link
G MMP9 matrix metallopeptidase 9 increases expression
multiple interactions
EXP Hydrochloric Acid results in increased expression of MMP9 protein
Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein]
CTD PMID:18339021 NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
JBrowse link
G NOS2 nitric oxide synthase 2 increases activity EXP Hydrochloric Acid results in increased activity of NOS2 protein CTD PMID:14621274 NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
JBrowse link
Hypaconitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases transport EXP ABCB1 protein results in increased transport of hypaconitine CTD PMID:23200901 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 multiple interactions EXP [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of hypaconitine CTD PMID:23200901 NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
JBrowse link
hypericin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
ibuprofen term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Ibuprofen results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression EXP Ibuprofen results in increased expression of PTGS2 protein CTD PMID:16105799 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
icariin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NOS3 nitric oxide synthase 3 increases activity EXP icariin results in increased activity of NOS3 protein CTD PMID:17438405 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
JBrowse link
indometacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions EXP Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein] CTD PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Indomethacin results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
indoxyl sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A6 solute carrier family 22 member 6 multiple interactions EXP [Lansoprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican; [Omeprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican; [Pantoprazole results in decreased activity of SLC22A6 protein] which results in decreased uptake of Indican CTD PMID:36243147 NCBI chr18:53,736,669...53,745,001
Ensembl chr18:53,736,959...53,744,396
JBrowse link
inositol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions EXP [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate; Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides] CTD PMID:2579070 NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
JBrowse link
iprodione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [iprodione binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [iprodione binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
JBrowse link
isoprenaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin multiple interactions
increases activity
EXP Atenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Pindolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]; xibenolol inhibits the reaction [Isoproterenol results in increased activity of REN protein] CTD PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
kaempferol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G DHRS4 hydrogenase/reductase 4 decreases activity EXP kaempferol results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
ketoconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 decreases expression
multiple interactions
decreases activity
EXP Ketoconazole results in decreased expression of ABCB1 mRNA
[Ketoconazole results in decreased activity of ABCB1 protein] which results in decreased transport of Technetium Tc 99m Sestamibi
CTD PMID:19754906 PMID:22620706 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G CYP3A12 cytochrome P-450 3A12 multiple interactions
decreases activity
EXP Ketoconazole inhibits the reaction [CYP3A12 protein results in increased hydroxylation of Diazepam]
Ketoconazole results in decreased activity of CYP3A12 protein
CTD PMID:15677349
L-1,4-dithiothreitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP Dithiothreitol metabolite results in increased expression of HSPA5 protein CTD PMID:17416481 NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
JBrowse link
leukotriene C4 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC1 ATP binding cassette subfamily C member 1 affects transport EXP ABCC1 protein affects the transport of Leukotriene C4 CTD PMID:12516967 NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 affects transport EXP ABCC2 protein affects the transport of Leukotriene C4 CTD PMID:15507541 NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
JBrowse link
lithocholic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Lithocholic Acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
loperamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 affects response to substance
increases export
EXP ABCB1 protein affects the susceptibility to Loperamide
ABCB1 protein results in increased export of Loperamide
CTD PMID:25660379 PMID:28093773 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
loratadine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 increases activity EXP Loratadine results in increased activity of CASP3 protein CTD PMID:20570632 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
luteolin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CCL17 C-C motif chemokine ligand 17 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL17 promoter CTD PMID:33763461 NCBI chr 2:59,001,463...59,014,347
Ensembl chr 2:59,001,464...59,005,230
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of CCL2 promoter CTD PMID:33763461 NCBI chr 9:39,008,187...39,009,932 JBrowse link
G IL13 interleukin 13 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
JBrowse link
G IL31 interleukin 31 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr26:7,173,151...7,175,195
Ensembl chr26:7,172,451...7,175,195
JBrowse link
G IL31RA interleukin 31 receptor A multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of IL31RA promoter CTD PMID:33763461 NCBI chr 2:43,113,194...43,198,200
Ensembl chr 2:43,144,071...43,193,293
JBrowse link
G IL4 interleukin 4 multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL17 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of CCL2 mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of IL31RA mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA] CTD PMID:33763461 NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
JBrowse link
G TSLP thymic stromal lymphopoietin multiple interactions EXP [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] inhibits the reaction [[IL4 protein co-treated with IL13 protein co-treated with IL31 protein] results in increased expression of TSLP mRNA]; [Cannabidiol co-treated with Luteolin co-treated with 3,3',4,5'-tetrahydroxystilbene] results in increased methylation of TSLP promoter CTD PMID:33763461 NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696
JBrowse link
marbofloxacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP8 caspase 8 multiple interactions
increases expression
EXP TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA] CTD PMID:31005593 NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
JBrowse link
G FADD Fas associated via death domain increases expression EXP marbofloxacin results in increased expression of FADD mRNA CTD PMID:31005593 NCBI chr18:48,087,447...48,094,497 JBrowse link
G TNF tumor necrosis factor increases expression EXP marbofloxacin results in increased expression of TNF mRNA; marbofloxacin results in increased expression of TNF protein CTD PMID:31005593 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A multiple interactions
increases expression
EXP TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA]
marbofloxacin results in increased expression of TNFRSF1A mRNA; marbofloxacin results in increased expression of TNFRSF1A protein
CTD PMID:31005593 NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
JBrowse link
G TRADD TNFRSF1A associated via death domain multiple interactions
increases expression
EXP TNFRSF1A mRNA promotes the reaction [marbofloxacin results in increased expression of TRADD mRNA] CTD PMID:31005593 NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
JBrowse link
masitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA5 ATP binding cassette subfamily A member 5 increases expression EXP masitinib results in increased expression of ABCA5 mRNA CTD PMID:22747577 NCBI chr 9:15,708,070...15,781,100
Ensembl chr 9:15,420,835...15,783,045
JBrowse link
G ABHD14A abhydrolase domain containing 14A increases expression EXP masitinib results in increased expression of ABHD14A mRNA CTD PMID:22747577 NCBI chr20:37,738,500...37,744,689 JBrowse link
G ABITRAM actin binding transcription modulator decreases expression EXP masitinib results in decreased expression of ABITRAM mRNA CTD PMID:22747577 NCBI chr11:64,094,653...64,100,078
Ensembl chr11:64,094,721...64,109,421
JBrowse link
G ABLIM1 actin binding LIM protein 1 increases expression EXP masitinib results in increased expression of ABLIM1 mRNA CTD PMID:22747577 NCBI chr28:25,260,323...25,543,369
Ensembl chr28:25,260,873...25,545,304
JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 decreases expression EXP masitinib results in decreased expression of ACAT2 mRNA CTD PMID:22747577 NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327
JBrowse link
G ACSM3 acyl-CoA synthetase medium chain family member 3 increases expression EXP masitinib results in increased expression of ACSM3 mRNA CTD PMID:22747577 NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728
JBrowse link
G ACTL7A actin like 7A increases expression EXP masitinib results in increased expression of ACTL7A mRNA CTD PMID:22747577 NCBI chr11:64,031,305...64,033,908
Ensembl chr11:64,032,358...64,033,788
JBrowse link
G ACTR2 actin related protein 2 decreases expression EXP masitinib results in decreased expression of ACTR2 protein CTD PMID:22747577 NCBI chr10:64,696,068...64,733,027
Ensembl chr10:64,696,111...64,730,553
JBrowse link
G ADPRH ADP-ribosylarginine hydrolase increases expression EXP masitinib results in increased expression of ADPRH mRNA CTD PMID:22747577 NCBI chr33:23,218,633...23,226,844
Ensembl chr33:23,218,101...23,224,667
JBrowse link
G AGA aspartylglucosaminidase increases expression EXP masitinib results in increased expression of AGA mRNA CTD PMID:22747577 NCBI chr16:52,314,860...52,324,879
Ensembl chr16:52,314,535...52,324,894
JBrowse link
G AGO2 argonaute RISC catalytic component 2 decreases expression EXP masitinib results in decreased expression of AGO2 mRNA CTD PMID:22747577 NCBI chr13:35,169,243...35,230,252
Ensembl chr13:35,180,912...35,268,577
JBrowse link
G AGRN agrin increases expression EXP masitinib results in increased expression of AGRN mRNA CTD PMID:22747577 NCBI chr 5:56,239,621...56,273,679
Ensembl chr 5:56,239,701...56,272,745
JBrowse link
G AIG1 androgen induced 1 increases expression EXP masitinib results in increased expression of AIG1 mRNA CTD PMID:22747577 NCBI chr 1:34,643,994...34,884,445
Ensembl chr 1:34,643,764...34,884,119
JBrowse link
G ALAS2 5'-aminolevulinate synthase 2 increases expression EXP masitinib results in increased expression of ALAS2 mRNA CTD PMID:22747577 NCBI chr  X:46,703,477...46,731,767
Ensembl chr  X:46,703,477...46,723,529
JBrowse link
G ALDH5A1 aldehyde dehydrogenase 5 family member A1 decreases expression EXP masitinib results in decreased expression of ALDH5A1 mRNA CTD PMID:22747577 NCBI chr35:22,560,005...22,590,996
Ensembl chr35:22,560,008...22,587,875
JBrowse link
G AMN1 antagonist of mitotic exit network 1 homolog increases expression EXP masitinib results in increased expression of AMN1 mRNA CTD PMID:22747577 NCBI chr27:17,044,301...17,100,444
Ensembl chr27:17,044,309...17,361,570
JBrowse link
G ANKRD26 ankyrin repeat domain containing 26 increases expression EXP masitinib results in increased expression of ANKRD26 mRNA CTD PMID:22747577 NCBI chr 2:6,230,466...6,402,360 JBrowse link
G ANP32E acidic nuclear phosphoprotein 32 family member E decreases expression EXP masitinib results in decreased expression of ANP32E mRNA CTD PMID:22747577 NCBI chr17:59,460,864...59,482,467
Ensembl chr17:59,462,766...59,477,936
JBrowse link
G ANXA1 annexin A1 increases expression EXP masitinib results in increased expression of ANXA1 protein CTD PMID:22747577 NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
JBrowse link
G ANXA6 annexin A6 increases expression EXP masitinib results in increased expression of ANXA6 protein CTD PMID:22747577 NCBI chr 4:58,091,186...58,140,102
Ensembl chr 4:58,091,251...58,139,372
JBrowse link
G ARMC12 armadillo repeat containing 12 increases expression EXP masitinib results in increased expression of ARMC12 mRNA CTD PMID:22747577 NCBI chr12:4,868,831...4,879,801
Ensembl chr12:4,869,774...4,879,793
JBrowse link
G ASCC1 activating signal cointegrator 1 complex subunit 1 decreases expression EXP masitinib results in decreased expression of ASCC1 mRNA CTD PMID:22747577 NCBI chr 4:22,779,644...22,876,434
Ensembl chr 4:22,779,781...22,874,215
JBrowse link
G B4GALT7 beta-1,4-galactosyltransferase 7 increases expression EXP masitinib results in increased expression of B4GALT7 mRNA CTD PMID:22747577 NCBI chr11:3,497,860...3,507,513
Ensembl chr11:3,498,153...3,505,034
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 decreases expression EXP masitinib results in decreased expression of BIRC5 mRNA CTD PMID:22747577 NCBI chr 9:2,930,308...2,959,307 JBrowse link
G BTBD3 BTB domain containing 3 decreases expression EXP masitinib results in decreased expression of BTBD3 mRNA CTD PMID:22747577 NCBI chr24:10,478,635...10,512,773
Ensembl chr24:10,479,900...10,512,185
JBrowse link
G CA2 carbonic anhydrase 2 decreases expression EXP masitinib results in decreased expression of CA2 mRNA CTD PMID:22747577 NCBI chr29:31,959,225...31,975,309
Ensembl chr29:31,935,172...31,980,579
JBrowse link
G CAMK2G calcium/calmodulin dependent protein kinase II gamma increases expression EXP masitinib results in increased expression of CAMK2G mRNA CTD PMID:22747577 NCBI chr 4:24,244,063...24,299,362
Ensembl chr 4:24,245,960...24,299,357
JBrowse link
G CAPG capping actin protein, gelsolin like increases expression EXP masitinib results in increased expression of CAPG protein CTD PMID:22747577 NCBI chr17:39,619,429...39,640,944
Ensembl chr17:39,619,248...39,640,942
JBrowse link
G CCT2 chaperonin containing TCP1 subunit 2 decreases expression EXP masitinib results in decreased expression of CCT2 protein CTD PMID:22747577 NCBI chr10:11,560,287...11,586,559
Ensembl chr10:11,560,396...11,578,433
JBrowse link
G CD5L CD5 molecule like increases expression EXP masitinib results in increased expression of CD5L mRNA CTD PMID:22747577 NCBI chr 7:40,516,190...40,526,528
Ensembl chr 7:40,516,190...40,526,528
JBrowse link
G CDADC1 cytidine and dCMP deaminase domain containing 1 increases expression EXP masitinib results in increased expression of CDADC1 mRNA CTD PMID:22747577 NCBI chr22:2,443,459...2,489,147
Ensembl chr22:2,436,206...2,489,016
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression EXP masitinib results in increased expression of CDKN1A mRNA CTD PMID:22747577 NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
JBrowse link
G CIAPIN1 cytokine induced apoptosis inhibitor 1 decreases expression EXP masitinib results in decreased expression of CIAPIN1 mRNA CTD PMID:22747577 NCBI chr 2:58,977,592...58,992,785
Ensembl chr 2:58,977,676...58,992,581
JBrowse link
G CIRBP cold inducible RNA binding protein increases expression EXP masitinib results in increased expression of CIRBP mRNA CTD PMID:22747577 NCBI chr20:57,521,609...57,526,526
Ensembl chr20:57,519,119...57,526,435
JBrowse link
G CLEC2B C-type lectin domain family 2 member B decreases expression EXP masitinib results in decreased expression of CLEC2B mRNA CTD PMID:22747577 NCBI chr27:36,088,754...36,143,581
Ensembl chr27:36,120,134...36,143,040
JBrowse link
G CMTM7 CKLF like MARVEL transmembrane domain containing 7 increases expression EXP masitinib results in increased expression of CMTM7 mRNA CTD PMID:22747577 NCBI chr23:12,317,636...12,382,836
Ensembl chr23:12,328,303...12,382,837
JBrowse link
G CORO1A coronin 1A increases expression EXP masitinib results in increased expression of CORO1A protein CTD PMID:22747577 NCBI chr 6:18,161,850...18,167,915
Ensembl chr 6:18,160,601...18,167,818
JBrowse link
G CPNE1 copine 1 increases expression EXP masitinib results in increased expression of CPNE1 mRNA CTD PMID:22747577 NCBI chr24:24,554,636...24,589,748
Ensembl chr24:24,554,636...24,589,731
JBrowse link
G CTSK cathepsin K increases expression EXP masitinib results in increased expression of CTSK mRNA CTD PMID:22747577 NCBI chr17:59,928,725...59,938,293
Ensembl chr17:59,929,287...59,938,507
JBrowse link
G DHRS4 hydrogenase/reductase 4 increases expression EXP masitinib results in increased expression of DHRS4 mRNA CTD PMID:22747577 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
G DLA-12 MHC class I DLA-12 increases expression EXP masitinib results in increased expression of DLA-12 mRNA CTD PMID:22747577 NCBI chr12:933,321...936,671
Ensembl chr12:932,613...987,561
JBrowse link
G DLA-64 MHC class I DLA-64 increases expression EXP masitinib results in increased expression of DLA-64 mRNA CTD PMID:22747577 NCBI chr12:983,573...986,969 JBrowse link
G DLGAP1 DLG associated protein 1 decreases expression EXP masitinib results in decreased expression of DLGAP1 mRNA CTD PMID:22747577 NCBI chr 7:70,082,563...70,949,116
Ensembl chr 7:70,081,885...70,406,213
JBrowse link
G DLGAP5 DLG associated protein 5 decreases expression EXP masitinib results in decreased expression of DLGAP5 mRNA CTD PMID:22747577 NCBI chr 8:30,998,806...31,038,614
Ensembl chr 8:30,994,402...31,036,540
JBrowse link
G DPCD deleted in primary ciliary dyskinesia homolog decreases expression EXP masitinib results in decreased expression of DPCD mRNA CTD PMID:22747577 NCBI chr28:14,201,302...14,219,121
Ensembl chr28:14,201,351...14,219,121
JBrowse link
G DPYSL3 dihydropyrimidinase like 3 decreases expression EXP masitinib results in decreased expression of DPYSL3 mRNA CTD PMID:22747577 NCBI chr 2:41,687,725...41,809,402
Ensembl chr 2:41,690,845...41,802,376
JBrowse link
G EBPL EBP like increases expression EXP masitinib results in increased expression of EBPL mRNA CTD PMID:22747577 NCBI chr22:2,116,588...2,137,935
Ensembl chr22:2,116,131...2,182,633
JBrowse link
G EDEM2 ER degradation enhancing alpha-mannosidase like protein 2 increases expression EXP masitinib results in increased expression of EDEM2 mRNA CTD PMID:22747577 NCBI chr24:24,137,228...24,165,995
Ensembl chr24:24,137,228...24,165,968
JBrowse link
G EIF3A eukaryotic translation initiation factor 3 subunit A decreases expression EXP masitinib results in decreased expression of EIF3A protein CTD PMID:22747577 NCBI chr28:29,290,668...29,326,851
Ensembl chr28:29,291,422...29,326,701
JBrowse link
G EIF4A1 eukaryotic translation initiation factor 4A1 decreases expression EXP masitinib results in decreased expression of EIF4A1 protein CTD PMID:22747577 NCBI chr 5:32,495,606...32,500,805
Ensembl chr 5:32,484,572...32,500,805
JBrowse link
G EIF5A2 eukaryotic translation initiation factor 5A2 decreases expression EXP masitinib results in decreased expression of EIF5A2 mRNA CTD PMID:22747577 NCBI chr34:35,309,812...35,322,382
Ensembl chr34:35,314,172...35,322,392
JBrowse link
G ELSPBP1 epididymal sperm binding protein 1 increases expression EXP masitinib results in increased expression of ELSPBP1 mRNA CTD PMID:22747577 NCBI chr 1:108,159,609...108,187,224
Ensembl chr 1:108,159,611...108,188,076
JBrowse link
G ETFDH electron transfer flavoprotein dehydrogenase decreases expression EXP masitinib results in decreased expression of ETFDH mRNA CTD PMID:22747577 NCBI chr15:55,752,170...55,781,118
Ensembl chr15:55,752,200...55,792,105
JBrowse link
G GGT1 gamma-glutamyltransferase 1 increases expression EXP masitinib results in increased expression of GGT1 mRNA CTD PMID:22747577 NCBI chr26:28,301,455...28,315,029 JBrowse link
G GKN1 gastrokine 1 increases expression EXP masitinib results in increased expression of GKN1 mRNA CTD PMID:22747577 NCBI chr10:67,788,329...67,793,445
Ensembl chr10:67,788,110...67,793,589
JBrowse link
G GMFB glia maturation factor beta decreases expression EXP masitinib results in decreased expression of GMFB mRNA CTD PMID:22747577 NCBI chr 8:30,394,020...30,408,408
Ensembl chr 8:30,359,499...30,408,357
JBrowse link
G GSTA4 glutathione S-transferase alpha 4 increases expression EXP masitinib results in increased expression of GSTA4 mRNA CTD PMID:22747577 NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
JBrowse link
G GXYLT1 glucoside xylosyltransferase 1 decreases expression EXP masitinib results in decreased expression of GXYLT1 mRNA CTD PMID:22747577 NCBI chr27:11,754,609...11,810,245
Ensembl chr27:11,765,072...11,807,787
JBrowse link
G HEBP2 heme binding protein 2 decreases expression EXP masitinib results in decreased expression of HEBP2 mRNA CTD PMID:22747577 NCBI chr 1:30,716,395...30,724,814
Ensembl chr 1:30,716,606...30,724,613
JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP masitinib results in increased expression of HERPUD1 mRNA CTD PMID:22747577 NCBI chr 2:59,388,492...59,400,028
Ensembl chr 2:59,388,494...59,400,003
JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 increases expression EXP masitinib results in increased expression of HSP90B1 protein CTD PMID:22747577 NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311
JBrowse link
G HTR2B 5-hydroxytryptamine receptor 2B increases expression EXP masitinib results in increased expression of HTR2B mRNA CTD PMID:22747577 NCBI chr25:43,042,306...43,056,361
Ensembl chr25:43,042,173...43,056,612
JBrowse link
G HYAL3 hyaluronidase 3 increases expression EXP masitinib results in increased expression of HYAL3 mRNA CTD PMID:22747577 NCBI chr20:39,041,940...39,047,388
Ensembl chr20:39,042,070...39,047,365
JBrowse link
G IGFBP7 insulin like growth factor binding protein 7 increases expression EXP masitinib results in increased expression of IGFBP7 mRNA CTD PMID:22747577 NCBI chr13:49,138,406...49,207,235
Ensembl chr13:49,138,402...49,207,394
JBrowse link
G IL13 interleukin 13 increases expression EXP masitinib results in increased expression of IL13 mRNA CTD PMID:22747577 NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
JBrowse link
G IMMP2L inner mitochondrial membrane peptidase subunit 2 increases expression EXP masitinib results in increased expression of IMMP2L mRNA CTD PMID:22747577 NCBI chr14:50,487,679...51,336,906 JBrowse link
G IRX6 iroquois homeobox 6 increases expression EXP masitinib results in increased expression of IRX6 protein CTD PMID:22747577 NCBI chr 2:60,630,688...60,636,285
Ensembl chr 2:60,630,447...60,636,416
JBrowse link
G ITGA6 integrin subunit alpha 6 decreases expression EXP masitinib results in decreased expression of ITGA6 mRNA CTD PMID:22747577 NCBI chr36:16,777,363...16,858,725
Ensembl chr36:16,776,863...16,855,449
JBrowse link
G JAML junction adhesion molecule like decreases expression EXP masitinib results in decreased expression of JAML mRNA CTD PMID:22747577 NCBI chr 5:15,485,378...15,513,457
Ensembl chr 5:15,476,582...15,513,075
JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression EXP masitinib results in increased expression of JUN mRNA CTD PMID:22747577 NCBI chr 5:50,966,698...50,968,939 JBrowse link
G KCTD19 potassium channel tetramerization domain containing 19 increases expression EXP masitinib results in increased expression of KCTD19 mRNA CTD PMID:22747577 NCBI chr 5:82,060,946...82,093,248
Ensembl chr 5:82,061,449...82,093,246
JBrowse link
G KLHL5 kelch like family member 5 increases expression EXP masitinib results in increased expression of KLHL5 mRNA CTD PMID:22747577 NCBI chr 3:73,258,925...73,347,262
Ensembl chr 3:73,262,895...73,344,879
JBrowse link
G LBX2 ladybird homeobox 2 increases expression EXP masitinib results in increased expression of LBX2 mRNA CTD PMID:22747577 NCBI chr17:48,641,630...48,643,411
Ensembl chr17:48,641,674...48,643,239
JBrowse link
G LIN7C lin-7 homolog C, crumbs cell polarity complex component decreases expression EXP masitinib results in decreased expression of LIN7C mRNA CTD PMID:22747577 NCBI chr21:48,061,446...48,071,458
Ensembl chr21:48,064,929...48,071,429
JBrowse link
G LOC474850 heat shock 70 kDa protein 1-like increases expression EXP masitinib results in increased expression of HSPA1L mRNA CTD PMID:22747577 NCBI chr12:1,281,164...1,285,010
Ensembl chr12:1,281,472...1,285,440
JBrowse link
G LOC475707 GPN-loop GTPase 1 decreases expression EXP masitinib results in decreased expression of GPN1 mRNA CTD PMID:22747577 NCBI chr17:21,654,516...21,678,435
Ensembl chr17:21,545,673...21,673,157
JBrowse link
G LOC478000 phytanoyl-CoA hydroxylase-like increases expression EXP masitinib results in increased expression of PHYH mRNA CTD PMID:22747577 NCBI chr 2:23,185,901...23,206,719
Ensembl chr 2:23,185,782...23,253,497
JBrowse link
G LOC609402 hemoglobin subunit beta-like increases expression EXP masitinib results in increased expression of HBG1 mRNA CTD PMID:22747577 NCBI chr21:28,187,535...28,188,991 JBrowse link
G LONRF1 LON peptidase N-terminal domain and ring finger 1 increases expression EXP masitinib results in increased expression of LONRF1 mRNA CTD PMID:22747577 NCBI chr16:36,220,324...36,256,896
Ensembl chr16:36,221,156...36,256,897
JBrowse link
G LRP1 LDL receptor related protein 1 increases expression EXP masitinib results in increased expression of LRP1 mRNA CTD PMID:22747577 NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
JBrowse link
G LRP8 LDL receptor related protein 8 decreases expression EXP masitinib results in decreased expression of LRP8 mRNA CTD PMID:22747577 NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736
JBrowse link
G LYRM1 LYR motif containing 1 increases expression EXP masitinib results in increased expression of LYRM1 mRNA CTD PMID:22747577 NCBI chr 6:24,428,461...24,460,291
Ensembl chr 6:24,441,307...24,460,331
JBrowse link
G MAGEF1 MAGE family member F1 decreases expression EXP masitinib results in decreased expression of MAGEF1 mRNA CTD PMID:22747577 NCBI chr34:17,543,381...17,545,089
Ensembl chr34:17,543,906...17,544,868
JBrowse link
G MOB1B MOB kinase activator 1B decreases expression EXP masitinib results in decreased expression of MOB1B mRNA CTD PMID:22747577 NCBI chr13:60,145,168...60,197,916
Ensembl chr13:60,145,366...60,195,463
JBrowse link
G MPDZ multiple PDZ domain crumbs cell polarity complex component increases expression EXP masitinib results in increased expression of MPDZ mRNA CTD PMID:22747577 NCBI chr11:33,691,434...33,826,500
Ensembl chr11:33,692,296...33,826,437
JBrowse link
G MYOZ1 myozenin 1 increases expression EXP masitinib results in increased expression of MYOZ1 mRNA CTD PMID:22747577 NCBI chr 4:24,158,532...24,165,416
Ensembl chr 4:24,158,720...24,165,392
JBrowse link
G NAPG NSF attachment protein gamma decreases expression EXP masitinib results in decreased expression of NAPG mRNA CTD PMID:22747577 NCBI chr 7:76,403,561...76,424,994
Ensembl chr 7:76,403,595...76,423,170
JBrowse link
G NDUFS1 NADH:ubiquinone oxidoreductase core subunit S1 decreases expression EXP masitinib results in decreased expression of NDUFS1 mRNA CTD PMID:22747577 NCBI chr37:14,680,908...14,713,838
Ensembl chr37:14,683,083...14,713,754
JBrowse link
G NFKBIA NFKB inhibitor alpha increases expression EXP masitinib results in increased expression of NFKBIA mRNA CTD PMID:22747577 NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
JBrowse link
G NRAS NRAS proto-oncogene, GTPase decreases expression EXP masitinib results in decreased expression of NRAS mRNA CTD PMID:22747577 NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
JBrowse link
G NSG1 neuronal vesicle trafficking associated 1 decreases expression EXP masitinib results in decreased expression of NSG1 mRNA CTD PMID:22747577 NCBI chr 3:69,805,646...69,831,200
Ensembl chr 3:69,805,592...69,831,194
JBrowse link
G NTRK1 neurotrophic receptor tyrosine kinase 1 increases expression EXP masitinib results in increased expression of NTRK1 mRNA CTD PMID:22747577 NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
JBrowse link
G OCA2 OCA2 melanosomal transmembrane protein decreases expression EXP masitinib results in decreased expression of OCA2 mRNA CTD PMID:22747577 NCBI chr 3:32,361,825...32,713,631
Ensembl chr 3:32,361,517...32,713,572
JBrowse link
G OGT O-linked N-acetylglucosamine (GlcNAc) transferase increases expression EXP masitinib results in increased expression of OGT mRNA CTD PMID:22747577 NCBI chr  X:55,821,227...55,857,597
Ensembl chr  X:55,821,234...55,855,502
JBrowse link
G OXCT1 3-oxoacid CoA-transferase 1 increases expression EXP masitinib results in increased expression of OXCT1 protein CTD PMID:22747577 NCBI chr 4:67,709,846...67,841,737
Ensembl chr 4:67,527,531...67,841,518
JBrowse link
G PARP14 poly(ADP-ribose) polymerase family member 14 increases expression EXP masitinib results in increased expression of PARP14 mRNA CTD PMID:22747577 NCBI chr33:25,763,282...25,798,284
Ensembl chr33:25,763,255...25,798,198
JBrowse link
G PCM1 pericentriolar material 1 increases expression EXP masitinib results in increased expression of PCM1 mRNA CTD PMID:22747577 NCBI chr16:41,212,733...41,291,654
Ensembl chr16:41,214,417...41,291,376
JBrowse link
G PCOLCE2 procollagen C-endopeptidase enhancer 2 decreases expression EXP masitinib results in decreased expression of PCOLCE2 mRNA CTD PMID:22747577 NCBI chr23:38,424,408...38,486,800
Ensembl chr23:38,426,216...38,487,252
JBrowse link
G PDE6H phosphodiesterase 6H increases expression EXP masitinib results in increased expression of PDE6H mRNA CTD PMID:22747577 NCBI chr27:31,640,731...31,664,494
Ensembl chr27:31,640,737...31,664,401
JBrowse link
G PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 decreases expression EXP masitinib results in decreased expression of PDHA1 mRNA CTD PMID:22747577 NCBI chr  X:15,338,364...15,354,011
Ensembl chr  X:15,338,202...15,387,458
JBrowse link
G PDIA3 protein disulfide isomerase family A member 3 increases expression EXP masitinib results in increased expression of PDIA3 protein CTD PMID:22747577 NCBI chr30:10,487,926...10,513,437
Ensembl chr30:10,487,921...10,513,397
JBrowse link
G PEBP4 phosphatidylethanolamine binding protein 4 increases expression EXP masitinib results in increased expression of PEBP4 mRNA CTD PMID:22747577 NCBI chr25:34,329,160...34,574,086
Ensembl chr25:34,317,421...34,574,066
JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 increases expression EXP masitinib results in increased expression of PECAM1 mRNA CTD PMID:22747577 NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
JBrowse link
G PHF10 PHD finger protein 10 increases expression EXP masitinib results in increased expression of PHF10 mRNA CTD PMID:22747577 NCBI chr12:71,955,354...71,998,283
Ensembl chr12:71,787,082...71,998,243
JBrowse link
G POMT1 protein O-mannosyltransferase 1 decreases expression EXP masitinib results in decreased expression of POMT1 mRNA CTD PMID:22747577 NCBI chr 9:52,615,349...52,631,538
Ensembl chr 9:52,615,655...52,630,836
JBrowse link
G POR cytochrome p450 oxidoreductase increases expression EXP masitinib results in increased expression of POR mRNA CTD PMID:22747577 NCBI chr 6:7,247,780...7,316,282
Ensembl chr 6:7,263,574...7,316,297
JBrowse link
G PPA1 inorganic pyrophosphatase 1 decreases expression EXP masitinib results in decreased expression of PPA1 protein CTD PMID:22747577 NCBI chr 4:21,145,547...21,189,985
Ensembl chr 4:21,145,547...21,182,748
JBrowse link
G PRPS2 phosphoribosyl pyrophosphate synthetase 2 decreases expression EXP masitinib results in decreased expression of PRPS2 mRNA CTD PMID:22747577 NCBI chr  X:9,281,686...9,326,551
Ensembl chr  X:9,281,730...9,418,289
JBrowse link
G PSMB9 proteasome 20S subunit beta 9 increases expression EXP masitinib results in increased expression of PSMB9 mRNA CTD PMID:22747577 NCBI chr12:2,432,287...2,438,920
Ensembl chr12:2,432,505...2,438,069
JBrowse link
G PSMD6 proteasome 26S subunit, non-ATPase 6 decreases expression EXP masitinib results in decreased expression of PSMD6 protein CTD PMID:22747577 NCBI chr20:27,206,801...27,220,059 JBrowse link
G PSMD9 proteasome 26S subunit, non-ATPase 9 decreases expression EXP masitinib results in decreased expression of PSMD9 mRNA CTD PMID:22747577 NCBI chr26:7,376,154...7,400,655
Ensembl chr26:7,377,413...7,400,573
JBrowse link
G PTH parathyroid hormone increases expression EXP masitinib results in increased expression of PTH mRNA CTD PMID:22747577 NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
JBrowse link
G PXYLP1 2-phosphoxylose phosphatase 1 decreases expression EXP masitinib results in decreased expression of ACPL2 mRNA CTD PMID:22747577 NCBI chr23:37,145,065...37,197,808
Ensembl chr23:37,145,086...37,196,427
JBrowse link
G R3HDM2 R3H domain containing 2 increases expression EXP masitinib results in increased expression of R3HDM2 mRNA CTD PMID:22747577 NCBI chr10:1,377,664...1,504,008
Ensembl chr10:1,370,350...1,504,017
JBrowse link
G RAB44 RAB44, member RAS oncogene family increases expression EXP masitinib results in increased expression of RAB44 mRNA CTD PMID:22747577 NCBI chr12:5,769,056...5,804,963
Ensembl chr12:5,770,882...5,804,949
JBrowse link
G RASGRP2 RAS guanyl releasing protein 2 increases expression EXP masitinib results in increased expression of RASGRP2 mRNA CTD PMID:22747577 NCBI chr18:52,412,331...52,426,910
Ensembl chr18:52,412,367...52,426,916
JBrowse link
G RCAN1 regulator of calcineurin 1 increases expression EXP masitinib results in increased expression of RCAN1 mRNA CTD PMID:22747577 NCBI chr31:29,908,046...30,002,412
Ensembl chr31:29,909,388...30,002,418
JBrowse link
G RGS13 regulator of G protein signaling 13 decreases expression EXP masitinib results in decreased expression of RGS13 mRNA CTD PMID:22747577 NCBI chr38:6,291,146...6,316,662
Ensembl chr38:6,291,182...6,315,198
JBrowse link
G SAR1B secretion associated Ras related GTPase 1B decreases expression EXP masitinib results in decreased expression of SAR1A mRNA CTD PMID:22747577 NCBI chr11:22,713,459...22,743,190
Ensembl chr11:22,717,942...22,743,124
JBrowse link
G SCD stearoyl-CoA desaturase decreases expression EXP masitinib results in decreased expression of SCD mRNA CTD PMID:22747577 NCBI chr28:13,112,741...13,129,129
Ensembl chr28:13,113,006...13,125,801
JBrowse link
G SELENBP1 selenium binding protein 1 increases expression EXP masitinib results in increased expression of SELENBP1 protein CTD PMID:22747577 NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
JBrowse link
G SERPINE2 serpin family E member 2 increases expression EXP masitinib results in increased expression of SERPINE2 mRNA CTD PMID:22747577 NCBI chr37:29,699,551...29,750,151
Ensembl chr37:29,700,024...29,724,228
JBrowse link
G SFT2D2 SFT2 domain containing 2 decreases expression EXP masitinib results in decreased expression of SFT2D2 mRNA CTD PMID:22747577 NCBI chr 7:30,258,748...30,281,371 JBrowse link
G SLA Src like adaptor increases expression EXP masitinib results in increased expression of SLA mRNA CTD PMID:22747577 NCBI chr13:29,503,304...29,590,679
Ensembl chr13:29,504,867...29,569,773
JBrowse link
G SLC25A12 solute carrier family 25 member 12 decreases expression EXP masitinib results in decreased expression of SLC25A12 mRNA CTD PMID:22747577 NCBI chr36:16,185,011...16,391,080
Ensembl chr36:16,185,649...16,483,016
JBrowse link
G SMC5 structural maintenance of chromosomes 5 decreases expression EXP masitinib results in decreased expression of SMC5 mRNA CTD PMID:22747577 NCBI chr 1:87,192,988...87,285,678
Ensembl chr 1:87,194,867...87,285,606
JBrowse link
G SRR serine racemase increases expression EXP masitinib results in increased expression of SRR mRNA CTD PMID:22747577
G STING1 stimulator of interferon response cGAMP interactor 1 increases expression EXP masitinib results in increased expression of TMEM173 mRNA CTD PMID:22747577 NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072
JBrowse link
G STOX1 storkhead box 1 increases expression EXP masitinib results in increased expression of STOX1 mRNA CTD PMID:22747577 NCBI chr 4:20,013,893...20,065,480
Ensembl chr 4:20,014,007...20,060,394
JBrowse link
G STX16 syntaxin 16 increases expression EXP masitinib results in increased expression of STX16 mRNA CTD PMID:22747577 NCBI chr24:43,425,719...43,451,828
Ensembl chr24:43,426,470...43,449,077
JBrowse link
G STYXL1 serine/threonine/tyrosine interacting like 1 increases expression EXP masitinib results in increased expression of STYXL1 mRNA CTD PMID:22747577 NCBI chr 6:7,323,911...7,389,878
Ensembl chr 6:7,316,477...7,389,842
JBrowse link
G TARDBP TAR DNA binding protein decreases expression EXP masitinib results in decreased expression of TARDBP protein CTD PMID:22747577 NCBI chr 2:84,987,752...84,998,136
Ensembl chr 2:84,989,952...84,998,593
JBrowse link
G TBC1D14 TBC1 domain family member 14 decreases expression EXP masitinib results in decreased expression of TBC1D14 mRNA CTD PMID:22747577 NCBI chr 3:58,992,743...59,097,581
Ensembl chr 3:58,926,237...59,097,621
JBrowse link
G TCN2 transcobalamin 2 increases expression EXP masitinib results in increased expression of TCN2 mRNA CTD PMID:22747577 NCBI chr26:23,693,664...23,710,342
Ensembl chr26:23,693,773...23,709,832
JBrowse link
G TCP1 t-complex 1 decreases expression EXP masitinib results in decreased expression of TCP1 protein CTD PMID:22747577 NCBI chr 1:49,029,260...49,038,023
Ensembl chr 1:49,029,282...49,038,020
JBrowse link
G TEAD4 TEA domain transcription factor 4 increases expression EXP masitinib results in increased expression of TEAD4 mRNA CTD PMID:22747577 NCBI chr27:41,744,100...41,783,223
Ensembl chr27:41,748,871...41,803,556
JBrowse link
G THEMIS2 thymocyte selection associated family member 2 decreases expression EXP masitinib results in decreased expression of THEMIS2 mRNA CTD PMID:22747577 NCBI chr 2:72,465,719...72,501,962
Ensembl chr 2:72,464,026...72,502,928
JBrowse link
G TM2D2 TM2 domain containing 2 increases expression EXP masitinib results in increased expression of TM2D2 mRNA CTD PMID:22747577 NCBI chr16:26,551,563...26,557,554
Ensembl chr16:26,551,628...26,556,285
JBrowse link
G TMEM108 transmembrane protein 108 increases expression EXP masitinib results in increased expression of TMEM108 mRNA CTD PMID:22747577 NCBI chr23:29,992,038...30,331,791
Ensembl chr23:29,992,021...30,396,840
JBrowse link
G TMEM260 transmembrane protein 260 increases expression EXP masitinib results in increased expression of TMEM260 mRNA CTD PMID:22747577 NCBI chr 8:32,238,992...32,309,320
Ensembl chr 8:32,238,988...32,306,317
JBrowse link
G TNFSF10 TNF superfamily member 10 increases expression EXP masitinib results in increased expression of TNFSF10 mRNA CTD PMID:22747577 NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
JBrowse link
G TNPO1 transportin 1 decreases expression EXP masitinib results in decreased expression of TNPO1 mRNA CTD PMID:22747577 NCBI chr 2:55,795,737...55,859,366
Ensembl chr 2:55,799,907...55,851,213
JBrowse link
G TNS1 tensin 1 decreases expression EXP masitinib results in decreased expression of TNS1 mRNA CTD PMID:22747577 NCBI chr37:24,578,855...24,776,153
Ensembl chr37:24,581,806...24,808,049
JBrowse link
G TOX thymocyte selection associated high mobility group box increases expression EXP masitinib results in increased expression of TOX mRNA CTD PMID:22747577 NCBI chr29:9,542,471...9,841,759
Ensembl chr29:9,544,561...9,842,034
JBrowse link
G TSHB thyroid stimulating hormone subunit beta increases expression EXP masitinib results in increased expression of TSHB mRNA CTD PMID:22747577 NCBI chr17:52,659,137...52,685,388
Ensembl chr17:52,681,357...52,685,390
JBrowse link
G TSPAN2 tetraspanin 2 increases expression EXP masitinib results in increased expression of TSPAN2 mRNA CTD PMID:22747577 NCBI chr17:52,692,744...52,749,048
Ensembl chr17:52,694,603...52,744,276
JBrowse link
G TTC38 tetratricopeptide repeat domain 38 increases expression EXP masitinib results in increased expression of TTC38 protein CTD PMID:22747577 NCBI chr10:19,887,285...19,910,347
Ensembl chr10:19,773,373...19,910,683
JBrowse link
G TTLL1 TTL family tubulin polyglutamylase complex subunit L1 decreases expression EXP masitinib results in decreased expression of TTLL1 mRNA CTD PMID:22747577 NCBI chr10:22,456,150...22,492,375
Ensembl chr10:22,456,146...22,488,505
JBrowse link
G UCHL3 ubiquitin C-terminal hydrolase L3 increases expression EXP masitinib results in increased expression of UCHL3 protein CTD PMID:22747577 NCBI chr22:29,348,962...29,397,944
Ensembl chr22:29,348,706...29,407,965
JBrowse link
G UQCC1 ubiquinol-cytochrome c reductase complex assembly factor 1 decreases expression EXP masitinib results in decreased expression of UQCC1 mRNA CTD PMID:22747577 NCBI chr24:24,285,147...24,381,819
Ensembl chr24:24,286,320...24,381,699
JBrowse link
G UROD uroporphyrinogen decarboxylase increases expression EXP masitinib results in increased expression of UROD protein CTD PMID:22747577 NCBI chr15:15,313,808...15,317,130
Ensembl chr15:15,312,674...15,320,010
JBrowse link
G UROS uroporphyrinogen III synthase increases expression EXP masitinib results in increased expression of UROS mRNA CTD PMID:22747577 NCBI chr28:34,952,074...34,983,532
Ensembl chr28:34,948,003...34,983,532
JBrowse link
G VCPKMT valosin containing protein lysine methyltransferase decreases expression EXP masitinib results in decreased expression of VCPKMT mRNA CTD PMID:22747577 NCBI chr 8:26,611,333...26,636,700
Ensembl chr 8:26,625,677...26,636,316
JBrowse link
G WAPL WAPL cohesin release factor decreases expression EXP masitinib results in decreased expression of WAPAL mRNA CTD PMID:22747577 NCBI chr 4:34,219,644...34,297,456
Ensembl chr 4:34,219,645...34,302,839
JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta increases expression EXP masitinib results in increased expression of YWHAZ protein CTD PMID:22747577 NCBI chr13:2,729,404...2,764,422 JBrowse link
G ZNF23 zinc finger protein 23 increases expression EXP masitinib results in increased expression of ZNF23 mRNA CTD PMID:22747577 NCBI chr 5:77,246,374...77,260,761
Ensembl chr 5:77,246,667...77,260,350
JBrowse link
mastoparan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GNAQ G protein subunit alpha q multiple interactions EXP G(M1) Ganglioside inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein]; ganglioside, GD1a inhibits the reaction [mastoparan results in increased activity of and affects the localization of GNAQ protein]; mastoparan results in increased activity of and affects the localization of GNAQ protein CTD PMID:21671308 NCBI chr 1:80,733,530...80,928,065
Ensembl chr 1:80,715,366...80,928,065
JBrowse link
G HEXB hexosaminidase subunit beta multiple interactions
increases secretion
EXP G(M1) Ganglioside inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; ganglioside, GD1a inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein]; methyl-beta-cyclodextrin promotes the reaction [mastoparan results in increased secretion of HEXB protein]; Pertussis Toxin inhibits the reaction [mastoparan results in increased secretion of HEXB protein]; Quinacrine promotes the reaction [mastoparan results in increased secretion of HEXB protein]; YM-254890 inhibits the reaction [mastoparan results in increased secretion of HEXB protein] CTD PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
melittin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions
increases secretion
EXP G(M1) Ganglioside inhibits the reaction [Melitten results in increased secretion of HEXB protein]; sialogangliosides inhibits the reaction [Melitten results in increased secretion of HEXB protein]; trisialoganglioside GT1 inhibits the reaction [Melitten results in increased secretion of HEXB protein] CTD PMID:21334356 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
Mesaconitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases transport EXP ABCB1 protein results in increased transport of mesaconitine CTD PMID:23200901 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 multiple interactions EXP [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased transport of mesaconitine CTD PMID:23200901 NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
JBrowse link
metamizole sodium term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Dipyrone results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
metoprolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein CTD PMID:18820026 NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
JBrowse link
G CYP2D15 cytochrome P450 family 2 subfamily D member 15 affects metabolic processing EXP CYP2D15 affects the metabolism of Metoprolol CTD PMID:7786018 NCBI chr10:23,255,259...23,259,380
Ensembl chr10:23,255,249...23,259,298
JBrowse link
G EGR1 early growth response 1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein CTD PMID:18820026 NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
JBrowse link
G GATA4 GATA binding protein 4 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein CTD PMID:18820026 NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
JBrowse link
G NAB1 NGFI-A binding protein 1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein CTD PMID:18820026 NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
JBrowse link
G SLC8A1 solute carrier family 8 member A1 multiple interactions EXP [Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein CTD PMID:18820026 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
mexiletine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases response to substance EXP ABCB1 mutant form results in increased susceptibility to Mexiletine CTD PMID:16594604 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
ML-7 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP [ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin] CTD PMID:20510202 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G MYLK myosin light chain kinase multiple interactions EXP [ML 7 results in decreased activity of MYLK protein] affects the reaction [ABCB1 protein affects the transport of Digoxin] CTD PMID:20510202 NCBI chr33:26,663,991...26,867,370
Ensembl chr33:26,664,800...26,843,181
JBrowse link
mocetinostat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKAP12 A-kinase anchoring protein 12 increases expression EXP mocetinostat results in increased expression of AKAP12 mRNA CTD PMID:27255383 NCBI chr 1:41,614,893...41,712,350
Ensembl chr 1:41,614,714...41,709,798
JBrowse link
G ANK1 ankyrin 1 decreases expression EXP mocetinostat results in decreased expression of ANK1 mRNA CTD PMID:27255383 NCBI chr16:23,858,299...23,966,181
Ensembl chr16:23,766,193...23,964,226
JBrowse link
G ANK3 ankyrin 3 increases expression EXP mocetinostat results in increased expression of ANK3 mRNA CTD PMID:27255383 NCBI chr 4:12,166,275...12,827,175
Ensembl chr 4:12,167,550...12,827,037
JBrowse link
G AP2M1 adaptor related protein complex 2 subunit mu 1 decreases expression EXP mocetinostat results in decreased expression of AP2M1 mRNA CTD PMID:27255383 NCBI chr34:17,071,199...17,080,445
Ensembl chr34:17,071,235...17,080,445
JBrowse link
G AP2S1 adaptor related protein complex 2 subunit sigma 1 decreases expression EXP mocetinostat results in decreased expression of AP2S1 mRNA CTD PMID:27255383 NCBI chr 1:109,094,098...109,105,233
Ensembl chr 1:109,082,221...109,105,230
JBrowse link
G AP3S1 adaptor related protein complex 3 subunit sigma 1 increases expression EXP mocetinostat results in increased expression of AP3S1 mRNA CTD PMID:27255383 NCBI chr11:5,543,140...5,611,322
Ensembl chr11:5,543,222...5,610,930
JBrowse link
G ARF4 ADP ribosylation factor 4 increases expression EXP mocetinostat results in increased expression of ARF4 mRNA CTD PMID:27255383 NCBI chr20:32,849,725...32,871,127
Ensembl chr20:32,849,757...32,870,721
JBrowse link
G ATG4D autophagy related 4D cysteine peptidase decreases expression EXP mocetinostat results in decreased expression of ATG4D mRNA CTD PMID:27255383 NCBI chr20:50,618,458...50,623,703
Ensembl chr20:50,618,459...50,624,179
JBrowse link
G ATG7 autophagy related 7 decreases expression EXP mocetinostat results in decreased expression of ATG7 mRNA CTD PMID:27255383 NCBI chr20:6,916,354...7,154,849
Ensembl chr20:6,916,515...7,154,800
JBrowse link
G ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 increases expression EXP mocetinostat results in increased expression of ATP1A1 mRNA CTD PMID:27255383 NCBI chr17:53,828,482...53,847,043
Ensembl chr17:53,813,976...53,847,167
JBrowse link
G BCAP29 B cell receptor associated protein 29 increases expression EXP mocetinostat results in increased expression of BCAP29 mRNA CTD PMID:27255383 NCBI chr18:12,969,594...13,021,948
Ensembl chr18:12,970,411...13,022,022
JBrowse link
G BLOC1S1 biogenesis of lysosomal organelles complex 1 subunit 1 decreases expression EXP mocetinostat results in decreased expression of BLOC1S1 mRNA CTD PMID:27255383 NCBI chr10:116,993...120,244 JBrowse link
G BNIP1 BCL2 interacting protein 1 decreases expression EXP mocetinostat results in decreased expression of BNIP1 mRNA CTD PMID:27255383 NCBI chr 4:39,255,685...39,303,485
Ensembl chr 4:39,289,776...39,303,430
JBrowse link
G CACNB3 calcium voltage-gated channel auxiliary subunit beta 3 increases expression EXP mocetinostat results in increased expression of CACNB3 mRNA CTD PMID:27255383 NCBI chr27:5,705,587...5,714,620
Ensembl chr27:5,706,064...5,717,647
JBrowse link
G CAMK1D calcium/calmodulin dependent protein kinase ID increases expression EXP mocetinostat results in increased expression of CAMK1D mRNA CTD PMID:27255383 NCBI chr 2:23,680,395...24,113,922
Ensembl chr 2:23,685,672...24,114,084
JBrowse link
G CASK calcium/calmodulin dependent serine protein kinase increases expression EXP mocetinostat results in increased expression of CASK mRNA CTD PMID:27255383 NCBI chr  X:35,939,117...36,296,438
Ensembl chr  X:35,940,647...36,297,014
JBrowse link
G CAV1 caveolin 1 increases expression EXP mocetinostat results in increased expression of CAV1 mRNA CTD PMID:27255383 NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
JBrowse link
G CBY1 chibby 1, beta catenin antagonist decreases expression EXP mocetinostat results in decreased expression of CBY1 mRNA CTD PMID:27255383 NCBI chr10:26,125,064...26,134,693
Ensembl chr10:26,125,189...26,128,285
JBrowse link
G CHMP4B charged multivesicular body protein 4B decreases expression EXP mocetinostat results in decreased expression of CHMP4B mRNA CTD PMID:27255383 NCBI chr24:22,995,677...23,050,084
Ensembl chr24:22,995,672...23,049,287
JBrowse link
G CHMP5 charged multivesicular body protein 5 decreases expression EXP mocetinostat results in decreased expression of CHMP5 mRNA CTD PMID:27255383 NCBI chr11:50,363,488...50,376,081 JBrowse link
G CHMP6 charged multivesicular body protein 6 decreases expression EXP mocetinostat results in decreased expression of CHMP6 mRNA CTD PMID:27255383 NCBI chr 9:997,951...1,001,659
Ensembl chr 9:998,653...1,002,538
JBrowse link
G CLTCL1 clathrin heavy chain like 1 increases expression EXP mocetinostat results in increased expression of CLTCL1 mRNA CTD PMID:27255383 NCBI chr26:29,907,235...30,002,136
Ensembl chr26:29,906,278...30,002,128
JBrowse link
G COPB1 COPI coat complex subunit beta 1 increases expression EXP mocetinostat results in increased expression of COPB1 mRNA CTD PMID:27255383 NCBI chr21:37,186,380...37,224,549
Ensembl chr21:37,186,424...37,224,519
JBrowse link
G COPB2 COPI coat complex subunit beta 2 decreases expression EXP mocetinostat results in decreased expression of COPB2 mRNA CTD PMID:27255383 NCBI chr23:35,536,520...35,604,708
Ensembl chr23:35,536,615...35,566,569
JBrowse link
G COPG1 COPI coat complex subunit gamma 1 decreases expression EXP mocetinostat results in decreased expression of COPG1 mRNA CTD PMID:27255383 NCBI chr20:2,832,150...2,860,356
Ensembl chr20:2,832,198...2,860,320
JBrowse link
G DERL2 derlin 2 decreases expression EXP mocetinostat results in decreased expression of DERL2 mRNA CTD PMID:27255383 NCBI chr 5:31,319,660...31,330,846
Ensembl chr 5:31,319,717...31,330,841
JBrowse link
G DNM1L dynamin 1 like decreases expression EXP mocetinostat results in decreased expression of DNM1L mRNA CTD PMID:27255383 NCBI chr27:16,161,855...16,211,983
Ensembl chr27:16,163,357...16,211,957
JBrowse link
G GPAA1 glycosylphosphatidylinositol anchor attachment 1 decreases expression EXP mocetinostat results in decreased expression of GPAA1 mRNA CTD PMID:27255383 NCBI chr13:37,577,162...37,580,346
Ensembl chr13:37,576,354...37,580,345
JBrowse link
G HPS4 HPS4 biogenesis of lysosomal organelles complex 3 subunit 2 decreases expression EXP mocetinostat results in decreased expression of HPS4 mRNA CTD PMID:27255383 NCBI chr26:20,131,658...20,157,532
Ensembl chr26:19,933,281...20,157,058
JBrowse link
G HRC histidine rich calcium binding protein decreases expression EXP mocetinostat results in decreased expression of HRC mRNA CTD PMID:27255383 NCBI chr 1:107,304,718...107,308,741
Ensembl chr 1:107,304,924...107,308,740
JBrowse link
G KCNK1 potassium two pore domain channel subfamily K member 1 increases expression EXP mocetinostat results in increased expression of KCNK1 mRNA CTD PMID:27255383 NCBI chr 4:6,117,406...6,139,390
Ensembl chr 4:6,118,373...6,122,093
JBrowse link
G KCNMB4 potassium calcium-activated channel subfamily M regulatory beta subunit 4 increases expression EXP mocetinostat results in increased expression of KCNMB4 mRNA CTD PMID:27255383 NCBI chr10:12,211,372...12,251,739 JBrowse link
G KCNS3 potassium voltage-gated channel modifier subfamily S member 3 increases expression EXP mocetinostat results in increased expression of KCNS3 mRNA CTD PMID:27255383 NCBI chr17:13,297,242...13,338,319
Ensembl chr17:13,336,374...13,337,849
JBrowse link
G KIF5A kinesin family member 5A increases expression EXP mocetinostat results in increased expression of KIF5A mRNA CTD PMID:27255383 NCBI chr10:1,637,007...1,666,790
Ensembl chr10:1,636,932...1,664,767
JBrowse link
G KIF5B kinesin family member 5B decreases expression EXP mocetinostat results in decreased expression of KIF5B mRNA CTD PMID:27255383 NCBI chr 2:14,835,906...14,880,896
Ensembl chr 2:14,835,901...14,878,251
JBrowse link
G KIF5C kinesin family member 5C increases expression EXP mocetinostat results in increased expression of KIF5C mRNA CTD PMID:27255383 NCBI chr19:50,535,622...50,684,485
Ensembl chr19:50,535,456...50,668,738
JBrowse link
G LAMTOR1 late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 decreases expression EXP mocetinostat results in decreased expression of LAMTOR1 mRNA CTD PMID:27255383 NCBI chr21:25,981,170...25,986,942
Ensembl chr21:25,981,254...25,996,432
JBrowse link
G LAMTOR2 late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 decreases expression EXP mocetinostat results in decreased expression of LAMTOR2 mRNA CTD PMID:27255383 NCBI chr 7:41,760,632...41,764,926
Ensembl chr 7:41,760,638...41,763,299
JBrowse link
G LOC478702 tubulin beta-2B chain increases expression EXP mocetinostat results in increased expression of TUBB2B mRNA CTD PMID:27255383 NCBI chr35:3,494,982...3,498,274
Ensembl chr35:3,495,277...3,498,248
JBrowse link
G MAL2 mal, T cell differentiation protein 2 increases expression EXP mocetinostat results in increased expression of MAL2 mRNA CTD PMID:27255383 NCBI chr13:18,404,979...18,422,076
Ensembl chr13:18,406,633...18,420,469
JBrowse link
G MICAL1 microtubule associated monooxygenase, calponin and LIM domain containing 1 increases expression EXP mocetinostat results in increased expression of MICAL1 mRNA CTD PMID:27255383 NCBI chr12:66,350,459...66,358,391
Ensembl chr12:66,350,427...66,360,615
JBrowse link
G MYPN myopalladin decreases expression EXP mocetinostat results in decreased expression of MYPN mRNA CTD PMID:27255383 NCBI chr 4:19,364,146...19,468,827
Ensembl chr 4:19,381,416...19,465,995
JBrowse link
G PEX19 peroxisomal biogenesis factor 19 decreases expression EXP mocetinostat results in decreased expression of PEX19 mRNA CTD PMID:27255383 NCBI chr38:21,939,054...21,945,281
Ensembl chr38:21,939,018...21,944,602
JBrowse link
G POLE2 DNA polymerase epsilon 2, accessory subunit increases expression EXP mocetinostat results in increased expression of DNAAF2 mRNA CTD PMID:27255383 NCBI chr 8:26,264,220...26,295,089
Ensembl chr 8:26,251,160...26,295,317
JBrowse link
G PPP3CA protein phosphatase 3 catalytic subunit alpha increases expression EXP mocetinostat results in increased expression of PPP3CA mRNA CTD PMID:27255383 NCBI chr32:22,688,141...22,996,693
Ensembl chr32:22,688,143...22,996,688
JBrowse link
G RAB27A RAB27A, member RAS oncogene family increases expression EXP mocetinostat results in increased expression of RAB27A mRNA CTD PMID:27255383 NCBI chr30:20,633,576...20,706,240
Ensembl chr30:20,635,400...20,690,521
JBrowse link
G RAB31 RAB31, member RAS oncogene family increases expression EXP mocetinostat results in increased expression of RAB31 mRNA CTD PMID:27255383 NCBI chr 7:75,678,896...75,807,716
Ensembl chr 7:75,678,908...75,817,426
JBrowse link
G RAB3IP RAB3A interacting protein increases expression EXP mocetinostat results in increased expression of RAB3IP mRNA CTD PMID:27255383 NCBI chr10:11,673,749...11,714,282
Ensembl chr10:11,673,777...11,714,281
JBrowse link
G RABEPK Rab9 effector protein with kelch motifs increases expression EXP mocetinostat results in increased expression of RABEPK mRNA CTD PMID:27255383 NCBI chr 9:57,857,269...57,877,333
Ensembl chr 9:57,857,269...57,883,761
JBrowse link
G SCAMP3 secretory carrier membrane protein 3 decreases expression EXP mocetinostat results in decreased expression of SCAMP3 mRNA CTD PMID:27255383 NCBI chr 7:42,294,764...42,299,097 JBrowse link
G SCN10A sodium voltage-gated channel alpha subunit 10 increases expression EXP mocetinostat results in increased expression of SCN10A mRNA CTD PMID:27255383 NCBI chr23:8,420,468...8,527,414
Ensembl chr23:8,420,472...8,527,383
JBrowse link
G SDCBP syndecan binding protein increases expression EXP mocetinostat results in increased expression of SDCBP mRNA CTD PMID:27255383 NCBI chr29:9,331,876...9,370,489 JBrowse link
G SEC24B SEC24 homolog B, COPII coat complex component increases expression EXP mocetinostat results in increased expression of SEC24B mRNA CTD PMID:27255383 NCBI chr32:29,671,702...29,766,628
Ensembl chr32:29,671,738...29,772,192
JBrowse link
G SEC24D SEC24 homolog D, COPII coat complex component increases expression EXP mocetinostat results in increased expression of SEC24D mRNA CTD PMID:27255383 NCBI chr32:37,690,158...37,795,762
Ensembl chr32:37,690,399...37,924,252
JBrowse link
G SEC63 SEC63 homolog, protein translocation regulator increases expression EXP mocetinostat results in increased expression of SEC63 mRNA CTD PMID:27255383 NCBI chr12:64,983,442...65,028,573 JBrowse link
G SFT2D1 SFT2 domain containing 1 decreases expression EXP mocetinostat results in decreased expression of SFT2D1 mRNA CTD PMID:27255383 NCBI chr 1:54,335,832...54,354,199
Ensembl chr 1:54,336,005...54,354,137
JBrowse link
G SMTN smoothelin decreases expression EXP mocetinostat results in decreased expression of SMTN mRNA CTD PMID:27255383 NCBI chr26:24,085,356...24,108,005
Ensembl chr26:24,085,382...24,108,540
JBrowse link
G SNAP23 synaptosome associated protein 23 increases expression EXP mocetinostat results in increased expression of SNAP23 mRNA CTD PMID:27255383 NCBI chr30:9,453,931...9,493,506
Ensembl chr30:9,456,084...9,492,329
JBrowse link
G SNAPIN SNAP associated protein decreases expression EXP mocetinostat results in decreased expression of SNAPIN mRNA CTD PMID:27255383 NCBI chr 7:43,410,554...43,411,929
Ensembl chr 7:43,410,998...43,412,323
JBrowse link
G SNX15 sorting nexin 15 decreases expression EXP mocetinostat results in decreased expression of SNX15 mRNA CTD PMID:27255383 NCBI chr18:52,152,562...52,165,081
Ensembl chr18:52,152,561...52,165,048
JBrowse link
G SNX16 sorting nexin 16 increases expression EXP mocetinostat results in increased expression of SNX16 mRNA CTD PMID:27255383 NCBI chr29:28,882,768...28,922,713
Ensembl chr29:28,884,426...28,920,797
JBrowse link
G SNX17 sorting nexin 17 decreases expression EXP mocetinostat results in decreased expression of SNX17 mRNA CTD PMID:27255383 NCBI chr17:21,326,496...21,332,170
Ensembl chr17:21,326,503...21,331,857
JBrowse link
G SNX24 sorting nexin 24 increases expression EXP mocetinostat results in increased expression of SNX24 mRNA CTD PMID:27255383 NCBI chr11:12,776,934...12,869,304
Ensembl chr11:12,708,712...12,888,165
JBrowse link
G SNX7 sorting nexin 7 increases expression EXP mocetinostat results in increased expression of SNX7 mRNA CTD PMID:27255383 NCBI chr 6:51,004,307...51,388,283
Ensembl chr 6:51,025,203...51,094,539
JBrowse link
G SPTBN1 spectrin beta, non-erythrocytic 1 increases expression EXP mocetinostat results in increased expression of SPTBN1 mRNA CTD PMID:27255383 NCBI chr10:55,429,989...55,571,917
Ensembl chr10:55,429,940...55,571,916
JBrowse link
G STAM2 signal transducing adaptor molecule 2 decreases expression EXP mocetinostat results in decreased expression of STAM2 mRNA CTD PMID:27255383 NCBI chr19:53,213,904...53,256,711
Ensembl chr19:53,216,274...53,256,756
Ensembl chr19:53,216,274...53,256,756
JBrowse link
G STON1 stonin 1 increases expression EXP mocetinostat results in increased expression of STON1 mRNA CTD PMID:27255383 NCBI chr10:50,421,635...50,470,302
Ensembl chr10:50,436,715...50,467,878
JBrowse link
G STX4 syntaxin 4 decreases expression EXP mocetinostat results in decreased expression of STX4 mRNA CTD PMID:27255383 NCBI chr 6:17,184,044...17,189,481
Ensembl chr 6:17,184,399...17,189,370
JBrowse link
G SYTL1 synaptotagmin like 1 increases expression EXP mocetinostat results in increased expression of SYTL1 mRNA CTD PMID:27255383 NCBI chr 2:72,916,445...72,925,219
Ensembl chr 2:72,916,445...72,925,147
JBrowse link
G SYTL4 synaptotagmin like 4 increases expression EXP mocetinostat results in increased expression of SYTL4 mRNA CTD PMID:27255383 NCBI chr  X:74,537,937...74,617,580
Ensembl chr  X:74,539,183...74,565,753
JBrowse link
G TFRC transferrin receptor decreases expression EXP mocetinostat results in decreased expression of TFRC mRNA CTD PMID:27255383 NCBI chr33:29,206,024...29,237,221
Ensembl chr33:29,208,609...29,238,242
JBrowse link
G TMED1 transmembrane p24 trafficking protein 1 decreases expression EXP mocetinostat results in decreased expression of TMED1 mRNA CTD PMID:27255383 NCBI chr20:50,395,862...50,399,118
Ensembl chr20:50,396,005...50,407,535
JBrowse link
G TMED2 transmembrane p24 trafficking protein 2 decreases expression EXP mocetinostat results in decreased expression of TMED2 mRNA CTD PMID:27255383 NCBI chr26:6,039,046...6,047,490
Ensembl chr26:6,039,405...6,047,459
JBrowse link
G TRIM54 tripartite motif containing 54 decreases expression EXP mocetinostat results in decreased expression of TRIM54 mRNA CTD PMID:27255383 NCBI chr17:21,257,660...21,278,410
Ensembl chr17:21,257,706...21,278,274
JBrowse link
G TSG101 tumor susceptibility 101 decreases expression EXP mocetinostat results in decreased expression of TSG101 mRNA CTD PMID:27255383 NCBI chr21:40,910,870...40,952,922
Ensembl chr21:40,910,874...40,952,808
JBrowse link
G TTN titin decreases expression EXP mocetinostat results in decreased expression of TTN mRNA CTD PMID:27255383 NCBI chr36:22,146,870...22,417,858
Ensembl chr36:22,147,824...22,417,826
JBrowse link
G TUBA4A tubulin alpha 4a decreases expression EXP mocetinostat results in decreased expression of TUBA4A mRNA CTD PMID:27255383 NCBI chr37:25,799,075...25,803,257
Ensembl chr37:25,796,107...25,802,892
JBrowse link
G TUBG1 tubulin, gamma 1 decreases expression EXP mocetinostat results in decreased expression of TUBG1 mRNA CTD PMID:27255383 NCBI chr 9:20,358,683...20,363,455
Ensembl chr 9:20,322,253...20,363,455
JBrowse link
G USO1 USO1 vesicle transport factor decreases expression EXP mocetinostat results in decreased expression of USO1 mRNA CTD PMID:27255383 NCBI chr32:305,895...395,113
Ensembl chr32:305,935...394,896
JBrowse link
G VPS13B vacuolar protein sorting 13 homolog B decreases expression EXP mocetinostat results in decreased expression of VPS13B mRNA CTD PMID:27255383 NCBI chr13:1,101,226...1,834,933
Ensembl chr13:1,101,610...1,871,225
JBrowse link
G VPS16 VPS16 core subunit of CORVET and HOPS complexes decreases expression EXP mocetinostat results in decreased expression of VPS16 mRNA CTD PMID:27255383 NCBI chr24:18,401,440...18,424,605
Ensembl chr24:18,399,572...18,424,510
JBrowse link
G VPS26A VPS26, retromer complex component A decreases expression EXP mocetinostat results in decreased expression of VPS26A mRNA CTD PMID:27255383 NCBI chr 4:20,265,120...20,296,125
Ensembl chr 4:20,264,905...20,294,674
JBrowse link
G VPS29 VPS29 retromer complex component decreases expression EXP mocetinostat results in decreased expression of VPS29 mRNA CTD PMID:27255383 NCBI chr26:8,301,699...8,309,364
Ensembl chr26:8,301,699...8,309,364
JBrowse link
G VPS33A VPS33A core subunit of CORVET and HOPS complexes decreases expression EXP mocetinostat results in decreased expression of VPS33A mRNA CTD PMID:27255383 NCBI chr26:7,090,669...7,119,913 JBrowse link
G VPS33B VPS33B late endosome and lysosome associated decreases expression EXP mocetinostat results in decreased expression of VPS33B mRNA CTD PMID:27255383 NCBI chr 3:53,220,199...53,239,738
Ensembl chr 3:53,220,194...53,239,732
JBrowse link
G VPS35 VPS35 retromer complex component decreases expression EXP mocetinostat results in decreased expression of VPS35 mRNA CTD PMID:27255383 NCBI chr15:8,428,073...8,454,601
Ensembl chr15:8,428,172...8,454,049
JBrowse link
G VPS41 VPS41 subunit of HOPS complex decreases expression EXP mocetinostat results in decreased expression of VPS41 mRNA CTD PMID:27255383 NCBI chr18:10,788,846...10,956,207
Ensembl chr18:10,788,891...10,955,645
JBrowse link
G VPS52 VPS52 subunit of GARP complex decreases expression EXP mocetinostat results in decreased expression of VPS52 mRNA CTD PMID:27255383 NCBI chr12:2,697,508...2,712,831
Ensembl chr12:2,697,508...2,712,831
JBrowse link
G VPS54 VPS54 subunit of GARP complex increases expression EXP mocetinostat results in increased expression of VPS54 mRNA CTD PMID:27255383 NCBI chr10:63,598,373...63,676,753
Ensembl chr10:63,599,229...63,676,747
JBrowse link
G VTI1B vesicle transport through interaction with t-SNAREs 1B decreases expression EXP mocetinostat results in decreased expression of VTI1B mRNA CTD PMID:27255383 NCBI chr 8:41,619,365...41,650,389
Ensembl chr29:19,153,616...19,154,245
Ensembl chr 8:19,153,616...19,154,245
JBrowse link
monensin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC6A9 solute carrier family 6 member 9 affects localization
multiple interactions
EXP Monensin affects the localization of SLC6A9 protein
Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein]
CTD PMID:19473961 NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
JBrowse link
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL6 interleukin 6 multiple interactions
decreases expression
EXP N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of IL6 protein]
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of IL6 protein
CTD PMID:24105867 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta multiple interactions EXP N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Amphotericin B results in increased expression of PRKACG protein] CTD PMID:24105867 NCBI chr 6:63,615,445...63,729,386
Ensembl chr 6:63,618,323...63,730,146
JBrowse link
N-acetyl-L-cysteine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 multiple interactions EXP Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of CLDN4 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein] CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein] CTD PMID:23816505 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein] CTD PMID:23816505 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein] CTD PMID:23816505 NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions EXP Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein]; Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:23816505 NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
JBrowse link
nafenopin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SOD1 superoxide dismutase 1 affects response to substance EXP SOD1 protein affects the susceptibility to Nafenopin CTD PMID:6333936 NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
JBrowse link
naloxone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G POMC proopiomelanocortin increases expression EXP Naloxone results in increased expression of POMC protein CTD PMID:8277081 NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
JBrowse link
nefiracetam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 affects expression
increases expression
EXP nefiracetam affects the expression of PTGS2 mRNA
nefiracetam results in increased expression of PTGS2 protein
CTD PMID:16105799 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
nicotinamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PPARG peroxisome proliferator activated receptor gamma increases expression
multiple interactions
EXP Niacinamide results in increased expression of PPARG protein
Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]
CTD PMID:22539994 NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
JBrowse link
G RUNX2 RUNX family transcription factor 2 increases acetylation
multiple interactions
decreases expression
EXP Niacinamide results in increased acetylation of RUNX2 protein
Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein]
CTD PMID:22539994 NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785
Ensembl chr12:13,628,539...13,840,785
JBrowse link
G SIRT1 sirtuin 1 decreases expression
multiple interactions
EXP Niacinamide results in decreased expression of SIRT1 protein
Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein]
CTD PMID:22539994 NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
JBrowse link
nimesulide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL1B interleukin 1 beta decreases expression EXP nimesulide results in decreased expression of IL1B mRNA CTD PMID:19638440 NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP nimesulide results in decreased expression of PTGS2 mRNA CTD PMID:15198222 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
nitrites term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KNG1 kininogen 1 increases chemical synthesis EXP KNG1 protein modified form results in increased chemical synthesis of Nitrites CTD PMID:17644579 NCBI chr34:19,288,629...19,318,096
Ensembl chr34:19,287,109...19,318,081
JBrowse link
nitroglycerin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin decreases activity EXP Nitroglycerin results in decreased activity of REN protein CTD PMID:8640982 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
NS-398 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 mRNA; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 protein CTD PMID:12857884 PMID:15198222 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit decreases localization EXP N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased localization of RELA protein CTD PMID:12857884 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
JBrowse link
o-cresol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 affects metabolic processing EXP CYP2E1 protein affects the metabolism of 2-cresol CTD PMID:8592870 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
ochratoxin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTA2 actin alpha 2, smooth muscle multiple interactions
increases expression
EXP CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of ACTA2 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]
ochratoxin A results in increased expression of ACTA2 mRNA; ochratoxin A results in increased expression of ACTA2 protein
CTD PMID:33543323 NCBI chr26:38,700,434...38,714,915
Ensembl chr26:38,700,480...38,711,753
JBrowse link
G B9D2 B9 domain containing 2 increases expression
multiple interactions
EXP ochratoxin A results in increased expression of TGFB1 mRNA; ochratoxin A results in increased expression of TGFB1 protein
CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of TGFB1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]
CTD PMID:33543323 NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
JBrowse link
G CASP4 caspase 4, apoptosis-related cysteine peptidase increases cleavage
increases expression
multiple interactions
EXP ochratoxin A results in increased cleavage of CASP1 protein
ochratoxin A results in increased expression of CASP1 mRNA
CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]
CTD PMID:33543323 NCBI chr 5:27,133,778...27,147,954
Ensembl chr 5:27,132,565...27,149,736
JBrowse link
G GSDMD gasdermin D multiple interactions
increases expression
EXP CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of GSDMD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]
ochratoxin A results in increased expression of GSDMD mRNA; ochratoxin A results in increased expression of GSDMD protein
CTD PMID:33543323 NCBI chr13:37,221,219...37,226,912
Ensembl chr13:37,193,022...37,228,360
JBrowse link
G IL18 interleukin 18 multiple interactions
increases expression
EXP CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL18 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA] CTD PMID:33543323 NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
JBrowse link
G IL1B interleukin 1 beta multiple interactions
increases expression
EXP CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]
ochratoxin A results in increased expression of IL1B mRNA; ochratoxin A results in increased expression of IL1B protein
CTD PMID:33543323 NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
JBrowse link
G IL6 interleukin 6 increases secretion
increases expression
EXP ochratoxin A results in increased secretion of IL6 protein
ochratoxin A results in increased expression of IL6 mRNA
CTD PMID:33543323 NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
JBrowse link
G NLRP3 NLR family pyrin domain containing 3 multiple interactions
increases expression
EXP N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of NLRP3 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased cleavage of CASP1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of ACTA2 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of CASP1 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of GSDMD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL18 mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]
ochratoxin A results in increased expression of NLRP3 mRNA; ochratoxin A results in increased expression of NLRP3 protein
CTD PMID:33543323 NCBI chr 8:251,776...313,290
Ensembl chr 8:253,407...313,059
JBrowse link
G PYCARD PYD and CARD domain containing increases expression
multiple interactions
EXP ochratoxin A results in increased expression of PYCARD mRNA; ochratoxin A results in increased expression of PYCARD protein
N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of PYCARD protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD mRNA]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of PYCARD protein]
CTD PMID:33543323 NCBI chr 6:17,049,352...17,051,348
Ensembl chr 6:17,049,705...17,051,240
JBrowse link
G TNF tumor necrosis factor increases secretion
increases expression
EXP ochratoxin A results in increased secretion of TNF protein
ochratoxin A results in increased expression of TNF mRNA
CTD PMID:33543323 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G VIM vimentin multiple interactions
increases expression
EXP CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM mRNA]; CASP1 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [ochratoxin A results in increased expression of VIM protein]; NLRP3 protein affects the reaction [ochratoxin A results in increased expression of VIM protein]
ochratoxin A results in increased expression of VIM mRNA; ochratoxin A results in increased expression of VIM protein
CTD PMID:33543323 NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
JBrowse link
ofloxacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CAPN1 calpain 1 increases expression EXP Ofloxacin results in increased expression of CAPN1 mRNA CTD PMID:24582689 NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757
JBrowse link
G CASP12 caspase 12 increases expression EXP Ofloxacin results in increased expression of CASP12 mRNA; Ofloxacin results in increased expression of CASP12 protein CTD PMID:24582689 NCBI chr 5:27,162,840...27,176,964
Ensembl chr 5:27,161,700...27,177,683
JBrowse link
G CASP8 caspase 8 multiple interactions
increases expression
EXP TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA] CTD PMID:24582689 NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP Ofloxacin results in increased expression of DDIT3 mRNA CTD PMID:24582689 NCBI chr10:1,606,693...1,612,410
Ensembl chr10:1,606,693...1,611,303
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP Ofloxacin results in increased expression of HSPA5 mRNA CTD PMID:24582689 NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
JBrowse link
G TNF tumor necrosis factor increases expression EXP Ofloxacin results in increased expression of TNF mRNA; Ofloxacin results in increased expression of TNF protein CTD PMID:24582689 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A multiple interactions
increases expression
EXP TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA]; TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA]
Ofloxacin results in increased expression of TNFRSF1A mRNA; Ofloxacin results in increased expression of TNFRSF1A protein
CTD PMID:24582689 NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
JBrowse link
G TRADD TNFRSF1A associated via death domain multiple interactions
increases expression
EXP TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of TRADD mRNA] CTD PMID:24582689 NCBI chr 5:82,200,430...82,211,430
Ensembl chr 5:82,206,111...82,210,963
JBrowse link
ouabain term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin decreases secretion
multiple interactions
EXP Ouabain results in decreased secretion of REN protein
Vanadates inhibits the reaction [Ouabain results in decreased secretion of REN protein]
CTD PMID:6093556 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
p-cresol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C41 cytochrome P450 2C41 affects metabolic processing EXP CYP2C11 protein affects the metabolism of 4-cresol CTD PMID:8592870
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 affects metabolic processing EXP CYP2E1 protein affects the metabolism of 4-cresol CTD PMID:8592870 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
p-menthan-3-ol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TRPM8 transient receptor potential cation channel subfamily M member 8 increases activity
multiple interactions
EXP Menthol results in increased activity of TRPM8 protein
[Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium; N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide inhibits the reaction [[Menthol results in increased activity of TRPM8 protein] which results in increased transport of Calcium]
CTD PMID:16386244 NCBI chr25:45,261,092...45,357,560
Ensembl chr25:45,261,107...45,353,282
JBrowse link
paracetamol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Acetaminophen results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
G UGT1A6 UDP glucuronosyltransferase 1 family, polypeptide A6 increases glucuronidation EXP UGT1A6 protein results in increased glucuronidation of Acetaminophen CTD PMID:11903872 NCBI chr25:45,081,655...45,161,584
Ensembl chr25:45,032,130...45,160,941
JBrowse link
paraoxon term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCHE butyrylcholinesterase decreases activity EXP Paraoxon results in decreased activity of BCHE protein CTD PMID:4631366 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
pentane-2,3-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 increases reduction EXP DHRS4 protein results in increased reduction of 2,3-pentanedione CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
phalloidin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TJP1 tight junction protein 1 multiple interactions EXP Phalloidine inhibits the reaction [Calcium Oxalate results in decreased expression of TJP1 protein] CTD PMID:34147488 NCBI chr 3:38,997,122...39,076,617
Ensembl chr 3:38,997,076...39,241,574
JBrowse link
phenacetin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 affects metabolic processing EXP CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15801540 NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Phenacetin results in decreased activity of PTGS1 protein alternative form CTD PMID:12242329 NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
JBrowse link
phenylephrine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA1A adrenoceptor alpha 1A multiple interactions EXP Phenylephrine binds to and results in increased activity of ADRA1A protein; silodosin inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein] CTD PMID:19371927 NCBI chr25:30,690,959...30,801,484
Ensembl chr25:30,693,571...30,801,486
JBrowse link
G ADRA1D adrenoceptor alpha 1D multiple interactions EXP BMY 7378 inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1D protein]; naftopidil inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1D protein]; Phenylephrine binds to and results in increased activity of ADRA1D protein CTD PMID:19371927 NCBI chr24:17,231,771...17,239,110
Ensembl chr24:17,213,643...17,214,761
Ensembl chr24:17,213,643...17,214,761
JBrowse link
G REN renin increases secretion EXP Phenylephrine results in increased secretion of REN protein CTD PMID:6347479 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
phenylglyoxylic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 increases reduction EXP DHRS4 protein results in increased reduction of phenylglyoxylic acid CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
phorbol 13-acetate 12-myristate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G INS insulin multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein CTD PMID:12639917 NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein CTD PMID:12639917 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein CTD PMID:12639917 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G SLC6A9 solute carrier family 6 member 9 multiple interactions
affects localization
EXP Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein]
Tetradecanoylphorbol Acetate affects the localization of SLC6A9 protein
CTD PMID:19473961 NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
JBrowse link
G SOD1 superoxide dismutase 1 affects response to substance EXP SOD1 protein affects the susceptibility to Tetradecanoylphorbol Acetate CTD PMID:6333936 NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
JBrowse link
phosphatidylinositol 3-phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; [Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; [Norepinephrine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate; Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate] CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
pindolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin multiple interactions EXP Pindolol inhibits the reaction [Isoproterenol results in increased activity of REN protein] CTD PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
pitavastatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NCF1 neutrophil cytosolic factor 1 decreases expression EXP pitavastatin results in decreased expression of NCF1 mRNA CTD PMID:15502390 NCBI chr 6:5,702,222...5,719,515
Ensembl chr 6:5,605,694...5,719,458
JBrowse link
G NOS3 nitric oxide synthase 3 increases activity
increases expression
EXP pitavastatin results in increased activity of NOS3 protein
pitavastatin results in increased expression of NOS3 mRNA
CTD PMID:15502390 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
JBrowse link
G NOX4 NADPH oxidase 4 decreases expression EXP pitavastatin results in decreased expression of NOX4 mRNA CTD PMID:15502390 NCBI chr21:10,615,153...10,782,927
Ensembl chr21:10,615,970...10,775,277
JBrowse link
prochloraz term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein CTD PMID:24389113 NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
JBrowse link
progesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ESR1 estrogen receptor 1 affects expression EXP Progesterone affects the expression of ESR1 protein CTD PMID:16483645 NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
JBrowse link
G PGR progesterone receptor affects binding EXP Progesterone binds to PGR protein CTD PMID:16054490 NCBI chr21:447,197...552,511
Ensembl chr21:447,319...552,511
JBrowse link
propranolol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRB2 adrenoceptor beta 2 multiple interactions EXP [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased secretion of Norepinephrine CTD PMID:2884805 NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
JBrowse link
G NPPA natriuretic peptide A increases expression EXP Propranolol results in increased expression of NPPA protein CTD PMID:2566282 NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
JBrowse link
G REN renin multiple interactions
decreases activity
EXP Propranolol inhibits the reaction [Isoproterenol results in increased activity of REN protein]
Propranolol results in decreased activity of REN protein
CTD PMID:2566282 PMID:6103674 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
G VIP vasoactive intestinal peptide decreases expression EXP Propranolol results in decreased expression of VIP protein CTD PMID:2566282 NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
JBrowse link
prostaglandin E2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin increases expression EXP Dinoprostone results in increased expression of REN protein CTD PMID:495730 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
quercetin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Quercetin results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
G HSP70 heat shock protein 70 decreases expression EXP Quercetin results in decreased expression of HSP70 protein CTD PMID:17009600 NCBI chr12:1,285,282...1,287,670 JBrowse link
quinacrine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions EXP Quinacrine promotes the reaction [mastoparan results in increased secretion of HEXB protein] CTD PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
rac-lactic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SCT secretin decreases abundance EXP SCT protein results in decreased abundance of Lactic Acid CTD PMID:2418308
ranolazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 affects expression
multiple interactions
EXP Ranolazine affects the expression of ATP2A2 protein
[Ranolazine co-treated with Enalapril] affects the expression of ATP2A2 protein; [Ranolazine co-treated with Metoprolol] affects the expression of ATP2A2 protein
CTD PMID:18820026 NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
JBrowse link
G EGR1 early growth response 1 multiple interactions
affects expression
EXP [Ranolazine co-treated with Enalapril] affects the expression of EGR1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of EGR1 protein
Ranolazine affects the expression of EGR1 protein
CTD PMID:18820026 NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
JBrowse link
G GATA4 GATA binding protein 4 affects expression
multiple interactions
EXP Ranolazine affects the expression of GATA4 protein
[Ranolazine co-treated with Enalapril] affects the expression of GATA4 protein; [Ranolazine co-treated with Metoprolol] affects the expression of GATA4 protein
CTD PMID:18820026 NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
JBrowse link
G NAB1 NGFI-A binding protein 1 affects expression
multiple interactions
EXP Ranolazine affects the expression of NAB1 protein
[Ranolazine co-treated with Enalapril] affects the expression of NAB1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of NAB1 protein
CTD PMID:18820026 NCBI chr37:1,207,619...1,243,546
Ensembl chr37:1,207,638...1,241,610
JBrowse link
G SLC8A1 solute carrier family 8 member A1 affects expression
multiple interactions
EXP Ranolazine affects the expression of SLC8A1 protein
[Ranolazine co-treated with Enalapril] affects the expression of SLC8A1 protein; [Ranolazine co-treated with Metoprolol] affects the expression of SLC8A1 protein
CTD PMID:18820026 NCBI chr17:32,004,207...32,381,399
Ensembl chr17:32,005,245...32,307,700
JBrowse link
resveratrol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACP5 acid phosphatase 5, tartrate resistant multiple interactions EXP Resveratrol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:21239502 NCBI chr20:49,812,444...49,816,262
Ensembl chr20:49,814,032...49,816,260
JBrowse link
G EP300 E1A binding protein p300 multiple interactions EXP [[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein] CTD PMID:21239502 NCBI chr10:24,076,538...24,156,708
Ensembl chr10:24,077,971...24,156,396
JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions EXP Resveratrol inhibits the reaction [TNFSF11 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] CTD PMID:21239502 NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions EXP Resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] CTD PMID:22539994 NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions EXP [[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased localization of and results in increased activity of RELA protein] CTD PMID:21239502 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
JBrowse link
G RUNX2 RUNX family transcription factor 2 multiple interactions
decreases acetylation
increases expression
EXP [Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide results in increased acetylation of RUNX2 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of RUNX2 protein]; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased acetylation of RUNX2 protein]
Resveratrol results in increased expression of RUNX2 protein
CTD PMID:21239502 PMID:22539994 NCBI chr12:13,723,535...13,842,565
Ensembl chr12:13,628,539...13,840,785
Ensembl chr12:13,628,539...13,840,785
JBrowse link
G SIRT1 sirtuin 1 increases expression
multiple interactions
increases activity
EXP Resveratrol results in increased expression of SIRT1 protein
[[Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein] which results in decreased acetylation of RELA protein; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] which results in decreased activity of EP300 protein; [Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to RUNX2 protein]; Resveratrol inhibits the reaction [Niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]; Resveratrol inhibits the reaction [Niacinamide results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of SIRT1 protein]; Resveratrol promotes the reaction [[SIRT1 protein binds to EP300 protein] which binds to RUNX2 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]; Resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased acetylation of RUNX2 protein]
CTD PMID:21239502 PMID:22539994 NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
JBrowse link
G TNFSF11 TNF superfamily member 11 multiple interactions
decreases response to substance
EXP [Resveratrol promotes the reaction [SIRT1 protein binds to EP300 protein]] inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of RUNX2 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in decreased expression of SIRT1 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased acetylation of and results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased localization of and results in increased activity of RELA protein]; Resveratrol inhibits the reaction [TNFSF11 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
Resveratrol results in decreased susceptibility to TNFSF11 protein
CTD PMID:21239502 NCBI chr22:8,226,931...8,257,926
Ensembl chr22:8,227,555...8,258,645
JBrowse link
rifampicin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases expression EXP Rifampin results in increased expression of ABCB1 mRNA; Rifampin results in increased expression of ABCB1 protein CTD PMID:22620706 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Rifampin results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
JBrowse link
Rilmenidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G REN renin decreases activity EXP Rilmenidine results in decreased activity of REN protein CTD PMID:2866274 NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
JBrowse link
ritonavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP allicin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Ritonavir results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
JBrowse link
salicylamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions EXP [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin CTD PMID:24389113 NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
JBrowse link
saquinavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 affects transport EXP ABCC2 protein affects the transport of Saquinavir CTD PMID:12702717 NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
JBrowse link
SDZ PSC 833 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]; valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Vincristine]; valspodar inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] CTD PMID:15492788 PMID:24975508 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
serotonin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGT angiotensinogen increases response to substance
multiple interactions
EXP AGT protein modified form results in increased susceptibility to Serotonin
Deferoxamine inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]; Reactive Oxygen Species inhibits the reaction [AGT protein modified form results in increased susceptibility to Serotonin]
CTD PMID:8021468 NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
JBrowse link
G EDN1 endothelin 1 increases activity EXP Serotonin results in increased activity of EDN1 protein CTD PMID:9918753 NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
JBrowse link
silodosin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRA1A adrenoceptor alpha 1A multiple interactions EXP silodosin binds to and results in decreased activity of ADRA1A protein; silodosin inhibits the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein] CTD PMID:19371927 NCBI chr25:30,690,959...30,801,484
Ensembl chr25:30,693,571...30,801,486
JBrowse link
simvastatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NOS3 nitric oxide synthase 3 increases expression
decreases expression
EXP Simvastatin results in increased expression of NOS3 protein
Simvastatin results in decreased expression of NOS3 mRNA
CTD PMID:11087217 NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
JBrowse link
sincalide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of Sincalide CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
sodium arsenite term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GSR glutathione-disulfide reductase multiple interactions
decreases activity
EXP [monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] CTD PMID:18163546 NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
JBrowse link
G HSP70 heat shock protein 70 increases expression
multiple interactions
EXP sodium arsenite results in increased expression of HSP70 protein
carvacrol promotes the reaction [sodium arsenite results in increased expression of HSP70 protein]; leucinostatin A promotes the reaction [sodium arsenite results in increased expression of HSP70 protein]
CTD PMID:31940135 NCBI chr12:1,285,282...1,287,670 JBrowse link
sodium chloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 increases expression
multiple interactions
EXP Sodium Chloride results in increased expression of CLDN4 protein
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased expression of CLDN4 protein]
CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
EXP Sodium Chloride results in increased expression of JUN protein
pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]; U 0126 inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]
CTD PMID:23816505 NCBI chr 5:50,966,698...50,968,939 JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation
multiple interactions
EXP Sodium Chloride results in increased phosphorylation of MAPK1 protein
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK1 protein]
CTD PMID:23816505 NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation
multiple interactions
EXP Sodium Chloride results in increased phosphorylation of MAPK3 protein
Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK3 protein]
CTD PMID:23816505 NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
EXP Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein] CTD PMID:23816505 NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 multiple interactions
increases phosphorylation
EXP Acetylcysteine inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]; Glutathione inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:23816505 NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
JBrowse link
G SOD2 superoxide dismutase 2 increases expression EXP Sodium Chloride results in increased expression of SOD2 protein CTD PMID:22718889 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
JBrowse link
G SP1 Sp1 transcription factor multiple interactions
increases expression
EXP pyrazolanthrone inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; pyrazolanthrone inhibits the reaction [Sodium Chloride results in increased expression of SP1 protein]; Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]; U 0126 inhibits the reaction [Sodium Chloride promotes the reaction [SP1 protein binds to JUN protein]]; U 0126 inhibits the reaction [Sodium Chloride results in increased expression of SP1 protein] CTD PMID:23816505 NCBI chr27:1,802,587...1,861,187
Ensembl chr27:1,805,184...1,847,226
JBrowse link
Soman term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase multiple interactions
decreases activity
EXP [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein] CTD PMID:16915560 NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
JBrowse link
G BCHE butyrylcholinesterase decreases activity EXP Soman results in decreased activity of BCHE protein CTD PMID:16915560 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
SR 144528 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CNR2 cannabinoid receptor 2 multiple interactions EXP SR 144528 binds to and results in decreased activity of CNR2 protein CTD PMID:21871882 NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
JBrowse link
styrene oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP3A12 cytochrome P-450 3A12 multiple interactions EXP CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] CTD PMID:12051674
G EPHX1 epoxide hydrolase 1 multiple interactions EXP CYP3A12 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] CTD PMID:12051674 NCBI chr 7:38,964,319...39,004,902
Ensembl chr 7:38,964,338...38,999,238
JBrowse link
succimer term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GSR glutathione-disulfide reductase multiple interactions EXP [monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] CTD PMID:18163546 NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
JBrowse link
succinylcholine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCHE butyrylcholinesterase increases hydrolysis
multiple interactions
EXP BCHE protein results in increased hydrolysis of Succinylcholine
Succinylcholine inhibits the reaction [BCHE protein results in increased hydrolysis of butyrylcholine]
CTD PMID:4985882 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
sulindac term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP Sulindac results in decreased expression of PTGS2 protein CTD PMID:12857884 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit decreases localization EXP Sulindac results in decreased localization of RELA protein CTD PMID:12857884 NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
JBrowse link
taurocholic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLCO1B2 solute carrier organic anion transporter family member 1B2 increases transport EXP SLCO1B3 protein results in increased transport of Taurocholic Acid CTD PMID:20079461 NCBI chr27:26,411,008...26,496,174
Ensembl chr27:26,411,010...26,470,989
JBrowse link
tebuconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A2 solute carrier family 22 member 2 decreases activity EXP tebuconazole results in decreased activity of SLC22A2 protein CTD PMID:36669674 NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
JBrowse link
G SLC22A5 solute carrier family 22 member 5 decreases activity EXP tebuconazole results in decreased activity of SLC22A5 protein CTD PMID:36669674 NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases activity EXP tebuconazole results in decreased activity of SLC47A1 protein CTD PMID:36669674 NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
JBrowse link
G SLC47A2 solute carrier family 47 member 2 decreases activity EXP tebuconazole results in decreased activity of SLC47A2 protein CTD PMID:36669674 NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
JBrowse link
Temocaprilat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 affects transport EXP ABCC2 protein affects the transport of temocaprilat CTD PMID:15507541 NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
JBrowse link
tert-butyl hydroperoxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDKN2A cyclin dependent kinase inhibitor 2A decreases expression EXP tert-Butylhydroperoxide results in decreased expression of CDKN2A protein CTD PMID:14729356 NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha increases expression
decreases expression
EXP tert-Butylhydroperoxide results in increased expression of GADD45A protein
tert-Butylhydroperoxide results in decreased expression of GADD45A protein
CTD PMID:14729356 NCBI chr 6:77,393,026...77,396,473
Ensembl chr 6:77,393,036...77,396,618
JBrowse link
G TERT telomerase reverse transcriptase increases activity EXP tert-Butylhydroperoxide results in increased activity of TERT protein CTD PMID:14729356 NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951
JBrowse link
testosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G B9D2 B9 domain containing 2 increases expression EXP Testosterone results in increased expression of TGFB1 mRNA CTD PMID:17157324 NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
JBrowse link
G KCND3 potassium voltage-gated channel subfamily D member 3 increases expression EXP Testosterone results in increased expression of KCND3 protein CTD PMID:17054656 NCBI chr17:63,470,829...63,668,354
Ensembl chr17:63,470,415...63,668,035
JBrowse link
G KCNJ2 potassium inwardly rectifying channel subfamily J member 2 increases expression EXP Testosterone results in increased expression of KCNJ2 protein CTD PMID:17054656 NCBI chr 9:16,468,938...16,475,722
Ensembl chr 9:16,468,938...16,475,722
JBrowse link
tetradecanoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Myristic Acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
thapsigargin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression EXP Thapsigargin results in increased expression of HSPA5 protein CTD PMID:17416481 NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
JBrowse link
tolfenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression EXP tolfenamic acid results in decreased expression of PTGS2 mRNA CTD PMID:15198222 NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
JBrowse link
toluene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C41 cytochrome P450 2C41 affects metabolic processing EXP CYP2C11 protein affects the metabolism of Toluene CTD PMID:8592870
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions
affects metabolic processing
EXP Ditiocarb inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene]; Fomepizole inhibits the reaction [CYP2E1 protein affects the metabolism of Toluene] CTD PMID:8592870 NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
JBrowse link
toosendanin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BAX BCL2 associated X, apoptosis regulator increases expression EXP toosendanin results in increased expression of BAX mRNA; toosendanin results in increased expression of BAX protein CTD PMID:36809669 NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression EXP toosendanin results in decreased expression of BCL2 mRNA; toosendanin results in decreased expression of BCL2 protein CTD PMID:36809669 NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
JBrowse link
G CASP3 caspase 3 increases cleavage EXP toosendanin results in increased cleavage of CASP3 protein CTD PMID:36809669 NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
JBrowse link
G CASP9 caspase 9 increases cleavage EXP toosendanin results in increased cleavage of CASP9 protein CTD PMID:36809669 NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
JBrowse link
G CYCS cytochrome c, somatic multiple interactions EXP toosendanin results in increased expression of and affects the localization of CYCS protein CTD PMID:36809669 NCBI chr14:38,579,446...38,581,983
Ensembl chr14:38,579,446...38,581,983
JBrowse link
G TP53 tumor protein p53 increases expression EXP toosendanin results in increased expression of TP53 mRNA; toosendanin results in increased expression of TP53 protein CTD PMID:36809669 NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
JBrowse link
triticonazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A5 solute carrier family 22 member 5 decreases activity EXP triticonazole results in decreased activity of SLC22A5 protein CTD PMID:36669674 NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases activity EXP triticonazole results in decreased activity of SLC47A1 protein CTD PMID:36669674 NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
JBrowse link
troleandomycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Troleandomycin results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
JBrowse link
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase multiple interactions EXP [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein] CTD PMID:16915560 NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
JBrowse link
G SCT secretin multiple interactions EXP Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates] CTD PMID:3562434
uniconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A5 solute carrier family 22 member 5 decreases activity EXP uniconazole results in decreased activity of SLC22A5 protein CTD PMID:36669674 NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases activity EXP uniconazole results in decreased activity of SLC47A1 protein CTD PMID:36669674 NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
JBrowse link
urea term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CLDN4 claudin 4 increases expression EXP Urea results in increased expression of CLDN4 protein CTD PMID:23816505 NCBI chr 6:6,492,706...6,506,750
Ensembl chr 6:6,493,513...6,494,145
JBrowse link
G SOD2 superoxide dismutase 2 increases expression EXP Urea results in increased expression of SOD2 protein CTD PMID:22718889 NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
JBrowse link
UTP term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G P2RY2 purinergic receptor P2Y2 multiple interactions
increases activity
EXP [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid; [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] CTD PMID:10604969 NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
JBrowse link
valproic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHRS4 hydrogenase/reductase 4 decreases activity EXP Valproic Acid results in decreased activity of DHRS4 protein CTD PMID:17827741 NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
JBrowse link
vasopressin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G INS insulin multiple interactions EXP INS protein promotes the reaction [Sodium results in increased abundance of Vasopressins] CTD PMID:1324617 NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
JBrowse link
verapamil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions EXP [Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin CTD PMID:20510202 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
vincristine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases export
multiple interactions
affects response to substance
EXP ABCB1 protein results in increased export of Vincristine
valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Vincristine]
CTD PMID:24975508 PMID:28093773 NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 decreases response to substance EXP ABCC1 protein results in decreased susceptibility to Vincristine CTD PMID:12516967 NCBI chr 6:27,855,702...27,950,140
Ensembl chr 6:27,855,702...27,989,331
JBrowse link
vitamin E term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TNF tumor necrosis factor multiple interactions EXP Vitamin E inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] CTD PMID:14973143 NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
JBrowse link
vorinostat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASQ1 calsequestrin 1 decreases expression EXP Vorinostat results in decreased expression of CASQ1 mRNA CTD PMID:27255383 NCBI chr38:22,012,060...22,020,430
Ensembl chr38:22,011,060...22,020,383
JBrowse link
G HSP70 heat shock protein 70 decreases expression EXP Vorinostat results in decreased expression of HSP70 mRNA CTD PMID:27255383 NCBI chr12:1,285,282...1,287,670 JBrowse link
G TNNI3K TNNI3 interacting kinase decreases expression EXP Vorinostat results in decreased expression of TNNI3K mRNA CTD PMID:27255383 NCBI chr 6:71,825,853...72,107,832
Ensembl chr 6:71,815,734...72,119,476
JBrowse link
VX nerve agent term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase multiple interactions
decreases activity
EXP [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX-agent results in decreased activity of ACHE protein] CTD PMID:16915560 NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
JBrowse link
G BCHE butyrylcholinesterase decreases activity EXP VX-agent results in decreased activity of BCHE protein CTD PMID:16915560 NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
JBrowse link
WIN 55212-2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CNR2 cannabinoid receptor 2 affects binding EXP (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone binds to CNR2 protein CTD PMID:21871882 NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
JBrowse link
YM-254890 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HEXB hexosaminidase subunit beta multiple interactions EXP YM-254890 inhibits the reaction [mastoparan results in increased secretion of HEXB protein] CTD PMID:21671308 NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
JBrowse link
yohimbine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions EXP Yohimbine inhibits the reaction [[Clonidine results in increased activity of PIK3CG protein] which results in increased chemical synthesis of phosphatidylinositol 3-phosphate]; Yohimbine inhibits the reaction [Clonidine results in increased activity of PIK3CG protein] CTD PMID:15958164 NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
JBrowse link
G PRKCZ protein kinase C zeta multiple interactions EXP Yohimbine inhibits the reaction [Clonidine results in increased phosphorylation of PRKCZ protein] CTD PMID:15958164 NCBI chr 5:57,012,020...57,113,346
Ensembl chr 5:57,012,070...57,112,664
JBrowse link
zearalenone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCG2 ATP binding cassette subfamily G member 2 increases transport EXP ABCG2 protein results in increased transport of Zearalenone CTD PMID:30576553 NCBI chr32:11,443,778...11,517,674
Ensembl chr32:11,443,780...11,517,674
JBrowse link
zileuton term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase decreases activity EXP zileuton results in decreased activity of ALOX5 protein CTD PMID:1618819 NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 1276
    chemical entity 1276
      atom 1276
        s-block element atom 1218
          s-block molecular entity 1218
            alkali metal molecular entity + 11
            alkaline earth molecular entity + 7
            helium molecular entity + 0
            hydrogen molecular entity + 1218
Path 2
Term Annotations click to browse term
  CHEBI ontology 1276
    subatomic particle 1276
      composite particle 1276
        hadron 1276
          baryon 1276
            nucleon 1276
              atomic nucleus 1276
                atom 1276
                  main group element atom 1269
                    main group molecular entity 1269
                      s-block molecular entity 1218
                        alkali metal molecular entity + 11
                        alkaline earth molecular entity + 7
                        helium molecular entity + 0
                        hydrogen molecular entity + 1218
paths to the root